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ABSTRACT

ABSTRACT
Oxygen deficiency, known as hypoxia, in arterial walls has been linked to increased
intimal hyperplasia, which is the main adverse biological process causing in-stent
restenosis. Stent implantation can have significant effects on the oxygen transport into
the arterial wall. Helical flow has been theorised to improve the local haemodynamics
and the oxygen transport within stented arteries.
In this study an advanced oxygen transport model was developed to assess different
stent designs. This advanced oxygen transport model incorporates both the free and
bound oxygen contained in blood and includes a shear-dependent dispersion coefficient
for red blood cells. In two test cases undertaken the results predicted by the advanced
oxygen transport model were compared those predicted by simpler models, and in vivo
measurements. Two other test cases analysed the predicted oxygen transport in three
different stent designs, and the effects of helical flow on the haemodynamics and
oxygen transport in stented coronary arteries.
The advanced model showed good agreement with experimental measurements within
the mass-transfer boundary layer and at the luminal surface; however, more work is
needed for predicting the oxygen transport within the arterial wall. Simplifying the
oxygen transport model within the blood produces significant errors in predicting the
oxygen transport in arteries. It was found that different stent designs can produce
significantly different amounts of hypoxic regions within the stented region.
Additionally, helical flow increases the amount of oxygen transferred into the arterial
wall, but only in a helical ribbon through the stented region that also experiences high
wall shear stress spatial gradients.
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Abbreviations
RBC

Red blood cells

VSMC

Vascular smooth muscle cell

EC

Endothelial cell

CFD

Computational fluid dynamics

FEA

Finite element analysis

MI

Myocardial infarction

CABG

Coronary artery bypass graft

PTCA

Percutaneous transluminal coronary angioplasty

BMS

Bare metal stent

DES

Drug eluting stent

CAD

Coronary artery disease

ISR

In-stent restenosis

DAPT

Dual antiplatelet therapy

WSS

Wall shear stress

WSSG

Wall shear stress gradient

WSSAG

Wall shear stress angle gradient

OSI

Oscillatory shear index

RRT

Relative residence time

SS

Shear Stress

IEL

Internal elastic lamina

EEL

External elastic lamina

ICAM-1

intercellular adhesion molecule 1
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VCAM-1

Vascular cell adhesion molecule 1

GP

Glycoprotein

NO

Nitric oxide

CO2

Carbon dioxide

ECM

Extracellular matrix

MAC-1

Macrophage-1 antigen

NIH

Neointimal hyperplasia

IH

Intimal hyperplasia

PDGF

Platelet-derived growth factor

MMP-9

Matrix metalloproteinase-9

bFGF

Basic fibroblast growth factor

G-CSF

Granulocyte colony-stimulating factor

SPC

Smooth muscle progenitor cells

TGF

Transforming growth factor

VEGF

Vascular endothelial growth factor

EC-CFU

Endothelial cell colony forming units

EPC

Endothelial progenitor cells

MTBL

Mass transport boundary layer

Da

Damkohler number

Sc

Schmidt Number

C

Concentration of oxygen

RCA

Right coronary artery

LCA

Left coronary artery

LCX

Left circumflex artery
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CT

Computed tomography

MRI

Magnetic resonance imaging

SMAHT

Small amplitude helical technology

ePTFE

expanded polytetrafluorethylene

VFT

Vascular Flow Technologies

ICHEC

Irish Centre for High-End Computing

CPU

Central processing unit

RAM

Random access memory

2D

Two-dimensional

3D

Three-dimensional

CCA

Common carotid artery

ICA

Internal carotid artery

ECA

External carotid artery

Scalars
u,v,w

Velocity magnitudes in x, y, and z directions

t

Time

dt

Infinitesimally small increment of time

dα,dβ

Infinitesimally small angles of rotation

ds

Infinitesimally small surface area

μ

Dynamic viscosity



Shear rate

t

Time constant

n

Power law index (Bird-Carreau)

Hk

Kinetic helicity density
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LNH

Local normalised helicity

PO2

Oxygen tension in plasma

α

Solubility of oxygen in plasma

C

Concentration of free oxygen in plasma

S

Saturation of haemoglobin in RBCs

n

Hill parameter (Hill equation)

Db

Diffusivity of free oxygen in blood

r

Rate of release of oxygen from haemoglobin

[Hb]

Total oxygen carrying capacity of haemoglobin

Dc

Diffusivity of oxyhaemoglobin in blood

D’

Diffusivity coefficient of PO2 in blood

M

Michaelis-Menten consumption rate of oxygen

M0

Maximum consumption rate

DT

Diffusivity of oxygen in arterial wall tissue

T

Solubility of oxygen in arterial wall tissue

Sh

Sherwood number

PO2

Partial pressure of dissolved oxygen

Dia

Diameter of artery

Da

Damkholer number

ρ

Density

fb

Body forces exerted on fluid element

g

Gravity constant



Conserved variable

eff

Effective diffusivity
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S

Source term

 (Section 3.6.2)

Blend factor

rn

Residual

Vectors

V

Velocity vector

i, j,k

Cartesian unit vectors

ω

Rate of rotation vector

ζ

Vorticity vector



Del operator

ni

Normal vector

r

Vector from upwind node to integration point

[]

Solution vector

Second-order tensors

ε ij

Strain rate tensor

σ ij

Stress tensor

τ ij

Viscous stress tensor

Matrices
[A]

Sparse coefficient matrix

Subscripts
v

Volume

s

Surface

in

Inlet

x

NOMENCLATURE

out

Outlet

w

Wall

up

Upwind node

ip

Current node
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Background Material

Introduction

This chapter provides the initial background material required for this project. First, the
cardiovascular system is introduced with specific reference to the heart, blood, coronary
arteries, and cardiac veins. Following this, the burden of coronary artery disease (CAD)
is highlighted along with the biological understanding of how atherosclerotic lesions
form and their classifications. The available treatments for CAD are listed and
described. One treatment option, specifically relevant, is angioplasty with stenting
which is considered the standard treatment for patients with CAD presenting with either
stable or unstable angina, or with acute myocardial infarction (MI).178 The history and
current status of stent technology is discussed briefly with a mention of one limitation
of stent technology which is the re-narrowing of the stented artery post-implantation,
known as in-stent restenosis (ISR) (this is discussed in greater detail in Chapter 2).
Hypoxia is briefly described followed by the reasoning behind using computational
software for prediction of hypoxic regions and in the analysis of stent designs. A brief
introduction to helical flow is given which is directly linked to one of the aims of this
research. Finally, the aims, structure, novelty and contribution, and relevant publications
of this research are highlighted.
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1.2

Cardiovascular System

As a whole, the cardiovascular system is responsible for the transportation of oxygen,
carbon dioxide (CO2), nutrients, hormones, chemical messengers, immune cells, stem
cells, platelets, proteins, and waste products throughout the body, as well as acting as a
system for temperature regulation. The cardiovascular system comprises the heart,
approximately five litres of blood and the blood vessels.

1.2.1

Blood

Blood consists of liquid plasma in which three types of cellular elements are suspended:
red blood cells (RBCs), white blood cells (leukocytes) and platelets. Plasma is a dilute
electrolyte solution mainly composed of water (approximately 95% by volume) which
contains about 8% by weight of proteins (fibrinogen, globulin, prothrombin, and
albumin), as well as glucose, clotting factors, hormones, and dissolved oxygen and CO2.
About 45% by volume of the blood consists of cellular elements with RBCs constituting
about 95% of the cellular elements, leukocytes constituting about 0.13% of the cellular
elements, and platelets constituting the remaining 4.9%.121 RBCs are the main carriers
of oxygen in the blood. Leukocytes are responsible for fighting infections and disposing
of damaged cells. Platelets are part of the primary response to injury of the arterial wall
and form a critical element of the initial healing process following injury.

1.2.2

Heart

The heart is a muscular organ that serves to pump blood around the vessels and beats
approximately 100,000 times per day, continuously, for the duration of a person’s life.
The human heart is approximately the size of two hands entwined and is located just
left-of-centre in the upper chest cavity. The heart is comprised of four chambers: the left
ventricle and atrium, and the right ventricle and atrium, as shown in Figure 1.1. Both
2
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atria are thin-walled, low-pressure chambers that act predominantly as reservoirs for the
two ventricles, which act as the pumping chambers.
The cardiovascular system can be divided into the pulmonary circulation and the
systemic circulation, which are linked through these four chambers of the heart. The
pulmonary circulation is primarily responsible for the exchange of oxygen and CO2
with the atmosphere through the lungs, and the systemic circulation delivers oxygenated
blood to the body’s cells and returns deoxygenated blood back to the heart.
The pulmonary circulation begins in the right ventricle where the blood is propelled into
the pulmonary artery. The pulmonary artery feeds into the lungs where the blood is
oxygenated and then returns to the left atrium in the heart through the pulmonary veins.
From here the oxygenated blood enters the left ventricle, the systemic circulation
pumping chamber, which propels the blood out into the aorta. Through a network of
connected arteries, arterioles and capillaries it is then distributed to every part of the
body. It is predominantly as the blood passes through the capillaries that the oxygen
leaves the blood and diffuses out into the surrounding tissue. The deoxygenated blood
then returns to the right atrium of the heart through the connected capillaries, venules
and veins, completing the systemic circulation. The deoxygenated blood then enters the
right ventricle of the heart to begin the pulmonary circulation again.

3

CHAPTER 1: Background Material

Aortic Arch

Superior
Vena Cava

Left
Pulmonary
Arteries

Right
Pulmonary
Arteries

Left
Pulmonary
Veins

Right Atrium

Left Atrium

Pulmonary
Valve

Mitral
Valve

Tricuspid
Valve
Right Ventricle

Left Ventricle

Inferior
Vena Cava

Descending
Aorta

Figure 1.1: A cross-section of the human heart with the relevant chambers,
arteries, veins and valves annotated. The path of the blood flow is marked by blue
(deoxygenated) and red (oxygenated) arrows.154

The four chambers of the heart are separated by four valves which help control the flow
of the blood through the heart. The right atrium receives the deoxygenated blood back
from the systemic circuit through the superior vena cava and the inferior vena cava. The
right atrium is separated from the right ventricle by the tricuspid valve which is
composed of three fibrous flaps. These flaps are connected to papillary muscles on the
inner wall of the right ventricle which open when the right ventricle is expanding
allowing blood to flow through from the right atrium. Once at full capacity the right
ventricle then contracts, the tricuspid valve closes preventing blood back-flow into the
right atrium and the pulmonic valve opens, allowing the blood to pass into the right and
4

CHAPTER 1: Background Material

left pulmonary arteries feeding the lungs. The oxygenated blood then returns to the left
atrium through the right and left pulmonary veins. The mitral valve, which is composed
of two flaps connected to papillary muscles on the inner wall of the left ventricle and
separates the left atrium from the left ventricle, remains closed until shortly after the left
ventricle begins to expand. Once the expansion of the left ventricle is complete and it
begins to contract, the mitral valve closes, preventing back-flow of the blood into the
left atrium, and the aortic valve opens. The blood then flows into the aortic arch and on
into the rest of the systemic circulation.
The walls of the heart are composed of three layers: the epicardium, the myocardium
and the endocardium. The epicardium is a smooth membrane that covers the outer
surface of the heart. The myocardium is the muscular wall of the heart which forms the
four chambers. Within this layer is the cardiac muscle, the blood vessels which feed
these muscles and the nerves which help control the muscles. The endocardium is a
layer of cells, similar to endothelial cells (ECs) discussed later, which covers the inner
surfaces of the four chambers and the valves and serves to protect the underlying
muscle. The two ventricles differ in size with the muscular walls of the left ventricle
thicker than the right. This is because of the extent of the vascular network and its
respective resistance which needs to be overcome in order to pump the blood around the
body compared with the resistance experienced through the lungs.

1.2.3

The Coronary Arteries

The muscles of the heart need to be constantly supplied with oxygen and nutrients to
maintain their functionality, and this is accomplished by the coronary arteries. The
coronary arteries originate at the base of the ascending aorta, immediately downstream
of the aortic valve, and follow the curvature of the outer surface of the heart muscle.
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There are two coronary arteries: the left and the right with their origins in the aortic arch
as shown in Figure 1.2. The right coronary artery (RCA) supplies blood to right atrium,
portions of both ventricles and areas of the heart which deal with regulating the heart
rate. The RCA gives rise to one or more marginal arteries and also supplies the posterior
descending artery as shown in Figure 1.3. The left coronary artery (LCA) supplies blood
to the left atrium and ventricle, and the wall which divides the two ventricles. The artery
itself gives rise to the circumflex artery (LCX) and also the left anterior descending
artery (LAD). There are some interconnections between the left and right coronary
arteries which help keep the blood supply constant despite fluctuations between heart
beats which can be seen in Figure 1.2.

Aortic Arch
LCA

LCX
RCA
Anterior
Interventricular
Artery
Great Cardiac
Vein

Atrial
Arteries
Anterior
Cardiac Veins
Small Cardiac
Vein

Figure 1.2: Coronary vessels supplying and draining blood to the anterior surface
of the heart.154
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Figure 1.3: Coronary vessels supplying and draining blood to the posterior surface
of the heart.154
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Figure 1.4: Typical arterial wall composition.154
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All arterial walls, including those of the coronary arteries, are composed of three
separate layers: the intima, media and adventitia, as shown in Figure 1.4. The intima is
the inner layer of the arterial wall and is comprised of an endothelium, a thin basement
membrane and a thin layer of elastic fibres called the internal elastic lamina (IEL). The
endothelium, comprised of ECs lining the luminal surface, serves several important
functions: to present a smooth surface to the blood flow, regulate the influx of
molecules from the blood into the arterial wall, control the tone of the smooth muscle
cells within the arterial wall and respond to changes in the local haemodynamic
environment.205 The basement membrane supports the endothelium and regulates
molecular movement. The IEL acts as the boundary between the intima and the media.
The media is commonly the thickest layer and is comprised of several concentric sheets
of vascular smooth muscle cells (VSMCs) contained within a framework of
extracellular matrix. The extracellular matrix is predominantly composed of elastin and
collagen which provides support for the VSMCs and forms the primary load-bearing
components of the arterial wall.40 The elastin fibres provide a degree of compliance in
the artery allowing for the changes in pressure throughout the cardiac cycle. The
VSMCs are responsible for changing the calibre of the arteries by contracting, causing
vasoconstriction of the vessel, and relaxing, causing vasodilation of the vessel. Chronic
vasoconstriction can lead to high blood pressure (hypertension) and excessive
vasodilation can occur when a patient goes into shock and leads to low blood pressure.
The media is separated from the adventitia by the external elastic lamina. The adventitia
consists of elastin and collagen fibres, with nerves and small capillaries running through
it. These small capillaries are known as vasa vasorum (vessels within vessels) and are
critical in providing oxygen to the cells contained within the media.
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1.2.4

The Cardiac Veins

The blood which supplies the heart muscles with oxygen and nutrients is drained away
by a series of veins which include the great cardiac vein, the posterior cardiac vein, the
middle cardiac vein, the small cardiac vein and the anterior cardiac veins. Each of which
drain the blood away from different areas of the heart and empty into the coronary
sinus, which in turn empties into the right atrium, near the base of the vena cava. The
cardiac veins contain valves to prevent blood backflow and typically are not prone to
atherosclerotic plaque development.
1.3

Coronary Artery Disease

In order for the heart to function properly its muscles must receive a constant supply of
blood. Restriction of the blood flow to the heart muscles can result in the muscles dying
due to lack of oxygen. This is called myocardial infarction, or death of the myocardial
muscle, and can be fatal. Coronary artery disease refers to areas within the coronary
arteries where the blood flow is partially or fully blocked, and is predominantly caused
by atherosclerosis. The risk factors for CAD include, but are not limited to poor diet,
smoking, lack of exercise, obesity, diabetes, genetic predisposition to CAD,
hypertension and high cholesterol.77 Atherosclerosis is characterised by the build-up of
fatty plaque deposits or lesions within the arterial wall of the coronary artery. Reasons
why some regions within arteries are more prone to atherosclerosis compared with
others is not known, although it is thought to be related to the haemodynamic features.24
To understand the process through which atherosclerotic lesions develop it is first
required to look at the formation of lipoproteins in the liver and small intestine. Lipids,
of which cholesterol is one, are not commonly water soluble and, consequently, do not
dissolve in the blood. The body needs cholesterol for many functions, including the
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maintenance of cell membranes and the production of crucial hormones and vitamins.
Therefore, it needs to transport it around the body within the blood. To make cholesterol
more dissolvable in blood, and hence easier to transport, it is combined with
lipoproteins in the liver. The two main lipoproteins are low-density lipoproteins (LDLs)
and high-density lipoproteins (HDLs). LDLs have been implicated in the development
of atherosclerotic lesions and HDLs, though, remove excess cholesterol from cells and
transport it to the liver for elimination.
Figure 1.5 shows the typical progression of an atherosclerotic lesion over time. An
atherosclerotic lesion begins when excess LDLs penetrate the arterial wall under the
endothelium and accumulate within the intima. This penetration of the endothelium by
LDLs has been linked to a dysfunctional endothelium possibly caused by proatherogenic local haemodynamics; however, what constitutes pro-atherogenic local
haemodynamics is debateable.161 The lipids and proteins in the LDLs then begin to
oxidise, i.e. lose electrons, and bind to sugars within the arterial wall. In response the
ECs on the surface and the VSMCs within the media release chemical messengers
which attract monocytes (a type of leukocyte) from the blood into the wall, where they
change to macrophages. These macrophages then begin consuming the oxidised LDL
particles. After a period of time the macrophages become laden with these LDL
particles, developing into foam cells. Another type of leukocyte, i.e. T-cells, are also
among the first cells to be recruited within the atheroma and by releasing cytokines
further increase the inflammatory response.2
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Time Progression
Figure 1.5: A typical progression of an atherosclerotic lesion over time (adapted
from Koenig and Khuseyinova.123

The cytokines released by the macrophages encourage the proliferation and migration of
VSMCs from the media into the intima.254 The migrated VSMCs can then form a cap
over the plaque, separating it away from the lumen. Through this remodelling of the
arterial wall the calibre of the lumen can be maintained and the lesion has less impact on
the blood flow. However, this method of mitigating the effects of the lesion only
functions up to when the lesion occupies 40% of the area encompassed by the IEL. 76
After this, the arterial wall can no longer accommodate the lesion growth and the lesion
begins to grow into the lumen; thus, it increasingly restricts the blood flow downstream.
In advanced lesions the macrophages undergo apoptosis, i.e. programed death, which
can lead to the development of a necrotic core when they are not properly cleared away.
The necrotic core can slowly expand over time and result in the disruption of the plaque
stability and acute thrombosis.175 When the fibrous cap over the atherosclerotic plaque
ruptures, releasing thrombotic agents from the T-cells into the blood stream, this results
in the instigation of a thrombotic cascade and the formation of clots and emboli, which
block the vessels downstream, resulting in MI.
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1.3.1

Classification of Atherosclerotic Lesions

Stary et al. classified atherosclerotic lesions into eight types according to the stage of
development:


Type I: the lesion contains enough atherogenic LDLs to encourage increased
macrophage infiltration and there is evidence of isolated macrophage foam cells



Type II: the lesions primarily contain layers of macrophages and lipid-laden
VSMCs



Type III: an intermediary stage between Type II and IV, consists of scattered
collections of extracellular lipid droplets which can not only disrupt the
coherence of the VSMCs but also are precursors to more serious Type IV lesions



Type IV: presence of lipid core and a fibrous cap



Type V: lipid core with thick layers of fibrous connective tissue and possibly
calcific lesion



Type VI: lipid core with fissure, hematoma and thrombus



Type VII: calcification predominates, possibly replacing the accumulated
remnants of dead cells and extracellular lipid



Type VIII: fibrous tissue changes predominate with the normal intima replaced
and thickened with fibrous connective tissue.238

1.4

Treatment of CAD

The type of treatment to be recommended for CAD is predominantly based on how far
the disease has progressed, or essentially how severe the atherosclerotic lesion, or
lesions, has developed. In the initial stages of the disease lifestyle changes are the
recommended treatment. These include quitting smoking, regular exercise, eating
healthily, losing excess weight and reducing stress. Additionally, drugs may be
12
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prescribed, such as statins, which lower the level of LDLs in the blood, or aspirin,
which helps to thin the blood, reducing its tendency to clot. If these measures fail to
produce satisfactory outcomes further treatment is recommended in the form of a
coronary artery bypass graft (CABG) or angioplasty, with or without stenting.

1.4.1

Coronary Artery Bypass Graft

In the case of atherosclerotic lesions in the later stages of development, where the
restriction or narrowing of the coronary artery is considerable, more immediate and
aggressive treatment is needed. CABG is one of the treatments offered to patients with
stable angina and suitable coronary anatomy where their symptoms are not satisfactorily
controlled by lifestyle changes and medication.179 CABG is classed as a major surgery
as it is termed open-heart surgery, meaning the risk of infection post-surgery is not
negligible. CABG is generally recommended over angioplasty in cases of multi-vessel
coronary disease where it is seen to lead to a reduction in long-term mortality, MI and
repeat revascularisations.87,233 Guidelines for managing stable angina recommend that
both options are presented and discussed with patients, as there are other factors, such
as diabetes, which can affect the decision.179 The procedure itself involves opening the
patient’s chest and sternum, exposing the heart, stopping the heart and keeping the
blood pumping through a mechanical pump. Once this is achieved a blood vessel is
taken from another part of the body and used to bypass the site of the restriction(s).
Originally the greater saphenous vein from the leg was the vessel of choice for the
bypass graft; however, the internal mammary arteries from the chest or the radial artery
from the forearm are currently favoured as they are less likely to re-block. Previously,
the only treatment option in the late stages of CAD, CABG has seen a decline in use
since the introduction of angioplasty.233
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1.4.2

Angioplasty

Balloon angioplasty was developed by Charles Dotter in the 1960s as a minimally
invasive treatment for arterial narrowing caused by atherosclerotic lesions in the
peripheral arteries.54 Later, in the 1970s, it was applied to renal, coronary and iliac
arteries by Andreas Gruentzig and co-workers.83–85 The procedure is also referred to as
percutaneous transluminal coronary angioplasty (PTCA). It involves making a small
incision in the groin to gain access to the femoral artery (or in the arm to gain access to
the radial artery) whereupon a hollow tube, called a catheter, is threaded up through the
femoral artery, the iliac artery, the descending aorta, around the aortic arch, through to
the ascending aorta and down into the relevant coronary artery. Once within the
coronary artery a contrast agent is injected into the catheter and released into the
coronary artery. This helps highlight the site of the restriction or narrowing on an X-ray
to the cardiologist, who then feeds the tip of the catheter to the site. Once in position, a
balloon on the end of the catheter is inflated, pushing the plaque out against the arterial
wall and restoring blood flow to the tissue downstream.
Re-blockage of a treated coronary artery following this procedure, known as restenosis,
was reported in 30-60% of patients,73 with these patients consequently needing retreatment with either additional percutaneous methods or bypass surgery. Restenosis
following balloon angioplasty is attributed to three key responses: acute elastic recoil,
negative wall remodelling (reduction in lumen area without a change in wall mass) and
arterial wall thickening into the lumen (due to an increase in the number of cells within
the arterial wall).
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1.4.3

Angioplasty with Stenting

Bare metal stents (BMS) were first used in an angioplasty procedure by Puel and
Sigwart in 1986,230 and were gradually incorporated in the 1990s to serve as a rigid
scaffold, thus eliminating elastic recoil and reducing wall remodelling, 92 with some
cases of positive remodelling reported.176 A stent, generally, is a cylindrical metal mesh
that is crimped onto the angioplasty catheter, which upon expansion of the catheter
balloon is expanded radially out against the arterial wall. BMSs are commonly made of
316L stainless steel, platinum-iridium alloy, tantalum, cobalt-chromium alloy, titanium,
pure iron, magnesium alloys or nitinol.147
The most common type of stent is balloon expandable, although nitinol stents are selfexpanding. Self-expanding stents make use of the superelastic behaviour of the nitinol
material, whereby the stent can transition between a strong Austenite phase and a
weaker Martensite phase when stressed. For implantation of these stents a balloon is not
needed and instead a sheath is withdrawn and the stent expands to a predetermined
shape; however, balloon angioplasty may be carried out prior to implantation. Even
though stenting reduced restenosis rates to between 22% and 32%, 61,73,223 it still
continued to be a burden. Restenosis with stents, known as ISR, is mostly due to arterial
wall thickening. Understanding and consequently devising ways of reducing the
frequency of ISR has been a continuing goal of research into improved stent designs.
From this research drug-eluting stents (DES) were developed which use antiproliferative, immunosuppressive, pro-healing and anti-inflammatory drugs in an
attempt to prevent ISR. DESs have proved effective, with ISR rates at six-month
follow-up as low as 2.6-10.1%.240 As a result, DESs have surpassed BMSs as the
preferred stent choice, with 70-80% of stent procedures in the US carried out with DESs
by mid-2009.67,125 However, ISR is still a problem along with stent thrombosis, and
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delayed re-endothelialisation (re-growth of the endothelium) due to the antiproliferative properties of some DES drugs.70 Newer stents currently in development or
undergoing clinical trials are predominantly variations of the DES design with
perceived improvements, such as biodegradable polymer and polymer-free coatings,
novel coatings which encourage re-endothelialisation, and completely biodegradable
platforms.98,163 However, there are other ideas for reducing ISR which are beginning to
show promise, based on the fact that the biological healing response to stent
implantation is partially dependent on local haemodynamics in the stented artery. These
will be discussed in detail in Chapter 4. BMSs are still implanted in patients with a high
bleeding risk or who may not be able to conform to dual antiplatelet therapy (DAPT)
required post-implantation. Therefore, research into how to improve the long-term
outcomes of angioplasty with stenting using means other than drugs is warranted.
1.5

Hypoxia

The delivery of oxygen to the cells within an arterial wall is crucial to maintaining a
healthy artery. The blood passing through the vasa vasorum within the adventitia
supplies most of the oxygen needed to the media, and the intima is predominantly
supplied through diffusion from the blood contained within the central lumen Hypoxia,
a deficiency in the amount of oxygen reaching the cells within the arterial wall, has been
found to exacerbate some of the biological processes which can result in ISR.20,134,215,216
The amount of oxygen diffusing into the arterial wall can be affected by the
haemodynamic conditions within the lumen.
The geometry of an implanted stent can have a significant impact on the haemodynamic
conditions within the artery. The main beneficial effect is the restoration of blood to the
downstream vasculature; however, locally within the stented region recirculation zones
can be created around stent struts which can influence the amount of oxygen reaching
16

CHAPTER 1: Background Material

the underlying arterial wall cells. Predicting the amount of oxygen that reaches the
arterial wall cells is valuable so that the design of stents, and other medical devices, can
be improved upon.
1.6

Computational Analysis of Coronary Stents

With the aforementioned dependency of the biological processes that can result in ISR
on the local haemodynamics and oxygenation of the arterial wall, analysis of these
features is required. Given the small size of the coronary arteries and the scale of the
haemodynamic features that takes place within the artery computational analysis
techniques have proved to be powerful tools. Considering the complexity of the
biological processes that take place within a coronary artery, with a degree of
simplification computational techniques can focus on certain aspects of the physical
phenomena and help predict the impact of stents on the artery environment.
Traditionally, there are two aspects which are focused upon using computational
analysis: the structural injury inflicted on the arterial wall and the luminal
haemodynamic environment created by stent implantation. The stresses placed upon an
arterial wall by stent implantation, which inflict the structural injury, are analysed using
advanced finite element analysis (FEA) software and the local haemodynamics are
analysed using computational fluid dynamics (CFD).
For predicting the oxygen transport in arteries there are three types of studies which are
commonly employed: lumen-free analyses, wall-free analyses and lumen-wall coupled
analyses. In lumen-free analyses a constant value for oxygen concentration is imposed
on the luminal surface; hence, the impact of the blood flow is neglected. For wall-free
analyses a constant oxygen concentration value is applied on the luminal surface and the
oxygen flux into the wall is quantified using a dimensionless variable, the Sherwood
number (discussed in more detail in Section 3.4). Finally, lumen-wall coupled analyses
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are beneficial because the unrealistic assumption of a constant oxygen concentration on
the luminal surface is not made and a more detailed indication of oxygen concentration
levels, and consequently the extent of hypoxia, within the arterial wall is given.
1.7

Helical Flow

Local hemodynamics have a significant influence on the cellular activity within an
arterial wall. Atherosclerosis has been found to preferentially develop in areas of
disturbed flow and regions of low wall shear stress (WSS).59,176,182,183,185 Natural blood
flow in the arterial system has been found to be helical in nature, meaning it has a
secondary circular motion in addition to the primary forward motion. The
beneficial/detrimental implications of helical flow in the cardiovascular system are open
to conjecture;186 however, two novel stent designs are being developed that endeavour
to elicit helical flow and take advantage of its beneficial characteristics in terms of
inhibiting neo-atherosclerotic lesions (new lesions formed within the stented region)
post-implantation and ISR. These two novel stent designs are the BioMimics 3D stent
as developed by Veryan Medical Ltd, which is currently undergoing assessment in the
MIMICS-2 clinical study with a total of 271 patients, and the Vascular Flow
Technologies Ltd spiral flow inducer which originally had some success in synthetic
grafts and may also be incorporated into stent designs. Data is available from the first
MIMICS study where 76 patients undergoing femoropopliteal artery intervention were
enrolled of which 50 were implanted with the BioMimics 3D stent and 26 were
implanted with a straight control stent. There were two key findings from this two-year
study. First, the Kaplan Meier survival analysis of freedom from loss of primary
patency at two years was 72% for the BioMimics 3D subjects vs. 55% for the control
group (P=0.0497). Second, there was no increase in the clinically driven target lesion
revascularisation rate in the BioMimics arm between 12 and 24 months (9% at both
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time-points) compared to an increase of 16% (8% at 12 months and 24% at 24 months)
in the control arm.272 Significantly for this work, the data indicated a correlation
between primary patency and stent curvature.272 Helical flow and these two devices will
be discussed in greater detail in Chapter 4 with direct relevance to Test Case 4 presented
in Chapter 8 which assesses the effects of helical-flow-inducing stent designs on oxygen
transport.
1.8

Aim of this Research

The aim of this research was to develop an advanced oxygen transport model that
incorporates both the free oxygen dissolved in plasma and the bound oxygen contained
in RBCs, and also accounts for the shear-induced dispersion of RBCs, which could be
used to assess stent designs. More detail on the reasoning for this is discussed in
Chapter 3. Additionally, this research was undertaken to demonstrate both the
limitations of simpler models and also, potential applications of the advanced model;
specifically, assessment of oxygen transport in stented coronary arteries. Finally,
assessment of the theoretical benefits of helical flow in terms of local haemodynamics
and oxygen transport in stented coronary arteries was undertaken.
1.9

Structure of Thesis

Chapter 2 provides the background material to the instigating factors and biological
processes involved in ISR. Chapter 3 gives an introduction to fundamental fluid
dynamics theory and the haemodynamic variables used, the oxygen transport theory and
relevant variables, and also numerical methodologies employed by the CFD software, as
used in this study. Chapter 4 is a thorough literature survey of previous work in the
areas of oxygen transport, haemodynamic assessment of stent designs, and helical flow.
Chapter 5 is a prelude to the four test cases describing the aims of each. Chapter 6
presents the results of Test Case 1 where the results of five different oxygen transport
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models were compared with experimental results from dog carotid arteries. The five
different oxygen transport models were also compared with experimental results from
rabbit aortae in Test Case 2, as presented in Chapter 7, along with Test Case 3 which
compares three different coronary stent designs using the most advanced oxygen
transport model. Finally in Chapter 8, the predicted haemodynamics and oxygen
transport in five helical stent designs are compared with those of a straight stent. The
limitations and conclusions of the work undertaken, and also possible future work, are
discussed in Chapter 9. Appendix A presents some relevant validation test cases and
appendix B describes the required mesh convergence tests.
1.10 Novelty and Contribution
This research contributes to two specific biomedical fields: oxygen transport modelling
and assessment of coronary stents. The novelty of the research is that it is the first time
that:
1. An oxygen transport model has incorporated the free and bound oxygen along
with a variable shear-induced dispersion coefficient.
2. The simplifications of blood oxygen transport models, which are prevalent in the
literature, have been assessed in 3D geometries and their effects on the PO2
profile within the arterial lumen and wall have been analysed.
3. It is the first time that the oxygen transport has been modelled in three different
stent designs with the predicted low and hypoxic PO2 volumes within the arterial
wall assessed.
4. An advanced oxygen transport model has been used to assess different helicalflow-inducing stent designs.
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1.11 Publications
The work presented in this thesis has led to publications in three peer-reviewed journals:
Oxygen mass transport in stented coronary arteries, Murphy, E.A., Dunne, A.S., Martin,
D.M., Boyle, F.J., Annals of Biomedical Engineering, Volume 44, Issue 2, 2016.
Computational fluid dynamics analysis of balloon-expandable coronary stents:
influence of stent and vessel deformation, Martin, D.M., Murphy, E.A., Boyle, F.J.,
Medical Engineering and Physics, Volume 36, Issue 8, 2014.
Reducing in-stent restenosis through novel stent flow field augmentation, Murphy, E.A.,
Boyle, F.J., Cardiovascular Engineering and Technology, Volume 3, Issue 4, 2012.
Additionally, this work has been presented at several conferences:
Oxygen transport in stented arteries using computational fluid dynamics, Eoin A
Murphy, Fergal J Boyle, John G Houston. University of Dundee Medical Symposium,
Crieff, February 2016. (Poster)
Assessing the effect of helical flow on the hemodynamic environment post-stentimplantation in the coronary artery, Proceedings of the 20th Annual Bioengineering in
Ireland Conference, Co. Limerick, Ireland, 2014
An improved methodology for hemodynamic analysis of stent designs with an
application to helical-flow-inducing stents, Proceedings of the 19th Annual
Bioengineering in Ireland Conference, Co. Meath, Ireland, 2013
The influence of stent and vessel deformation on wall shear stress and wall shear stress
gradient in a stented LAD coronary artery, Proceedings of the Bioengineering Society
(UK) Conference, Oxford, England, 2012
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CHAPTER
Chapter 2.
2.1

2

In-Stent Restenosis

Introduction

In this chapter the biological background material relevant to the project is described.
This chapter is crucial in detailing the biological processes which take place at a cellular
level within the human arterial wall post-stent-implantation, highlighting how they
interact, and are influenced by their instigating factors. This offers a justification, in
addition to reasons given in Section 1.8, as to why one would be interested in
numerically modelling the local haemodynamics and oxygen transport within a stented
coronary artery.
2.2

In-Stent Restenosis

A diagram of a healthy arterial wall is shown in Figure 2.1; however, the exact
composition of an atherosclerotic artery deviates from this ideal form with plaque,
inflammation, and intimal hyperplasia. Stent implantation has three effects on a treated
artery: it induces structural injury, introduces a foreign body and alters the local
haemodynamics. These three effects instigate and influence four interacting biological
processes which can lead to re-narrowing of the stented artery, known as ISR. ISR is
defined as angiographic evidence of a loss of greater than 50% of the lumen diameter
post intervention.159
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Structural injury is inflicted on the arterial wall during the implantation procedure. The
stent and balloon denude most of the endothelium on contact, exposing the underlying
collagen fibres and leaving some damaged ECs directly adjacent to the stent struts.208
Stent implantation stretches, and therefore stresses, the arterial wall and as a result the
cellular structure of VSMCs present in the media can be disrupted, and the IEL and the
media can rupture. Atherosclerotic lesions present at an implantation site are inelastic
and frequently split rather than stretch upon stent implantation. This combined damage
induces a healing response within the arterial wall.

Arterial
Lumen

EC
Collagen Fibres
Intima
IEL

Elastin
VSMC

Media
Extracellular Matrix
EEL
Fibroblast
Adventitia

Connective Tissue

Figure 2.1: Simplified diagram of a healthy artery showing the separate layers and
the main cellular components and fibres. Abbreviations: internal elastic lamina
(IEL), external elastic lamina (EEL), endothelial cell (EC) and vascular smooth
muscle cell (VSMC).

When a stent is inserted in the artery its non-biological surface composition induces a
foreign-body response. This response is dependent on properties such as the
biocompatibility of the surface material and the surface roughness, along with the
existence of contaminants on the surface of the stent. The surface material and
roughness of a stent affects how quickly the arterial wall heals over the struts.
Contaminants, such as powder from surgical gloves, have been found on a stent surface
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due to handling before catheter insertion.11 The improved biocompatibility of stent
materials and the rinsing of stents before implantation reduce the foreign-body
response; however, the non-biological nature of stents instigates cells and proteins in the
body to react to what they perceive as a foreign invader.
When a stent is implanted in a diseased artery the geometry of the artery is altered,
which in turn augments the local haemodynamics. The lesion is compressed out against
the arterial wall, clearing the lumen blockage and reinstating blood flow. The stented
artery adopts a new geometry based on the stent strut configuration with the struts
pressed against the arterial wall and prolapsed tissue between them. In some cases of
over-inflation of the balloon, a step-up phenomenon at the ends of the stent can occur,
creating recirculation zones at these points. Also, some degree of longitudinal
straightening by stent implantation has been reported in curved arteries, although with
more flexible stent designs currently on the market this is no longer a serious issue.86
These changes are a deviation from the smooth surface presented to the blood flow by a
healthy artery and lead to disturbed flow within the stented artery. This disturbed flow
can encompass flow separation and reattachment, stagnation and recirculation zones,
long particle residence times, low and high shear stress (SS) within the blood flow, low
and high WSS zones, oscillatory WSS, and high WSS gradient (WSSG) and angle
gradient (WSSAG). Cellular components of the arterial wall are impelled to respond to
this augmentation of the local haemodynamics in order to return the artery to a circular
luminal cross-section with smooth walls. Also, some of the changes in the local
haemodynamics are not conducive to the natural healing of the arterial wall and instead
hinder or adversely affect it, which consequently can lead to ISR.
It is important to note that historically it was thought that human arteries try to maintain
a physiological WSS value of approximately 15dyne/cm2 (1.5Pa), although this has
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since been refuted with one of the current hypotheses being that the WSS varies
inversely with vessel radius, becoming larger when the vessel radius decreases.37
Although, conveniently here, in the case of coronary arteries the basal physiological
WSS has been observed to be approximately 1.5Pa.37 Additionally, physiological WSS
values have also been shown to vary across different species which is worth noting as
studies involving animals are referenced throughout this section with different values
for low WSS values adopted by the researchers involved.
The four interacting biological processes, instigated by these three effects of stent
implantation, are thrombus formation, inflammation, neointimal hyperplasia (NIH) and
re-endothelialisation. These biological processes, their interactions and the influences of
the three instigators on each are described in the following sections. Separate to this,
hypoxia and how it affects the biological processes is described in Section 2.3. Also, the
influence of stent design on these instigators and biological processes is discussed in
Section 2.4.

2.2.1

Thrombus Formation

Thrombus formation, in general, is the body’s emergency response mechanism to
structural injury and entails primary and secondary haemostasis. Primary haemostasis
involves blood-borne platelets quickly adhering to form a plug at an injury site.
Occurring in parallel with this is secondary haemostasis which involves the formation
of fibrin fibres through the coagulation cascade, and these fibrin fibres bind the adhered
platelets together at the injury site.
When structural injury is inflicted on an artery by stent implantation, platelets present in
the bloodstream are activated by exposed collagen and plaque, and by proteins
expressed by damaged ECs (e.g. fibronectin and von Willebrand factor (vWf)).
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Activated platelets are more sensitive to chemical signals and adhere to the collagen,
plaque and proteins on the arterial wall, changing their cytoskeleton (cell scaffolding) to
become more flexible and capable of spreading out over the injury site. Activated
platelets also release platelet activating factor (PAF), adenosine diphosphate (ADP) and
thromboxane A2 into the bloodstream which in turn activate more platelets and aid in
the aggregation of platelets at an injury site. The coagulation cascade involves several
coagulation factors present in the bloodstream and those released by adhered platelets
and leukocytes, and VSMCs (e.g. tissue factor). Through the coagulation cascade
prothrombin, present in the blood plasma, is converted to thrombin which both activates
more platelets and causes soluble fibrinogen molecules in the blood plasma to convert
into fibrin monomers. These fibrin monomers form fibrin fibres that bind the platelets
that have aggregated together at the injury site, forming a thrombus.
In addition to this response to structural injury, thrombus formation is also initiated by
the presence of a foreign body. Blood-soluble proteins adsorb onto the stent surface,
forming a thin film which provides a provisional matrix that controls the subsequent
biological processes of the foreign-body response.3 Different proteins (e.g. albumin,
fibrinogen, fibronectin, vitronectin and y-globulin) adsorb onto the stent surface
depending on the properties of the surface material.3 These adsorbed proteins produce
different effects; fibrinogen for example is pro-thrombotic, promoting activation and
adhesion of platelets, whereas albumin reduces platelet adhesion and aggregation.138
Fibrinogen is adsorbed preferentially over other proteins on many surfaces, especially
polymers,138 and thus facilitates thrombus formation at a stent implantation site.
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Activated Platelet:
Thromboxane A2,
ADP, PAF

Damaged ECs:
Fibronectin
vWf
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Fibrin
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Stent Strut
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Figure 2.2: Diagram showing the cells, pro-thrombotic agents and proteins
involved in thrombus formation at an injury site around a stent strut.

Thrombus formation has been found to be heavily flow dependent. The platelets,
coagulation factors and chemical substances involved in thrombus formation are
predominantly blood-borne particles and as such their movements are dictated by the
local haemodynamics. High particle residence times at the injury site facilitate increased
platelet exposure times to thrombotic arterial wall components and activating chemical
substances. This increased exposure time results in a greater probability of platelet
activation with enhanced platelet activation being observed in low flow conditions.9
Increased platelet adhesion has been observed downstream of recirculation zones, where
the main flow reattaches to the arterial wall, due to the convection of platelets towards
the arterial wall.56,221 RBCs can also get trapped by fibrin monomers in the thrombus
within recirculation zones or other low SS regions. Also, in regions of low WSS (<1.0
to 1.2 Pa) ECs respond by down-regulating the release of anti-thrombotic agents and
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up-regulating the expression of pro-coagulant and pro-thrombotic agents, thus also
instigating thrombus formation. High SS within the blood flow can also activate
platelets; this depends on the magnitude of the SS and the exposure time of platelets to
the high SS.31 Figure 2.2 shows the cells (platelets, RBCs and ECs), pro-thrombotic
agents and proteins involved in thrombus formation.

2.2.2

Inflammation

Inflammation involving leukocytes (e.g. lymphocytes, monocytes/macrophages,
neutrophils, eosinophils and basophils.) is the body’s primary defence mechanism
against infection. Leukocytes are attracted to an injury site in order to prevent the spread
of the tissue damage and infection, and to aid in wound healing and tissue repair.158
Structural injury to the arterial wall by stent implantation triggers the expression of
several cell adhesion molecules which mediate four steps, shown in Figure 2.3, that
each leukocyte undergoes in order to infiltrate an injury site. These four steps are the
initial contact (tethering), leading to rolling and activation of the leukocyte, followed by
firm adhesion and finally transmigration into the arterial wall. Tethering and rolling are
mediated by cell adhesion molecules P-selectin (expressed by adhered platelets and
damaged VSMCs) and E-selectin (expressed by damaged ECs) which interact with
ligands expressed on the leukocyte surface. Firm adhesion is mediated by platelet
glycoprotein (GP) Ib-𝛼, vascular cell adhesion molecule 1 (VCAM-1) and intercellular
adhesion molecule 1 (ICAM-1) expressed on the luminal surface of the damaged wall,
which interact with integrins expressed on the surface of the leukocytes, e.g.
macrophage-1 antigen (MAC-1). The final step is driven by concentration gradients of
chemokines (chemotactic cytokines) released by damaged ECs and VSMCs, and by the
leukocytes already present at the injury site. Neutrophil infiltration of the injury site
represents the initial acute phase of the inflammatory response and they are present up
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to, but not beyond, 30 days after BMS implantation.59 The chronic phase of the
inflammatory response involving lymphocyte and monocyte infiltration of the injury
site, extends from three days to beyond six months for BMSs.59 When monocytes
migrate across the platelet/fibrin thrombus to the site of initial injury, they differentiate
into macrophages. These cells consume the damaged cells around the injury site and
also secrete interleukins which attract more leukocytes to the area.

Tethering

Rolling
Firm Adhesion

Activated Platelets:
P-selectin, GPIb-𝛼
Damaged ECs:
E-selectin
Damaged VSMCs:
P-selectin

Transmigration
Stent Strut

Figure 2.3: Diagram showing the four steps leukocytes undergo in order to
infiltrate the injury site.

The thin layer of proteins adsorbed onto the implanted stent surface not only mediates
the adhesion of platelets, but also controls the inflammatory phase of the foreign-body
response to the stent. The complement system, which consists of more than 20 plasmabased proteins, is a primary contributor to the innate immune system and is activated by
the adsorbed protein layer. Activation of the complement system promotes the
formation of enzymes and binding proteins which regulate the inflammatory response to
a foreign body. Leukocytes, particularly neutrophils and monocytes, follow increased
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concentration gradients of chemo-attractant anaphylatoxins, such as C5a, which are
fragments produced by activation of the complement system. Other products of
complement activation, such as C3b and iC3b, through a process called opsonisation
mark foreign particles for phagocytic removal (ingestion) by leukocytes and subsequent
proteolysis (digestion) by proteases (cellular enzymes). This is the case for any
contaminants on the stent surface; however, in the case of a relatively large foreign
body, such as a stent, which cannot be ingested, adhered neutrophils and monocytes
undergo a frustrated phagocytosis whereby they release their array of potent oxygen
metabolites and proteolytic enzymes.81 This can lead to an unresolved chronic
inflammatory response exemplified by the increased fusion of macrophages into foreign
body giant cells around an implanted stent. Platelets which adhere to the adsorbed
protein layer on stent struts also release P-selectin to aid leukocyte adhesion and these
adhered leukocytes can also encourage thrombus formation through elevated expression
of tissue factor.57 Products of the complement system can interact with proteins
involved in thrombus formation and thus, can also regulate each other. Metallic stent
struts or the presence of a polymer coating on a stent can induce an allergic
inflammatory reaction in some people, which is observed as eosinophil activation and
presence at the implantation site.185
The local haemodynamics can also mediate the adhesion of leukocytes at an
implantation site. With increased thrombus formation due to the haemodynamics in
certain regions, e.g. re-attachment areas where flow is directed towards the arterial wall,
there is a greater amount of cell adhesion molecules available to capture passing
leukocytes. In addition to this, it has been found that local vascular haemodynamics can
affect leukocyte ligand expression,65 shape46 and consequently interaction with other
cells.246 Leukocyte-EC interaction is heavily influenced by the local haemodynamics
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which becomes more relevant as the endothelium reforms over the implantation site.
For instance, leukocytes retract their pseudopodia (temporary projections from
leukocytes used to adhere to a surface) when exposed to nitric oxide (NO),160 which is
produced by functioning ECs in response to physiological WSS (1.5 to 7 Pa).32
However, when ECs are exposed to low WSS (<1.0 to 1.2 Pa) or disturbed flow they
decrease their expression of anti-inflammatory mediators (e.g. NO) and upregulate cell
adhesion

molecules

(e.g.

E-selectin,

VCAM-1

and

ICAM-1).32

Increased

macromolecule transport across the endothelium, as a result of abnormal endothelial
permeability, has been shown to occur in reattachment zones of high WSSG
(>0.85Pa/mm).195 This may lead to increased uptake of monocytes across the
endothelium in reattachment zones, for instance, downstream of stent struts. Therefore,
the establishment of normal physiological blood flow within a stented artery following
the procedure is crucial to avoiding prolonged inflammation and consequently possible
ISR.

2.2.3

Neointimal Hyperplasia

NIH takes place up to 18 months post-implantation, results in a thickening of the intimal
layer, and is the main cause of ISR. NIH involves the migration and proliferation of
VSMCs originating in the media, and also differentiating from fibroblasts in the
adventitia and bone-marrow-derived stem cells in the bloodstream. In addition, the
VSMCs synthesise extracellular matrix (ECM). The degree of NIH is heavily
influenced by the degree of thrombus formation and inflammation which takes place at
an implantation site.
Damaged ECs and VSMCs, adhered leukocytes and platelets release cytokines (proteins
used for intercellular communication) and mitogens (proteins which encourage a cell to
commence the cell-division cycle) which encourage NIH at an injury site. The
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migration of the VSMCs is stimulated by cytokines (e.g. tumour necrosis factor (TNF)
and interleukin-1 (IL-1)) released by macrophages and also by some of the mitogens
(e.g. platelet-derived growth factor (PDGF)). PDGF is capable of stimulating migration
at a much lower concentration level than that needed for cell division and therefore,
migration is an earlier response than proliferation.82 In order for migration to occur
enzymes (e.g. matrix metalloproteinase (MMP)-9) released by adhered leukocytes and
VSMCs help in the dissolution of the IEL and the existing ECM. This dissolution, along
with the disruption to the ECM caused by stent implantation, allows the medial VSMCs
and myofibroblasts (activated fibroblasts) to migrate through to the neointimal region of
the arterial wall. The proliferation of VSMCs is instigated by mitogens (e.g. serotonin,
thromboxane A2, PDGF and basic fibroblast growth factor (bFGF)) which are released
by damaged ECs and VSMCs, adhered leukocytes and platelets. This proliferation
produces a greater amount of neointimal cells than does migration. In addition to
VSMC migration and proliferation, inflammatory and hematopoietic cytokines (e.g.
granulocyte colony-stimulating factor (G-CSF)) produced by ECs and leukocytes at the
injury site mobilise stem cells from the bone marrow to enter the bloodstream.108,109
These stem cells can differentiate into smooth muscle progenitor cells (SPCs), which
adhere to fibronectin and differentiate into VSMC-like cells in the presence of PDGFBB (a PDGF isoform) at the injury site.89,232 The stretching of the original VSMCs in
the arterial wall stimulates them to synthesise collagen, a component of ECM, which
may serve to alleviate the additional stress caused by stent implantation, but also
increases the overall wall volume.137 This, along with the synthesis of ECM by
neointimal VSMCs can contribute up to 80% of the resultant wall thickening.73
Leukocytes and platelets attracted to a foreign body can also release cytokines and
mitogens which encourage NIH. Macrophages activated by biomedical polymers in
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vitro have been shown to stimulate fibroblast activity.3 In addition to this, macrophages
and foreign-body giant cells on a biomaterial surface modulate ECM fibrosis. This
results in the formation of a fibrous capsule, mainly comprised of collagen fibres and
leukocytes, which isolates the stent from the surrounding tissue and blood.3
NIH can also be induced and influenced by local haemodynamics within the stented
arterial region. Where local haemodynamics cause increased thrombus formation and
inflammation, due to the release of mitogens by adhered leukocytes and platelets, this
subsequently induces increased NIH. In regions where the endothelium has been
denuded and the IEL damaged by stent implantation, underlining VSMCs may be
exposed and affected by the local haemodynamics. Human VSMCs exposed to
physiological or high WSS, taken as 1.4 and 2.8 Pa respectively in this particular study,
for 24 hours show an increase in transforming growth factor (TGF)-𝛽1 expression
which inhibits their proliferation, in comparison with a static control.260 High WSS
(>1.5 Pa) also stimulates the release of stored mitogens (PDGF and bFGF) within
VSMCs into the bloodstream while low WSS increases VSMC susceptibility to these
mitogens.239 Thus, in a stented artery where there is variability between high and low
WSS across the stent and arterial wall, increased proliferation would occur in low WSS
zones.173 In a study by Papadaki et al. into the effects of different shear stresses (0.5,
1.1, 1.5, 1.75 2.15, and 2.5 Pa) on a layer of human aortic VSMCs on glass slides found
that above 1.5 Pa the VSMCs showed decreased proliferation over a 24 hour period.187
In addition, pulsatile turbulent WSS has also been found to stimulate VSMC
proliferation,227 and murine VSMCs exposed to steady laminar WSS of 1.5 Pa have
been found to transdifferentiate into ECs.266 Within the arterial wall, VSMCs and
myofibroblasts are exposed to transmural interstitial shear stress, estimated to be
normally around 0.1 Pa, which can be increased by endothelium denudation, activating
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these cells and promoting their migration into the intima or wound site.225 ECs present
in the stented region downregulate anti-proliferative gene expression and upregulate the
release of VSMC growth factors in response to low WSS.32 Areas experiencing elevated
WSSG (>0.2Pa/mm) in the toe region of an end-to-side arterial anastomosis have been
found to develop increased NIH.129,136,184 The oxygen flux from the blood into the
arterial wall, which is also heavily flow dependent, has also been found to influence
VSMC behaviour. NIH has been found to be reduced in rabbits treated with
supplemental oxygen,135 and areas of low WSS where the oxygen flux into the arterial
wall is low are hypothesised to experience increased NIH.252

2.2.4

Re-Endothelialisation

The endothelium fulfils several important physiological functions which include acting
as a selective permeability barrier, participation in cardiovascular homeostasis and
inflammatory responses, regulation of cellular growth and proliferation within the
arterial wall, angiogenesis and tumour metastasis.214 Considering its importance, once
denudation

by stent

implantation

has

occurred,

its

reinstatement,

i.e.

re-

endothelialisation, is critical in order for the artery to return to its normal functioning
behaviour.
Damaged ECs, adhered platelets, VSMCs and macrophages present at the injury site
release mitogens capable of instigating re-endothelialisation. These mitogens include
vascular endothelial growth factor (VEGF), PDGF and bFGF and induce the ECs
remaining around the stent struts and outside the stented area to migrate and proliferate
into the denuded section. In addition, increased levels of VEGF circulating in the
bloodstream induce precursors of endothelial cell colony forming units (EC-CFUs)
(angiogenic monocytes and lymphocytes) and endothelial progenitor cells (EPCs)
derived from bone marrow stem cells, to mobilise, enter the bloodstream and home in
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on the injury site. It has been hypothesised that EC-CFUs precursors arrive earlier than
EPCs to provide rapid coverage of the injury site and secret angiogenic factors (e.g.
VEGF and G-CSF) which encourage EPC homing and proliferation.186 EPCs attach to
proteins and adhesion molecules on the arterial wall and subsequently differentiate into
mature ECs.

Figure 2.4: Phase-contrast monographs of confluent bovine aortic endothelial
monolayers show a distinct difference between ECs under static flow conditions
(A) and those exposed to physiological WSS for 24 hours (B). Reproduced and
adapted with permission from the Journal of Cell Science.145

ECs or EPCs will not adhere directly to, or proliferate over, a normal stent surface and
as such re-endothelialisation over the stent struts cannot occur without an adsorbed
protein layer and adhesion molecules expressed by cells adhered to the surface. 48 Some
stent designs endeavour to promote re-endothelialisation by applying coatings to the
stent surface.13,48,224 The surface texture of a stent also influences re-endothelialisation
and thus some new stents are exploring different surface modifications which may aid
re-endothelialisation.17 In addition to this the surface chemical composition also affects
re-endothelialisation, e.g. endothelial migration onto stainless steel via interaction with
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adsorbed fibrinogen is significantly greater than that observed onto gold surfaces. This
could be due to the surface charge, hydrophobicity, or chemical composition of the
surface material.235
Local haemodynamics at a stent implantation site also have an effect on the initial and
continued adherence of ECs and EPCs. Large WSS oscillations over positive and
negative values, i.e. 1Hz reversing sinusoidal WSS of mean 2.0 Pa with an amplitude of
4.0 Pa, has been found to cause the detachment of cultured bovine aortic ECs,94 which
would delay re-endothelialisation. ECs have been shown to migrate downstream of an
area where the WSSG is above 0.3 Pa/mm.47,255 The migration of ECs into denuded
areas from adjacent areas with an intact endothelium has been shown to be increased
when exposed to undisturbed laminar flow as opposed to disturbed laminar flow or
static flow.106 Re-endothelialisation of the stent surface has also been found to be WSS
dependent, with low WSS regions experiencing delayed re-endothelialisation and high
WSS encouraging EC migration onto stent surfaces.234 In addition to this, as the healing
process progresses and the endothelium layer reforms, ECs can sense and are responsive
to WSS conditions. In physiological flow conditions ECs align themselves in the flow
direction and are in an atheroprotective state, releasing anticoagulants, antioxidants and
vasodilators such as NO. When ECs are in regions of low WSS or high WSSG they
switch to an atherogenic state in which they adopt a cobblestone shape in a more
random arrangement, shown in Figure 2.4, no longer aligned with the flow and
presenting gaps in the endothelial layer, thus encouraging cellular and lipid
infiltration.195,211–213 In this form they also up-regulate inflammatory mediators,
adhesion molecules, pro-coagulant and pro-thrombotic agents, and VSMC growth
factors, all of which can lead to increased NIH and result in ISR.144
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2.3

Hypoxia

Oxygen is critical for the maintenance of arterial wall physiology and is supplied to the
cells within the arterial wall from both the luminal blood and blood passing through
vasa vasorum in the adventitia. The vasa vasorum generally supplies the outer two
thirds of the arterial wall, with the inner third supplied by diffusion from the lumen.95
Oxygen is transported in blood as free oxygen dissolved in plasma and oxygen
reversibly-bound to haemoglobin within the RBCs. In the arterial wall oxygen can
diffuse up to a maximum of 300μm, and as the thickness of the arterial wall increases
due to the formation of atherosclerotic plaque more of the arterial wall is in danger of
becoming hypoxic. Hypoxia can contribute in the formation of foam cells from
macrophages in atherosclerotic lesions and also causes an increase in the secretion of
interleukins.20,215 Therefore, hypoxia can influence the severity of inflammation in
atherosclerotic lesions. Hypoxia has been associated with increased adventitial vasa
vasorum34 and IH in animal studies.216,218 When VSMCs become hypoxic they express
growth factors, such as VEGF and PDGF, that play a critical role in both
neovascularisation and IH.34 VEGF encourages the proliferation of vasa vasorum into
the medial layer.216,262 Although this proliferation of the vasa vasorum may be an
adaptive mechanism to counteract hypoxia, it can also promote plaque rupture.156 When
the endothelium is exposed to hypoxic levels of oxygen concentration in the short term
it expresses vaso-constricting effectors which results in reversible augmentation of the
local blood flow.58 However, when exposed to chronic hypoxic levels of oxygen
concentration growth factors are expressed that result in VSMC proliferation and
remodelling of the arterial wall, which have more lasting effects on the artery and local
blood flow. Additionally, the growth factor expression can induce EC apoptosis which
can increase LDL transport through leaky junctions.252
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In terms of the augmentation of the haemodynamic environment, stenting produces a
predominantly beneficial effect, i.e., restoration of required blood flow to downstream
vasculature; however, locally within the stented region, the haemodynamics impact the
natural healing processes within the arterial wall. This local augmentation of the
haemodynamic environment due to the presence of a stent in turn affects the oxygen
flux into the arterial wall which can result in hypoxia in some regions. Conversely, as
mentioned earlier, Lee et al. (2001) found that rabbits treated with supplemental oxygen
following graft-to-artery anastomosis had reduced NIH.135 Although, it should be noted
that the routine use of high-flow oxygen in uncomplicated MI has been found to result
in greater infarct size and possibly increase the risk of mortality and high oxygen partial
pressures within blood have been found to act as a vasoconstrictor.197,269 Therefore,
although there may not be any benefit in treatment with supplemental oxygen, the
oxygen mass-transfer from the blood into the arterial wall has a crucial role to play in
the control of NIH in arteries post stent implantation.
2.4

Influence of Stent Design on ISR

There are many different stents available on the market with varying strut
configurations, thicknesses, materials, and deployment mechanisms, and in the case of
DESs different coatings, drug types, doses and drug release kinetics. These varying
designs produce different degrees of structural injury, foreign-body reactions and
haemodynamic flow field alterations, which in turn affect the biological processes
taking place within the stented artery and the resultant ISR rates. A study by Kastrati et
al. (2001) of 3,370 patients (4,229 stented lesions) who underwent angioplasty with
stenting using different BMS types concluded that following vessel size, stent design
was the second strongest factor in determining the occurrence of ISR.118
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The structural injury caused by stent implantation to the arterial wall is assumed to be
proportional to the stress induced within the wall, which is dependent, in part, upon the
stent design. Self-expanding stents have been found to cause less injury to the
endothelium than balloon-expandable stents, because only the stent struts, in contrast
with both the struts and an expanded balloon, are in contact with the arterial wall. 90 The
injury caused by the balloon depends on the inflation pressure, stent geometry and
distance between struts.209 Stent foreshortening upon expansion, elastic recoil,55 and
deformations of the stent under flexion,267 have been studied using FEA and are
hypothesised to affect the degree of injury inflicted upon the arterial wall. High stresses
within the arterial wall can cause increased damage, and in cases of medial injury or
lipid core penetration by stent struts there is a propensity for increased inflammation.59
By reducing the number of strut-strut intersections by one third, disruption of the IEL
and the media layer were reduced by nearly one half in a study of steel stents deployed
in denuded rabbit iliac arteries.207 Several clinical studies have linked the degree of
arterial wall prolapse between stent struts with the occurrence of ISR. 101,110,199 The
amount of prolapse between stent struts is also dependent on the strut spacing.
Following implantation, a stent must also be able to withstand additional stresses placed
upon it from vessel deformation. In the case of coronary arteries the beating of the heart
causes slight movements and deformations of the arteries.49–51 Also, in peripheral
arteries, such as the femoral, popliteal and tibial arteries, deformation is caused by the
flexion of the hip, knee or ankle, which in some cases can cause fracture of an
implanted stent possibly resulting in renewed injury to the arterial wall and ISR.219
Therefore, not only does the stent design have an effect on the structural injury inflicted
on the arterial wall initially, but the properties of the stent material and its ability to
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withstand cyclic loading of the heart beating or a limb moving can also affect the
probability of ISR occurring during the lifetime of a stent.
The stent material also has implications for each biological process in the response to a
foreign body. Stainless steel, used in most BMSs, is found to oxidise in the body
causing varying degrees of cell toxicity.270 First-generation DES permanent polymer
coatings were found to cause delayed healing, impaired stent-strut endothelialisation,
and hypersensitivity reactions, which can culminate in stent thrombosis in some
cases.70,75,113,114,182,265 In a study of different DESs implanted in rabbits by Joner et al. it
was found that struts lacking endothelial coverage at 14 days showed focal aggregates
of platelets and inflammatory cells, including foreign body giant cells.114 Therefore, in
the absence of complete endothelialisation of polymeric strut surfaces increased
inflammation and thrombus formation may result. New DES coatings such as
phosphorycholine

and

the

co-polymer

poly(vinylidene

fluoride-co-

hexafluoropropylene) mimic the phospholipids on the outer surfaces of RBCs.151 This
improves the biocompatibility of the DES by masking its foreign nature. As a result of
the observed detrimental effects of permanent polymers implanted in the body,
biodegradable polymer coatings and completely polymer free stents are also being
developed.71
The resultant local haemodynamics created within the stented lumen are also partially
dependent on the stent design. Thrombus formation, as mentioned previously, is heavily
flow dependent with highest platelet deposition occurring where flow is directed
towards the arterial wall.56 Monocyte adhesion rates were found to be affected by not
only the local WSS, but also the radial component of velocity and the dynamics of the
recirculation region and flow reattachment.201 Flow separation away from the arterial
wall and recirculation zones occur both upstream and downstream of rectangular cross40
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sectional stent struts. Platelets within these zones experience long particle residence
times in proximity to activating substances, which increases their probability of
activation. With thinner and more streamlined stent struts, the recirculation zones, and
also consequently, the particle residence times can be reduced.111 WSS, WSSG and
WSSAG within an idealised stented artery can be predicted using CFD and different
stent designs have been shown to produce significantly different distributions of
each.132,133,173 The angle that stent struts make with the primary direction of blood flow
has been shown to strongly influence the amount of intrastrut area of the luminal wall
exposed to low WSS.133 Stents with a greater final diameter than the implanted artery
not only cause increased damage within the arterial wall, but also increase the crosssectional area of the stented artery, reducing the blood flow velocity and as a result
reduce the WSS within that region. Alternatively, stent undersizing can result in stent
strut malapposition to the arterial wall, thus increasing the resistance to flow and
decreasing the WSS.35
2.5

Summary

The biological processes: thrombus formation, inflammation, NIH, and reendothelialisation, that can result in ISR are instigated, and significantly affected by, the
damage caused by stent implantation, the presence of a foreign body and the local
abnormal haemodynamics created within a stented artery, as summarised in Figure 2.5.
The haemodynamics can in turn impact the oxygen transport from the luminal blood
into the arterial wall. Analysis of the haemodynamics and the oxygen transport within a
stented artery is warranted to elucidate beneficial stent design characteristics that may
improve the conditions within a stented artery post-implantation. The next chapter will
present the fundamental fluid mechanics and oxygen transport theory relevant to the
project.
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Figure 2.5: Summary of biological processes instigated by stent implantation that can result in ISR.
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CHAPTER
Chapter 3.
3.1

3

Fundamental Theory

Introduction

To study the flow of blood through, and the oxygen transport within, an artery using
CFD, it is important to first understand the fundamental theory applicable to both and
also how they are modelled in the CFD software. In this chapter the theory will be given
which includes the derivation of the fluid stress tensor, the haemodynamic variables of
interest to this study, the oxygen transport theory, and the oxygen transport variable of
interest. Also the CFD governing equations, discretisation technique, and how the
equations are employed in the software are presented.
3.2

Fluid Mechanics Theory

The fluid stress tensor, as described below, is used in the calculation of WSS and
WSSG (Section 3.3), and the shear-rate dependent dispersion coefficient (Section
3.4.1). To derive the fluid stress tensor consider a fluid element in a Cartesian
coordinate system with side lengths of dx, dy and dz in the x, y, and z direction
respectively, and analyse all the forces acting upon it, as shown in Figure 3.1. The
forces that act on a fluid element can be classified as body forces and surface forces.
Body forces include the forces experienced by the fluid element due to gravity,
electromagnetic and nuclear interactions. The surface forces which the fluid element
will be subjected to are forces normal and tangential to its surfaces that could result in
deformation of the fluid element. Looking at a fluid element in isolation within a flow,
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it is understood to possibly undergo four types of deformation: translation, rotation,
linear strain and shear strain. Considering that a fluid element may be in constant
motion within a flow, and for the purpose of the derivation of the momentum equations,
these deformations are studied in terms of rates and a Cartesian coordinate system is
used as shown in Figure 3.1.

dy
dz

y
dx

x
z

Figure 3.1: Fluid element in a Cartesian coordinate system with side lengths of dx,
dy and dz, in the x, y, and z direction respectively, used for analysis of
deformations and derivation of momentum equation.

3.2.1

Rate of Translation

Translation is the distance a fluid element has moved through in a certain period of
time. The rate of translation is the velocity of a fluid element which is represented by
the velocity vector in Cartesian coordinates:
V  ui  vj  wk

(3.1)

where u, v and w are the velocity magnitudes in the x, y and z directions respectively,
with i, j and k defined as the Cartesian unit vectors in these directions also. To calculate
the translation distance after an infinitesimally small increment of time dt, the velocity
magnitudes are multiplied by dt, i.e. udt, vdt and wdt.
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Figure 3.2: The relevant velocities and distances for derivation of the deformations
imposed on a two-dimensional (2D) face of a fluid element during time increment
dt. The 2D face is shown at time t as ABCD, and time t+dt as A’B’C’D’.

3.2.2

Rate of Rotation

The rate of rotation at a point, also known as the angular velocity, is the average rotation
rate of two initially perpendicular lines which meet at that point. For simplicity, here the
rate of rotation is derived for a 2D face on the x-y plane of a fluid element in motion
from time t to t+dt, as shown in Figure 3.2. For the purpose of this derivation the point
B at time t is considered along with the two initially perpendicular lines labelled as AB
and BC. The velocity magnitudes in the x and y directions are also shown at point B.
Because the velocities vary with position, the velocities at points A and C are slightly
different and for clarity only the relevant velocity at both points are shown as first order
∂u

∂v

Taylor series: u+ ∂y dy at point A and v+ ∂x dx at point C. At time t+dt the points have
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all moved through certain distances as prescribed by these velocities with the
assumption that the accelerations do not vary over such small distances within the flow.
The four points at time t+dt are labelled as A’, B’, C’ and D’. Lines A’B’ and B’C’
have rotated through angles dβ in a clockwise direction and dα in a counter-clockwise
direction, respectively, about the z-axis. The average rotation about the z-axis at point B
is:

dz 

1
 d  d 
2

(3.2)

where dβ, clockwise, is defined as negative. To derive the rate of rotation the angles are
divided by the time increment:

dz 1  d d 
   
dt 2  dt dt 

(3.3)

The angles can be calculated based on the inverse tan of the opposite and adjacent sides,
as shown in Figure 3.2. For the purpose of this derivation, the angles can be related to
the velocity derivatives through the limits of the angles as dt→0 given as follows:






v
dxdt  u

x
1


d  lim tan
dt
dt 0 
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dx 
dxdt  x
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u
dydt 
 1
y
u
d  lim  tan
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dt 0

y

v
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(3.4)

(3.5)

Substituting Equations (3.4) and (3.5) into Equation (3.3), and cancelling dt on the
right-hand-side results in a formula for the rate of rotation about the z axis at point B:
dz 1  v u 
   
dt 2  x y 

(3.6)

The rate of rotation around the x and y axis can also be derived in a similar fashion and
are:
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dx 1  w v 
 
 
dt
2  y z 
dy

1  u w 
  

dt
2  z y 

(3.7)

(3.8)

These angular velocities are conventionally written as ωx , ωy and ωz and collectively
define the rate of rotation vector in the Cartesian coordinate system as:

ω  x i  y j  zk

(3.9)

1  w v  1  u w  1  v u 
ω 
 i   
 j   k
2  y z  2  z y  2  x y 

(3.10)

By defining a new vector ζ , the vorticity of the fluid, the halves can be cancelled:
 w v   u w   v u 
ζ  2ω  
 i   
 j   k
 y z   z y   x y 

(3.11)

Here, the three components of the vorticity vector are recognised as the curl of the
velocity vector V, and hence:
ζ   V

(3.12)

where  is the gradient operator defined as:






i  j k
x y z

(3.13)

With this two types of flow can be defined:


Rotational flow where    V  0 at every point, and the fluid elements move,
deform and rotate.



Irrotational flow where    V  0 at every point, and the fluid elements
move, and deform, but do not rotate.
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3.2.3

Linear Strain Rate

Linear strain is defined as the change in length divided by the original length, and the
linear strain rate is the rate of change of the linear strain and can be defined for each
Cartesian direction. Referring to the line labelled BC and the deformed line at time t+dt
B’C’ in Figure 3.2, the x component of the rate of linear strain is defined as follows:

 xx


u


dx 
dxdt   dx 
d  
u
x


 
dt 
dx
 x





(3.14)

Conventionally, εij corresponds to the strain in the i direction and acting on the surface
which has its surface normal vector in the j direction. For example, the notation in this
case, εxx corresponds to the linear strain rate in the x direction which is exerted on a
surface which is perpendicular to the direction of the strain. The corresponding rate of
linear strain in the z and y direction can also be defined accordingly as:

3.2.4

 yy 

v
y

(3.15)

 zz 

w
z

(3.16)

Shear Strain Rate

The shear strain rate in 2D is defined as the average rate of decrease in the angle
between two lines, here taken as AB and BC for the face of the fluid element parallel to
the xy plane in Figure 3.2, which are initially perpendicular at time t. The average shear
strain rate is defined as:
1  d d  1  v u 
 xy  
    
2  dt dt  2  x y 

(3.17)

Likewise, the shear strain rate can be defined for the faces parallel to the yz and zx faces
also:
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1  w v 
 yz  
 
2  y z 

(3.18)

1  u w 
zx   

2  z x 

(3.19)

The shear strain rate is symmetric and hence:

yx  xy , zy  yz , xz  zx

3.2.5

(3.20)

Strain Rate Tensor

The linear strain rate and shear strain rate of the fluid element can be combined into one
symmetric second-order tensor:

  xx

ij    yx

 zx

 xy
 yy
 zy


u
1  v u  1  u w  
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(3.21)

A fundamental property of symmetric tensors is that there is at least one coordinate
system for which the off-diagonal components of the tensor are reduced to zero. For
convenience, the coordinate system here is assumed to be coincident with the principle
axes of the strain tensor. Therefore, the principle diagonal terms remain and the off
diagonal terms, where i≠j, reduce to zero. Hence the strain rate tensor reduces to:

 1 0

ij   0  2
0 0


0

0
3 

where ε1 , ε2 and ε3 are referred to as the principle strain rates.
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3.2.6

Fluid Stress Tensor

For an infinitesimally small cubic fluid element fixed within a fluid domain, as shown
in Figure 3.3, the total forces acting on it are composed of body and surface forces.
Body forces consist of the forces experienced by the fluid element due to gravity,
electromagnetic and nuclear interactions.
In the case of surface forces, these comprise of forces due to pressure within the fluid
that act normal to the surfaces, and the viscous forces that act tangentially and
perpendicularly to the surfaces. For the purpose of this derivation the surfaces of the
fluid element are assumed to be parallel with the Cartesian coordinate planes. A second
order stress tensor is defined as:
  xx

ij    yx

 zx

 xy
 yy
zy

 xz 

 yz 
zz 

(3.23)

where σij correspond to the stress exerted in the i direction and acting on the surface
which has its surface normal vector in the j direction. Therefore, the diagonal terms
where i=j represent stresses exerted in the same direction as the surface normal vector
and when i≠j the stresses are acting tangentially to the surface, as shown in Figure 3.3.
When the fluid is stationary the only stresses acting on the surfaces of the fluid element
is the hydrostatic pressure and hence, the stress tensor reduces to:
  xx

ij    yx

 zx

 xy
 yy
zy

 xz   P 0
0 
 

 yz    0 P 0 
zz   0
0 P 

(3.24)

where P is the pressure which acts normal to the surface and inwardly, hence the
negative sign.
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𝜎𝑦𝑦
𝜎𝑦𝑥

𝜎𝑦𝑧

𝜎𝑥𝑦
𝜎𝑧𝑦

𝜎𝑧𝑥

𝜎𝑥𝑥

𝜎𝑥𝑧

𝜎𝑧𝑧

y
x
z

Figure 3.3: The nine positive stresses exerted on a fluid element. An additional nine
negative stresses would also act on the other three surfaces of the fluid element.

When the fluid is in motion the total stresses acting on the fluid element are comprised
of the hydrostatic pressure stresses, as above, and also the viscous stresses. This is
represented by the viscous stress tensor, τij , which combined with the hydrostatic
pressure stresses gives the total stress on the fluid element as:
 xx

ij    yx

 zx

xy
 yy
zy

 xz   P 0
0   xx
 
 
 yz    0 P 0     yx
zz   0
0 P   zx

 xy
 yy
zy

 xz 

 yz 
zz 

(3.25)

To complete the derivation of the stress tensor it is necessary to relate the viscous stress
tensor to the previously derived strain rate tensor. To this end, the fluid is assumed to be
incompressible and Newtonian, i.e. the viscous stress tensor is linearly proportional to
the strain rate tensor, and isotropic. As a consequence of these assumptions the
divergence of the velocity, .V , is zero and the dynamic viscosity, μ, is constant and
therefore, the two tensors are related by:

ij  2ij
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This results in a new equation for the stress tensor:
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(3.27)

Crucially, this equation allows the viscous stresses to be calculated from the velocity
gradients and is directly applicable here to the oxygen transport model used, as
discussed in Section 3.4.1, and also the post-processing of the results in the form of the
WSS and WSSG, as discussed in Section 3.3.

3.2.7

Shear Rate

The strain rate tensor, as defined in Equation (3.21), has three invariants, one of which
is referred to here as the shear rate and is defined by:
  2ij : ij

(3.28)

where γ̇ is the local shear rate and εij is the strain rate tensor. To find the magnitude of γ̇
Equation (3.28) is expanded upon, whereby the double product of the strain rate tensor
results in:

  u 
 v 
 w   u w   v u   w v 
  2    2    2 
 
  
    
 z   z x   x y   y z 
  x 
 y 
2

2

2

2

2

2





1
2

(3.29)

This is used in both the calculation of the non-Newtonian viscosity of blood using the
Bird-Carreau model, as shown below, and the shear-induced dispersion coefficient, as
described below in Section 3.4.1.
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3.2.8

Bird-Carreau Model

Human blood is a non-Newtonian fluid, in that its viscosity varies non-linearly
proportionally to the shear rate being exerted on it. Blood is a shear-thinning fluid
where the viscosity increases significantly with decreasing shear rate below a shear rate
of 100s-1.1,22,66 This effect is modelled using the Bird-Carreau model as described by:
2
    (0    ) 1    t  



 q 1 /2

(3.30)

where: μ0 is the low shear dynamic viscosity
μ∞ is the high shear dynamic viscosity
λt is the time constant
n is the power law index
3.3

Haemodynamic Variables of Interest

As discussed in Chapter 2 there are certain key haemodynamic variables which are
applicable to the assessment of stented arteries. The biological processes that are
instigated by stent implantation, namely thrombosis, inflammation, NIH and reendothelialisation, are affected by the haemodynamics which take place at the luminal
surface of the artery. In the work presented here the predicted WSS and WSSG
distributions are analysed. The WSS vector is a measure of the viscous stresses
imparted by the flowing blood on the luminal surface and is defined by:

WSS  ni ij

(3.31)

This can be written as:
ni  ij  i(n1xx  n 2  yx  n 3zx )  j(n1 xy  n 2 yy  n 3 zy ) 
k (n1xz  n 2  yz  n 3zz )
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where the normal vector, ni, is:

ni ij  n1i  n 2 j  n3k

(3.33)

For the purposes of CFD where the wall cell face normal vector may not be aligned
with the Cartesian coordinate frame the normal vector is written as:

ni  ij  a x i  a y j  a zk

(3.34)

where

ax 

a

ax

2
x

 a 2y  a z2 

,a y 

a

ay

2
x

 a 2y  a z2 

,a z 

a

az

2
x

 a 2y  a z2 

(3.35)

and ax, ay, and az are the components of the wall cell face area in the x, y, and z
directions respectively.
The spatial gradient of the WSS vector with respect to the Cartesian coordinate frame
describes the rate of change of each of the three WSS components in the three Cartesian
directions. In reference to the study here, the rate of change of the WSS parallel and
perpendicular to the local WSS vector is important for analysing the stent geometries, as
mentioned in Chapter 2. Therefore, the WSSG variable adopted in this study is the
magnitude of the rate of change of the WSS parallel (m-direction) and perpendicular (ndirection) to the local WSS vector, as given by:
     
WSSG   wm    wn 
 m   n 
2

2

(3.36)

where: τwm is the WSS in the m direction, i.e. parallel to the local WSS vector
τwn is the WSS in the n direction, i.e. perpendicular to the local WSS vector
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Finally, for the purpose of quantifying the strength and extent of the helical flow within
the geometries studied in Test Case 4 the helicity of the blood flow is needed. The
kinetic helicity density is defined as:

Hk    V   V

(3.37)

As described by Morbiducci et al., this variable can be normalised with respect to the
vorticity and velocity magnitudes resulting in the local normalised helicity (LNH):165

LNH 

  V   V
  V  V

 cos 

(3.38)

where θ is the angle between the velocity and vorticity vectors. The LNH is a measure
of the alignment/misalignment of the local velocity and vorticity vectors and has a range
of -1≤LNH≤1 where positive values are present in left-hand rotating flows and negative
values are present in right-hand rotating flows, when viewed in the direction of the
forward motion.38
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3.4

Oxygen Transport Theory

Blood consists of liquid plasma in which three types of cellular elements are suspended:
RBCs, white blood cells and platelets. RBCs constitute about 45%, by volume, of whole
blood and are the main carriers of oxygen. The coronary arteries act as a conduit for the
blood to deliver oxygen and nutrients to the heart muscle downstream. Oxygen is
critical for the maintenance of arterial wall physiology and is supplied to the cells
within the arterial wall from both the luminal blood and blood passing through vasa
vasorum in the adventitia.

3.4.1

Blood Oxygen Transport

Oxygen is transported in blood as free oxygen dissolved in plasma and oxygen
reversibly-bound to haemoglobin within the RBCs. The concentration of free oxygen
dissolved in plasma is quantified by the oxygen tension, i.e. the partial pressure of
oxygen in plasma. The oxygen tension is related to the free oxygen concentration by
Henry’s law:

PO2 

C


(3.39)

where PO2 is the oxygen tension, α is the solubility of oxygen in plasma, and C is the
concentration of free oxygen in plasma. The amount of bound oxygen contained in the
RBCs in the form of oxyhaemoglobin is proportional to the PO2 within the surrounding
plasma and can be approximated using the Hill equation (oxygen dissociation curve, as
shown in Figure 3.4):

S

POn2
n
POn2  PO2,50
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where S is the ratio of oxyhaemoglobin to total haemoglobin in the RBCs (commonly
expressed as a percentage), PO2,50 is the PO2 value at which the haemoglobin is 50%
saturated and n is the Hill parameter.

Figure 3.4: Oxygen dissociation curve for n=2.7.

For the purpose of modelling oxygen transport in blood, difficulty arises when the
bound oxygen is included in the model because of the non-linear nature of the Hill
equation. When included, the transportation of both free oxygen and bound oxygen in
the blood can be modelled using two advection-diffusion equations given as Equations
(3.41) and (3.42) respectively:



PO2
 .  DbPO2   r
t

 Hb
where

t

  Hb .  DcS  r

(3.41)
(3.42)

/ t is the substantial derivative, Db is the diffusivity of free oxygen in the

blood, r is the rate of release of oxygen from the haemoglobin, [Hb] is the total oxygen
carrying capacity of haemoglobin in blood, and Dc is the diffusivity of oxyhaemoglobin
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in blood. [Hb] is assumed to be constant, thus ignoring the plasma skimming layer
which has little effect on the oxygen transport.162 Oxyhaemoglobin is encapsulated in
RBCs and therefore the Dc value is interpreted as the shear-augmented dispersion
coefficient of RBCs in blood flow.
RBCs are present in the blood in high concentrations with approximately 5 × 109 RBCs
per cubic millimetre of blood. Due to these high concentrations, there are continuous
intercellular collisions and deformation of the RBCs. Through these collisions
individual RBCs have been seen to disperse radially within the blood flow. This radial
dispersion has been found to be proportional to the shear rate of the blood flow and also
improves the diffusion of molecules contained within the blood. Crucially, in the case of
oxygen transport, this radial dispersion of RBCs increases the effective diffusion of
oxygen within the blood because of the oxygen contained within them in bound form.
Because of the size of RBCs and the concentrations commonly found in vessels,
quantifying the magnitude of radial dispersion has proved to be difficult. To combat the
difficulty in the tracking of individual RBCs in blood flowing through a tube, some
researchers have resorted to using ghost RBCs, i.e. RBCs which have had the internal
contents, including the haemoglobin, removed through a process known as haemolysis.
By using ghost RBCs this improves the signal-to-noise ratio of the detection equipment
used, which allows tracer RBCs to be tracked more accurately. There is some debate as
to the effects of haemolysis on the mechanical properties of the ghost RBCs membrane
and, consequently, their dynamic properties when compared with RBCs.28,80 Therefore,
although the majority of the studies done on the dispersion coefficient of RBCs have
been done using ghost cells, there is a degree of uncertainty in the calculated
coefficients relative to normal RBCs.
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Figure 3.5: Dc as extrapolated from experimental studies for the shear rates
ranging from 1 - 500s-1.

In previous studies Dc is taken as 1.5×10-11 m2/s,162 which is the dispersion coefficient
for red tracer cells in a straight glass tube at an approximate shear rate of 20s-1.28 Higher
shear rates are encountered in carotid and coronary arteries and therefore, a variable
dispersion coefficient is employed, for the first time, in this work. This was extrapolated
from three separate studies by Goldsmith, Goldsmith and Marlow, and Cha and
Beissinger, as described in Equations (3.43) & (3.44), with the resultant Dc plotted
against the shear rate shown in Figure 3.5:30,79,80

For

0   100s1 : D  5.00 1012  5.00 1013 
c

(3.43)

  100s1 : D  3.68 1011  1.96 1013 
c

(3.44)

For

where  is the local shear rate, as described in Section 3.2. The two constants used in
Equation (3.43) are deduced from RBC ghost cell experiments by Goldsmith, and
Goldsmith and Marlow between average shear rates of 2-20s-1 at haematocrits of 39%
and 40% respectively.79,80 The two constants used in Equation (3.44) were deduced
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from the shear-induced particle diffusivity calculated by Cha and Beissinger at shear
rates between 200s-1 and 1000s-1 at a RBC ghost volume fraction of 0.45 corresponding
to the average haematocrit for a human male.30 It should be noted here that the model is
therefore only applicable for haematocrits within this range because the local Dc value
has been shown to vary with haematocrit.139

Figure 3.6: The gradient, dS⁄dPO2 , of the oxygen dissociation curve plotted
against PO2.

To reduce complexity when performing numerical simulations the two advectiondiffusion equations given above can be added together to form a single equation, as
described in Moore and Ethier:162

   Hb Dc dS  

  Hb dS  PO2
1



.
D
1


PO






2
 b
 dPO2 
t
 Db dPO2  
 



(3.45)

where the term dS/dPO2 , as shown in Figure 3.6, is the slope of the oxygen dissociation
curve given by:
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(3.46)

Given the shape of the oxygen dissociation curve, non-linearity enters the oxygen
transport equation through this term. In order to implement Equation (3.45) in the
commercially-available CFD software package used here it must be rearranged into the
form:
PO2
 . DPO2   Source
t

(3.47)

where the diffusivity coefficient D’ and the source term {Source} are given in Equations
(3.48) and (3.49) respectively:
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(3.48)


  Hb
dS 
 PO2 . 


dPO2  (3.49)

 

Equations (3.47) - (3.49) represent the complete non-linear blood oxygen transport
model, referred to herein as Model 1, which incorporates both the free oxygen and
bound oxygen.
3.4.1.1 Simplifications of the Blood Oxygen Transport Model
Previous studies have used simpler models in order to reduce computational expense.
Firstly, the non-linearity can be removed by replacing dS⁄dPO2 with a constant mean
value of ̅̅̅̅̅̅̅̅̅̅̅̅
dS⁄dPO2 calculated as follows:162
 nS 
dS

 1 S
dPO2  PO2 
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̅̅̅̅̅2 is a mean reference value fixed at 75mmHg and replaces PO2 in the Hill
where PO
equation in order to evaluate S̅ , as shown in Equation (3.51):

S

PO2

n

(3.51)

n

n
PO2  PO2,50

Secondly, the dispersion of the RBCs can be ignored by setting Dc =0, and finally, the
bound oxygen can be completely disregarded by setting [Hb]=0.
Similar to the study by Moore and Ethier (1997) the following five models were
employed as described below and summarised in Table 3.1:
Model 1: Both the free and bound oxygen are modelled and the non-linearity of the Hill
equation is retained.
Model 2: Both the free and bound oxygen are modelled and the non-linear element,
dS⁄dPO2 , is replaced with the constant value ̅̅̅̅̅̅̅̅̅̅̅̅
dS⁄dPO2 evaluated using Equation (3.50).
Model 3: Both the free and bound oxygen are modelled and the non-linearity of the Hill
equation is retained, but Dc =0 , thus neglecting the shear-augmented dispersion of
RBCs.
Model 4: Both the free and bound oxygen are modelled and the non-linear element,
dS⁄dPO2 , is replaced with the constant value ̅̅̅̅̅̅̅̅̅̅̅̅
dS⁄dPO2 , and Dc =0.
Model 5: Only the free oxygen is modelled, i.e. [Hb]=0.
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Models

Free O2

Bound O2

Dc

dS⁄dPO2

1

Y

Y

Eqn. (3.43 & 3.44)

Eqn. (3.46)

2

Y

Y

Eqn. (3.43 & 3.44)

0.00184 mmHg-1

3

Y

Y

0 m2/s

Eqn. (3.46)

4

Y

Y

0 m2/s

0.00184 mmHg-1

5

Y

N

-

-

Table 3.1: Summary of simplifications adopted for the blood oxygen transport
models.

3.4.2

Arterial Wall Oxygen Transport

As previously discussed, the arterial wall consists of three layers: the intima, media and
adventitia. In this study only the two inner layers, i.e. the intima and media, are included
in the arterial wall models, because the adventitia is supplied with oxygen through the
vasa vasorum, with distinct transport parameters assigned to each based on a study by
Richardson.206 In this study, the convection by the interstitial fluid in the arterial wall is
ignored as the convective velocity of interstitial fluid is two orders of magnitude lower
than the diffusive velocity.162 It is also assumed that the endothelial cells lining the
artery offer no resistance to the oxygen transport,237 and as oxygen diffuses through the
arterial wall it is consumed by the cells within.252 The consumption rate of oxygen
within the wall can be affected by a number of different variables, e.g. thickness of
arterial wall, presence of inflammation/atherosclerotic plaque, subject species and
age.206 For the purposes of this study the Michaelis-Menten Kinetics model was
employed to model the oxygen consumption within the arterial wall:

M  M0

PO2
PO2  PO2,M
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where M is the consumption rate of oxygen, M0 is the maximum consumption rate and
PO2,M is the value of PO2 at which the rate of reaction is half-maximal.200 The resultant
diffusion equation employed for the prediction of the transport of oxygen in the arterial
wall is:

dPO2
M
 .  DTPO2  
dt
T

(3.53)

where DT is the diffusivity of oxygen and αT is the solubility of oxygen in the arterial
wall tissue. Unless otherwise stated the values listed in Table 3.2 are used for the
parameters in all simulations and the boundary conditions are given at the end of each
test case description.
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Symbol

Units

Blood

Intima

Media

Reference

α

mlO2 /mlblood /mmHg

3.0×10-5

-

-

198

Db

m2 /s

1.2×10-9

-

-

162

[Hb]

ml O2 /ml blood

0.2

-

-

198

PO2,50

mmHg

26

-

-

162

n

-

2.7

-

-

96

DT

m2/s

-

0.9×10-9 1.05×10-9

206

αT

mlO2 /mltissue /mmHg

-

2.4×10-5

206

M0

mlO2 /mltissue /s

-

2.1×10-5 1.21×10-5

PO2,M

mmHg

-

1

2.4×10-5

1

206

78

Table 3.2: List of parameter values used for the blood and arterial wall oxygen
transport model.

3.4.3

Sensitivity Analysis

Of the values listed in Table 3.2 α, Db, and [Hb] are constant in human blood; although,
in reality there is some variability in the other parameter values,198 except for the
solubility of oxygen in the media layer tissue, αT, media, which is considered to be fixed
because the cellular composition of the media does not vary extensively for the arteries
assessed here.206 To assess the impact of variability of the other values on the oxygen
transport a sensitivity analysis was carried out whereby a simplified straight coronary
artery segment was modelled as shown in Figure 3.7. The radius of the lumen was 2.70
mm and the thickness of the intima and media were 0.24 mm and 0.32 mm,
respectively. Model 1, as defined in , was used to model the oxygen transport with
boundary conditions as follows: PO2,in=100 mmHg, PO2,adventitia=45 mmHg, PO2,out=0
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mmHg. An entry region was placed at the inlet to allow for development of the flow
with a zero oxygen flux boundary condition placed on the luminal wall surface.
Each parameter was assessed separately and varied according to minimum and
maximum values as listed in Table 3.3 while all other values were fixed at the values
defined in Table 3.2. Additionally, two other simulations were carried out where, first, a
fixed Dc value of 1.5×10-11 m2/s was used, as adopted by Moore and Ethier (1998),162
and second, intima layer properties were set which represented a high fat content in line
with a late-stage atherosclerotic plaque lesion, although the thickness was not increased.
To represent the effect of varying the parameter value in one number the difference
between the test and standard minimum PO2 value predicted in the intima domain is
shown in Figure 3.8.
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Figure 3.7: (a) Geometry and domain set up used for sensitivity analysis, (b) mesh
employed and (c) typical contour plot of PO2 along a slice within the lumen,
intima, and media.
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Parameter

Value used

Min

Max

PO2,50

26.6

23.1

30.6

n

2.7

1.7

3.2

DT, intima

0.9×10-9

0.72×10-9

0.9×10-9

DT, media

1.05×10-9

0.75×10-9

1.05×10-9

αT, intima

2.4×10-5

2.4×10-5

3.8×10-5

M0, intima

2.1×10-5

1.68×10-5

2.9×10-5

M0, media

1.21×10-5

1.21×10-5

1.89×10-5

PO2,M

1

0.5

1

Table 3.3: List of parameter values that were assessed for the sensitivity analysis.
For each parameter the value used in the Test Cases 1, 2, 3 & 4 is given along with
the minimum and maximum values possible in the human vasculature.

3.4.3.1 Results of Sensitivity Analysis
The oxygen dissociation curve is affected by several factors: blood temperature, pH, and
carbon dioxide concentration, and is defined by two values: the PO2,50 and n. PO2,50 is
the PO2 value at which the haemoglobin within the RBCs is at 50% saturation.88 The
typical value within the arterial system is 26.6 mmHg, although it can vary depending
on the pH of the blood which is affected by the amount of carbon dioxide (CO2)
dissolved in the blood. This is known as the Bohr effect and is actually useful in the
body because when CO2 dissolves in the water within the blood carbonic acid is formed
and the pH of the blood decreases resulting in the haemoglobin exhibiting less affinity
for oxygen, thus releasing oxygen to tissues most in need of oxygen that are producing
the CO2 as a waste product.174 The effects of changes in the partial pressure of CO2 and
pH in blood on PO2,50 was assessed by Hamilton et al. (2004),88 and the minimum and
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maximum PO2,50 values shown in Table 3.3 correspond to the range observed and are
taken here as 23.1 mmHg and 30.6 mmHg, respectively. As can be seen in Figure 3.8
the variation of PO2,50 has a small effect on the oxygen transport with a slightly
increased amount of oxygen reaching the intimal tissue in the case when PO2,50 is
minimum and the opposite with PO2,50 in maximum.

Figure 3.8: Variability in minimum PO2 within the intima domain with respect to
standard case.

Conversely, n is shown to have a significant effect on the amount of oxygen reaching
the arterial wall as shown by a significant increase in the minimum PO2 in the intima.
This can be explained by the considerable increase in the slope of the dissociation
curve, dS⁄dPO2 , when n=3.2 which means that for a small change in PO2 there is a
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large change in S. Therefore, the oxygen transport is sensitive to small changes in the n
value.
In the case of DT, intima the minimum value of 0.72×10-9 m2/s, which corresponds to the
lower diffusivity experienced in a six month old baby’s intima, has an almost negligible
effect on the oxygen transport into the arterial wall, as shown in Figure 3.8. DT, media has
a more noticeable effect with the minimum value of 0.75×10-9 m2/s, which likewise
corresponds to the lower diffusivity experienced in a six month old baby’s media,
exhibiting a drop in the minimum PO2 value in the intima of 5.77 mmHg. The standard
values of both DT,

intima

and DT,

media

are both the maximum values recorded in the

literature which do not vary significantly throughout the life of the arterial wall even in
the presence of a lesion.206
The maximum value of αT, intima, which represents the predicted solubility in an intima
with a high fat and calcium content, i.e. with a significant plaque lesion present,206
produces a significant change in the minimum PO2 levels within the intima with an
increase of 12.36 mmHg, as shown in Figure 3.8. This may on initial inspection appear
to mean that the presence of a plaque lesion in the intima produces a positive outcome
in terms of oxygen transport, but it should be noted that this simulation assumes
everything else remains equal which it would not in the case of a plaque lesion with the
consequence of increased intimal thickness increasing the diffusion distance and
eventually resulting in a necrotic plaque core. Nevertheless, αT,

intima

does have a

significant effect on the oxygen transport.
In the case of M0, intima this shows the largest effect on the oxygen transport into the
arterial wall, as shown in Figure 3.8, with maximum value producing a drop in the
minimum PO2 value of 15.78 mmHg, and the minimum value of M0, intima producing an
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increase of 7.11 mmHg. The maximum value of M0,

intima

corresponds to the value

predicted by Richardson (2008) in a 24 year old human with no plaque lesion present.206
Also noted in that study was that the oxygen consumption is predicted to decrease over
time in human arterial wall free of atherosclerosis. As such, the minimum M0, intima value
corresponds to the value predicted in a 70 year old with an 88% stenosis. It should be
noted again that this simulation assumes everything else remains constant including the
intimal thickness. However, it is clear that M0,

intima

has a significant impact on the

oxygen levels in the arterial wall. Likewise, the maximum value of M0,

media

also

produces a predicted decrease of 9.79 mmHg in the minimum PO2 value; however, it
should be noted that this value is theorised to only exist in a 6 month old baby.206 The
PO2, M minimum value of 0.5 mmHg is shown to have an almost negligible effect on the
oxygen levels, as would be expected considering the standard value used is 1 mmHg.
To demonstrate the effect of including a variable shear-induced dispersion coefficient,
Dc, a simulation was run with Dc=1.5×10-11 m2/s. As shown in Figure 3.8, by ignoring
the increase in Dc caused by the higher shear rates experienced in coronary arteries there
is a significant decrease of 20.65 mmHg in the predicted minimum PO2 value within the
intima. This provides an initial support for the use of a variable Dc value and shows one
disadvantage of simplification of the blood oxygen transport model.
Finally, a simulation was carried out to assess the effects of combining the two relevant
consequences of the presence of a 88% stenosis, i.e. an increased αT,
3.8×10-9 mlO2 ⁄mltissue ⁄mmHg and a decreased M0,

intima

intima

value of

value of 1.68×10-5

mlO2 ⁄mltissue ⁄s. This is predicted to have a positive effect with a significant increase
of 16 mmHg in the minimum PO2 value in the intima shown in Figure 3.8. This is again
with the stipulation that the increased intimal thickness is not factored in, but
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demonstrate how the plaque lesion properties could potentially affect the PO2 levels in
the arterial wall.
3.5

Oxygen Transport Variable of Interest – Sherwood Number

The Sherwood number (Sh) is a dimensionless mass-transfer coefficient and is used in
Test Cases 2 and 3, discussed in Chapter 6, along the luminal surface using:

dPO2 
Dia 
dn 

Sh =  PO2,in - PO2,w 

(3.54)

where Dia is the diameter of the artery, dPO2/dn is the gradient of PO2 normal to the
wall, PO2,in is the PO2 set at the inlet and PO2,w is the PO2 predicted at the arterial wall
luminal surface. Low Sh highlights potential areas on the luminal surface where the
underlining cells may be in danger of hypoxia. To establish what constitutes low Sh the
Damkholer number (Da), a dimensionless reaction rate coefficient, is first calculated
using:

Da =

M 0 TDia
α T DT PO2,in

(3.55)

where T is the arterial wall thickness. Using the assigned parameters for the coronary
artery models presented here the calculated Da≈17. When Sh≫Da the supply exceeds
the demand within the arterial wall; however, as Sh→Da the PO2 levels become
increasingly dependent upon the blood oxygen transport.252 Therefore, as the Sh drops
towards this calculated value of Da the PO2 levels within the arterial wall will decrease
to possible hypoxic levels.
3.6

Computational Fluid Dynamics

All simulations for this study were carried out in the commercial CFD software ANSYS
CFX 15.0 (ANSYS Inc., Canonsburg, PA, USA) which uses an element-based finite
volume method. ANSYS CFX makes the assumption of a continuum medium where the
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fluid is assumed to be evenly distributed throughout the domain. The information
presented here is adapted from the ANSYS Theory Guide with additional information
from books on the topic as referenced throughout.

3.6.1

Governing Equations

CFD is based on three fundamental governing equations of fluid dynamics: the
continuity, momentum and energy equations, which are based on three physical laws:
1. Continuity equation – mass is conserved, i.e. Law of Conservation of Mass
2. Momentum equation – net force on a body is equal to the mass of the body
multiplied by the acceleration, i.e. Newton’s Second Law
3. Energy equation – energy is conserved, i.e. Second Law of Thermodynamics
The energy equation is neglected in this instance as the process taking place is assumed
to be adiabatic and no mechanical energy is exchanged. If the flow is assumed to be
incompressible; i.e., there is no change in density, the continuity and momentum
equations in Cartesian coordinates can be presented as:

 V  0

(3.56)

 V


 V V    ij  f b
 t


(3.57)

The left hand side of Equation (3.57) represents the density multiplied by the
acceleration of the fluid element and the right hand side is the sum of all the forces
acting on the fluid element. Within the first term on the right σij represents the stress
tensor, as derived earlier in Section 3.2.6, and fb represents the body forces exerted on a
fluid element, which in this case is assumed to only consist of the force due to gravity,
ρg. In accordance with Equation (3.25), the first term on the right of Equation (3.57),
∇ ∙ σij , becomes (-∇P+∇∙(μeff ∇V)) for a Newtonian fluid, where μeff is the effective
viscosity. Thus, the momentum equation is expressed as:
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 V


  V   V   P     eff V   g
 t


(3.58)

Equation (3.58) is known as the Navier-Stokes equation and can be expressed in the
form of the transport (advection-diffusion) equation, Equation (3.59). The transport
equation is also used for modelling the transport of a passive scalar, such as PO2.






  V       eff    S
 t
advection 
diffusion
source
 transient


(3.59)

where φ is the conserved variable, Гeff is the effective diffusivity and Sφ is the source
term. Each of the terms in the transport equation represent a different component of the
overall transport of the conserved variable as signified by the notation under each. The
first term,

∂φ
∂t

, is called the transient term and represents how the conserved variable

changes with time. The second term,   V , is the advection term and describes how
the conserved variable is affected by the velocity of the fluid. The third term,

  eff  , is the diffusion term and describes how the conserved variable is affected
by diffusion due to gradients in values between neighbouring control volumes. In the
case of the Navier-Stokes equation V is the conserved variable, μeff (dynamic viscosity)
is the effective diffusivity and the source term is the sum of the pressure and gravity
forces. In the case of the transport of PO2, D’ is the effective diffusivity and the source
term is as described in Section 3.4.1.

3.6.2

Discretisation

As mentioned previously, ANSYS CFX uses an element-based finite volume method
and in order to solve the governing equations they need to discretised according to this
method. Firstly, the computational domain is spatially discretised into control volumes
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using a mesh. The mesh is comprised of nodes, where all solution variables and fluid
properties are stored, and these are surrounded by the control volumes. A control
volume is formed around a node by joining the centre points of all the surrounding mesh
elements and edge midpoints, as shown in a basic 2D mesh in Figure 3.9. Once the
computational domain is spatially discretised the governing equations are integrated
over each control volume. Taking the general transport equation, Equation (3.59), as
representative of all three governing equations, it can be integrated over the control
volume as follows:

  dv  v    V  dv  v    eff  dv  v Sdv
t



v

(3.60)

where v denotes the volume. Using the divergence theorem the second and third terms
can be converted from volume integrals to surface integrals:



v


  dv  s  V   nds  s  eff   nds  v Sdv
t

(3.61)

where n represents the surface normal vector. The surface integrals represent a
summation of all the fluxes crossing the boundaries of the individual control volumes
and the volume integrals represent source or accumulation terms. Once these integrals
have been derived they must be numerically discretised, essentially replacing each
integral with an algebraic equation.
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Control Volume
Node

Element centre

Element

Figure 3.9: Sample 2D mesh with control volume defined around node.

Looking at Equation (3.61) there are four terms, two of which have volume integrals
and two of which have surface integrals. Volume integrals are discretised within each
element sector and then the total for each control volume is a summation of all the
sector values within that control volume. The surface integrals are discretised at
integration points, located at the midpoint of sector edges as shown in Figure 3.10, and
then distributed to the adjacent control volumes. The surface integrals are equal in
magnitude and opposite in sign for the two control volumes to which they are
distributed to.
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Integration Points

Element Centre

Element Sector

Figure 3.10: 2D Mesh element taken from Figure 3.9 with integration points and
element sector highlighted.

The transient term in Equation (3.61) is a volume integral and discretising it using the
second-order backward Euler method results in the algebraic equation:


v 3
1
n
n 1
n 2

dv



2








 
v t

t  2
2


(3.62)

where v represents the control volume, ∆t is the time step, and the superscripts n, n-1
and n-2 represent the current, previous and second previous time steps respectively. The
advection term in Equation (3.61) is a surface integral and is discretised as the sum of
fluxes over all the faces of the control volume:
a

s  V   nds    V  nds ip ip

(3.63)

ip 1

where V  nds represents the mass flow rate normal to the control volume face
containing the integration point (ip) and φip is the conserved variable at that integration
point (total number of integration points represented by a). The solution variables are
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stored at the nodes and therefore, the face values are approximated at the integration
points using:

ip  up   r

(3.64)

where φup is the value of the conserved variable at the node directly upwind from the
integration point, β is the blend factor, ∇φ is the gradient of the conserved variable and
r is the vector from the upwind node to the integration point. The high resolution
scheme was implemented in all simulations herein, for which 0≤β≤1 and a nonlinear
recipe is used to calculate β at each node based on the boundedness principles used by
Barth and Jesperson.8 The gradients of conserved variable is calculated using shape
function which are linear in terms of the parametric coordinates. The diffusion term is
also a surface integral and is approximated as:
a

s  eff   nds    eff   nds

(3.65)

ip 1

The source term is a volume integral and is approximated as follows:

 S dv  S v
v





(3.66)

where S̅φ is the average value of the source term within the control volume and v is the
volume of the control volume. When all four terms are discretised the resultant equation
is:
a
a
v 3
1
n
n 1
n 2 


2





V

n
ds


   
   
ip ip   eff   nds  S v (3.67)
t  2
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ip 1

By putting the diffusion term on the right hand side, the equation becomes:
a
a
v 3
1
n
n 1
n 2 


2





V

n
ds










 eff   nds  S v (3.68)
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When this equation is applied to all control volumes throughout the computational
domain all of the algebraic equations can be combined into a matrix of the form:

 A   b

(3.69)

where [A] represents the sparse coefficient matrix, [φ] is the solution vector containing
the variable values at the nodes and [b] is the right hand side of Equation (3.68).

3.6.3

Solution

The discretised algebraic equations are solved in ANSYS CFX using an implicitly
coupled multigrid accelerated incomplete lower upper factorisation technique. This is an
iterative technique that involves the solution converging towards an exact solution over
the course of numerous iterations. The multigrid process comprises of early iterations
being solved on a fine mesh and later iterations being solved on progressively courser
virtual meshes.4 The results are then transferred from the coarsest mesh back to the
original fine mesh. This technique has the advantage of decreasing the time taken to
reach a converged solution.
Looking at Equation (3.69) above, the solution is reached by first using an approximate
solution of φ, φn, and improving this by a correction, φ’, which results in the solution
after a time step, φn+1, being closer to the exact solution, where:

n 1  n   '

(3.70)

The correction term is calculated using:

A '  r n
where rn is the residual of the previous time step calculated using:
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r n  b  An

(3.72)

The residuals are normalised for monitoring the solution and setting the convergence
criteria.
3.7

Summary

In this chapter the fundamental theory relevant to the study was presented. First, the
derivation of the fluid stress tensor was shown along with the haemodynamic variables
of interest to this study. Second, the oxygen transport theory relevant to both the blood
and the arterial wall was described along with the oxygen transport variable of interest,
Sh. The results of a sensitivity analysis of the oxygen transport model were presented
with variation of several parameters shown to have a significant effect on the amount of
oxygen reaching the arterial wall. Specifically, the Hill coefficient (n), the solubility of
oxygen in the intima (αT, intima), and the consumption of oxygen in both the intima (M0,
intima)

and media (M0, media) all play a dominant role in the oxygen transport. These also

are the parameters that would vary the most in diseased arterial walls and their effects
were previously assessed by Richardson (2008); however, the luminal oxygen transport
was ignored with a constant PO2 value fixed on the luminal surface.206 The effect of
using a constant Dc value of 1.5×10-11 m2/s as done previously by other researchers was
assessed and showed to have a significant effect on the oxygen transport in coronary
arteries where the shear rates are much higher than the shear rate where the fixed Dc
value is valid, i.e. 20 s-1. Finally, the CFD governing equations, discretisation technique,
and how the equations are employed in the software was presented. In the next chapter a
thorough review of the literature particular to this study is discussed.
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CHAPTER
Chapter 4.
4.1

4

Literature Survey

Introduction

In this chapter literature reviews of previous studies in the areas of oxygen transport in
arteries and haemodynamic analysis of stents are presented. In addition to this, with
specific relevance to Test Case 4, a thorough review of helical flow in the
cardiovascular system is given along with the studies related to two stent devices being
developed that not only re-establish blood-flow in an obstructed artery but establish
haemodynamics that theoretically inhibit ISR.
4.2

Oxygen Transport Analyses

The biological processes that can result in ISR are instigated by the effects of stent
implantation and include structural damage to the arterial wall, augmentation of the
local haemodynamic environment and the presence of a foreign body.171 In terms of the
augmentation of the haemodynamic environment, stenting produces a predominantly
beneficial effect, i.e. restoration of required blood flow to downstream vasculature;
however, locally within the stented region, the haemodynamics impact the natural
healing processes within the arterial wall. This local augmentation of the haemodynamic
environment due to the presence of a stent in turn affects the oxygen flux into the
arterial wall which can result in a deficiency of oxygen, known as hypoxia, in some
regions. Hypoxia has been associated with increased adventitial vasa vasorum34 and IH
in animal studies.216,218 Therefore, given that hypoxia and increased IH may result in
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ISR, investigation of the local oxygen transport within stented artery models using CFD
is important in order to elucidate the effects of stenting on the arterial wall cellular
components and also to aid in the design of future coronary stents.
Hypoxia is known to cause atherosclerosis in large arteries.252 Because of this, the
majority of numerical studies of oxygen transport in three-dimensional (3D) arteries
have been in relation to arteries with no implanted device. Many of these numerical
studies fall into the category of wall-free models where only the oxygen transport in the
blood is modelled and a constant value of oxygen concentration/PO2 value is specified
on the luminal surface.45 Another category of oxygen transport studies employs fully
coupled blood and arterial wall models, where diffusion and consumption of oxygen in
the arterial wall are modelled, and a constant flux or concentration/PO2 value boundary
condition is specified on the media/adventitia boundary interface.23,248 These models
offer the advantage of a more realistic representation of the oxygen transport conditions;
however, in these simulations the arterial wall was modelled as homogeneous which is
not physiologically correct. In contrast, a third analysis type is lumen-free models which
ignore the haemodynamic conditions within the lumen and assume a constant oxygen
concentration/PO2 value on the luminal surface. As an example, Richardson modelled
the oxygen transport within heterogeneous coronary arterial walls only, with varying
parameters according to age and stenosis, while ignoring the flow within the lumen.206
Considering the influence of haemodynamics on the oxygen transport into the arterial
wall, the wall-free and coupled analyses are discussed below.
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4.2.1

Wall-Free Analyses

Wall-free models are the simplest models as they just account for the mass transport
within the blood. The effects of the transport into the arterial wall are accounted for by
applying an appropriate set of boundary conditions. In oxygen mass transport studies
this is generally a PO2 value of 60mmHg, or equivalent in concentration/normalised
concentration values, being imposed on the luminal surface. This simplification
essentially ignores the oxygen consumption and diffusion in the arterial wall and is used
when the study of the haemodynamic effects are preferred. In these cases the Sh is
valuable as it can be calculated based on the spatial gradient of the PO2 normal to the
wall surface. For interpretation of the Sh there are three different scenarios where the
flow is: directed towards the wall, flowing parallel to the wall, and directed away from
the wall. In case (1), the mass transport boundary layer (MTBL) is relatively narrow
which results in a high PO2 gradient normal to the wall and consequently a high Sh. In
case (2), the MTBL is free to develop and will gradually increase until a constant
thickness is reached. For the PO2 gradient and Sh this results in a gradual transition
from high values to low values longitudinally along the wall. In case (3), a relatively
thicker MTBL is created and consequently, both the PO2 gradient and the Sh are
reduced. Areas of low Sh are then interpreted as areas which are prone to hypoxia
occurring in the underlying tissue and possibly increased IH and atherosclerosis.
One of the earliest numerical studies of oxygen transport in arteries was carried out by
Friedman and Ehrlich and published in 1975.64 They modelled the oxygen transport in a
2D arterial bifurcation in steady flow conditions and analysed the effects of spatial
variations in shear on the oxygen flux to the wall. It was found that there was as much
variation in the wall flux and concentration values as there was in shear. In a study
published in 1977 Back et al. examined the oxygen transport in 2D representations of
83

CHAPTER 4: Literature Survey

partially obstructed human coronary arteries and found that the oxygen flux into the
arterial wall was reduced in the flow separation region downstream of plaque locations.5
One of the recommendations of this study was that in vivo measurements with oxygen
microelectrodes in animals were needed to learn more about the variations in oxygen
transport in plaque regions. Two such studies carried out by Santilli et al. in 1995 and
2000 are used in Test Case 1 and 2 (Chapters 6 and 7) to compare the transport models
adopted in this work.217,218
In terms of 3D studies, Rappitsch et al. (1997) presented a numerical scheme for the
simulation of unsteady flow and mass transport in large arteries where the flow is
unsteady and the resistance of the arterial wall to transmural transport is governed by a
shear-dependent wall permeability model.204 The methodology is demonstrated in a 90°
arterial bend and the key observation noted is that the mass transfer flux is reduced on
the inner wall of the bend, which is critical in the modelling of not only oxygen
transport, but also of macromolecules such as LDLs and albumin. The shear-dependent
wall permeability model adopted was noted to not be valid for oxygen transfer through
the wall, but it would be important for future studies in the mass transport of
macromolecules such as albumin or LDL.204
In the same year Ma et al. (1997) published a study where they conducted a 3D
simulation of steady flow and oxygen transport in an idealised carotid bifurcation with a
constant PO2 value imposed at the arterial wall surface and predicted the oxygen flux
distribution over the inner wall surface.142 The geometry used was based on
measurements of biplanar angiograms of 57 patients by Bharadvaj et al. (1982a, b)15,16
which were also used in studies by Tada and Tarbell, discussed below.248,249 The mass
transfer was found to be five times lower along the outer wall of the carotid sinus in
comparison with the arterial wall immediately upstream or downstream of the sinus.
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Areas of predicted low mass transfer was found to correlate strongly with areas prone to
intimal thickening in humans, as shown in Figure 4.1. This study was important in that
it supported the relatively new hypothesis put forward by Simanonok in 1996 that nonischemic hypoxia of the arterial wall is the primary cause of atherosclerosis. 231 This
hypothesis was proposed to replace the dominant model of atherosclerosis at the time
which was the response-to-injury hypothesis which was originally proposed by Ross
and Glomset in 1976.210 This is a reoccurring theme in CFD simulations, in that there
are assumptions made throughout the process including in geometry generation which
affect the perceived accuracy of the simulations.

Figure 4.1: Low mass transfer rate is directly related to measured intimal
thickness with a correlation coefficient of 0.944. Thus, low mass transfer may be an
indication of plaque localisation and atherogenic growth.142
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Qiu and Tarbell (2000) modelled the oxygen mass transfer in a compliant curved tube
model of a coronary artery.202 In this study they modelled the movement of the coronary
artery arterial wall as predicted would occur due to the motion of the heart. In this study
the curvature of the coronary artery caused a difference between the Sh value on the
inner and outer, in terms of the centreline curvature, luminal surface of several
magnitudes which implied that the oxygen content of the arterial wall could be limited
by the flow conditions in this region. Interestingly, the effects of the movement of the
coronary artery caused by the motion of the heart on the results was not discussed by
the authors. In this study the authors neglected the bound oxygen transport and reasoned
that the Sh with the bound oxygen would be 2.5 times the predicted Sh without the
bound oxygen. This assumption is based on the results from the paper by Moore and
Ethier (1997) which compared five different models, similar to the models discussed in
Chapter 3. The validity of this assumption will be revisited in Chapter 9.
These results from Qui and Tarbell (2000) were found to be in agreement with a
separate study by Kaazemput-Mofrad and Ethier (2001) analysing the oxygen transport
within an anatomically realistic human RCA.116 The results of this study showed how
the oxygen concentration field within the RCA closely followed the primary and
secondary flow features. The secondary flow features mentioned are two Dean vortices
which are formed due to the curvature of the RCA centreline. As the flow develops
further one vortex becomes more dominant and as a result the concentration field is
pulled away from the inner wall leaving a zone of reduced oxygen concentration near
the inner wall. The importance of the secondary flow structure is a reoccurring issue in
the study of oxygen mass transport and will be elaborated on later. In this study the Sh
was found to vary by 800 fold from the inner to the outer wall of the curved RCA;
however, it was noted that with the addition of flow pulsatility and diameter reduction
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of the artery, this may be reduced to 23 fold. In comparison with the study by Qui and
Tarbell, the range of Sh was smaller and this was deemed to have been caused by the
enhanced mixing produced in a more realistic geometry.116

Figure 4.2: Velocity and concentration profiles in the non-symmetric stenosis
model.117

In 2005 Kaazempur-Mofrad and Ethier published a study where they analysed the
difference in terms of oxygen transport within a coronary artery partially obstructed by
axisymmetric and asymmetric plaque lesions, as shown in Figure 4.2.117 This again was
a wall-free model where the oxygen concentration was fixed on the arterial wall luminal
surface and the flux was analysed using the local Sh. The results indicated that there is a
considerable difference in mass transfer patterns between both models, concluding that
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accurate representations of the arterial geometries is essential in order to predict the
mass transfer in partially obstructed arteries.
Kolandavel et al. (2006) modelled both the LDL and oxygen mass transport in an
idealised moving coronary artery model under both steady and pulsatile flow
conditions.124 A physiological velocity profile was imposed at the inlet and the
curvature of the artery was varied according to a sinusoidal waveform over the period of
a cardiac cycle. In comparison with the steady flow simulation, the pulsatility was found
to decrease the oxygen flux to the inner wall. Conversely, with the addition of wall
motion an increase in oxygen flux in the distal region of the inner wall was observed.
Overall the oxygen wall flux was found to not vary appreciably over the course of a
cardiac cycle.
Tada and Tarbell (2006) modelled the oxygen transport in a compliant carotid
bifurcation model with realistic blood flow waveforms and PO2=0mmHg imposed on
the luminal surface.250 As with previous papers, the Sh was used to quantify the oxygen
flux into the arterial wall. A region of low Sh was predicted on the outer wall of the
carotid sinus where the flow separates away from the wall. Therefore, it was concluded
that flow separation provides a very strong haemodynamic barrier to oxygen transport.
Dramatic differences in the Sh were seen during the cardiac cycle between the
compliant model and rigid model; however, crucially, these transient differences did not
translate into significant differences in the time-mean Sh, as shown in Figure 4.3.
Additionally, the time-mean Sh values did not show considerable difference with the
transient models. Thus, neglecting the compliance of the arterial wall and the pulsatility
of the flow in simulations of oxygen transport in arteries is justifiable.
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Figure 4.3: Profiles of the time-mean Sh along the outer wall of the common
carotid artery and internal carotid artery, the outer wall of the CCA and external
carotid artery, and the periphery of the ICA sinus for three different
haemodynamic models: transient with compliant arterial walls (elastic mean),
transient with rigid walls (rigid mean) and steady state with rigid walls (steady)
from Tada and Tarbell (2006).250

Although slightly off topic, in terms of simulating oxygen transport in arteries, a 2D
study by Zierenberg et al. (2007) analysing the oxygen transfer from a circular cylinder
filled with an oxygen source to surrounding blood is worth mentioning.275 The
investigation was a fundamental study into the gas exchange and haemodynamic
conditions needed for the proper working of an artificial lung. In this particular study
the authors used an oxygen transport model which incorporated the bound oxygen as
well as the free oxygen present in the plasma. This is similar to the oxygen transport
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model adopted here, although a constant shear-augmented dispersion coefficient
(1.5×10-11m2/s) of RBCs was used and also the calculated Schmidt number (Sc) was
lower (1000) compared with other studies (~3600). Sc is a dimensionless number that is
ν

defined as the ratio of the viscous diffusion rate and the mass diffusion rate, Sc= D,
where in this case ν is the kinematic viscosity of blood and D is the mass diffusivity of
oxygen in blood. This study demonstrates some of the other applications of an accurate
oxygen transport model in the design of medical devices.
Coppola and Caro (2008) analysed the oxygen mass transport in two U-bends: one with
a straight centreline and one with a helical centreline.43 The adopted oxygen transport
model only incorporated the free oxygen, with the effect of the bound oxygen accounted
for by using the same correction factor of 2.5 as used by Qiu and Tarbell (2000) 203
based on results from Moore and Ethier (1997).162 They observed that the WSS and
oxygen supply uncoupled downstream of planar bends, and that secondary motion
resulting from the 3D geometry can influence both the WSS and Sh distribution.44 In
2009 Coppola and Caro analysed the WSS distribution and oxygen mass transport in an
artery with a helical section with a pulsatile inlet velocity.45 The pulsatile flow was
sinusoidal in nature with the effects of variation of the amplitude and frequency studied.
It was found that there is a sweeping motion of the Dean Vortices and with increasing
amplitude the WSS and oxygen flux increases. Increasing the frequency of the pulsatile
waveform increased the WSS, but had no effect on the oxygen mass transfer.
Liu et al. (2010) analysed the effect of spiral flow on the oxygen mass transfer in the
aorta.140 The simulations were carried out in four difference models of the aorta: a
realistic model constructed from MRI images with all geometrical features of the aorta
intact, and three other models with decreasing amounts of features included. They
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concluded that spiral flow may have physiological significance and enhance oxygen
flux into the arterial wall, which will be discussed further in Section 4.4.
Carroll et al. (2010) conducted an experimental validation of advection-diffusion
discretisation schemes used for solving mass transport numerically.29 In this study the
authors simulated the mass-transport of a species concentration in an idealised
aneurysm geometry solved using four different discretisation schemes: first-order
upwind, power law, second-order upwind and quadratic upstream interpolation for
convective kinetics (QUICK). The results of these simulations were then compared with
the experimental results taken from fluid samples extracted from a glass aneurysm
model. They concluded that second order or QUICK discretisation schemes are most
appropriate and produce the most accurate prediction of the mass transfer field when
compared with the experimental results.29
One interesting study was conducted by Biasetti et al. (2014) who assessed four patientspecific geometries for low oxygen mass flux into the arterial wall by locating regions
of low haematocrit.18 This was interesting because instead of modelling the oxygen
transport the authors modelled the RBC transport and from the results induced that areas
where the haematocrit was low must coincide with areas that the oxygen flux into the
arterial wall was low. The RBCs were modelled using the Phillips’ shear-inducedmodel for RBC dispersion where the RBCs are assumed to be rigid particles. 196 The
areas located matched with areas know to be prone to formation of atherosclerotic
lesions with an example shown in Figure 4.4. The authors also found that the shearinduced migration of the RBCs away from the arterial wall surface could be enhanced
or dampened by secondary flows within the blood flow that convect RBCs away or
towards the arterial wall. With the exception of this study by Biasetti et al. and the
previously mentioned study by Zierenberg et al. all of the above studies only included
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the free oxygen in their blood oxygen transport models. Additionally, the oxygen
concentration at the arterial wall surface was assumed to be constant with the Sh used to
analyse the oxygen flux. The test cases presented in Chapters 6 and 7 will consider the
advantages and disadvantages of this approach.

Figure 4.4: Wall haematocrit in the patient-specific normal carotid bifurcation
during the cardiac cycle at t=0.10s from Biasetti et al. (2014).18

4.2.2

Coupled Blood-Arterial Wall Analyses

Oxygen transport models which incorporate the blood and the arterial wall have an
advantage over the previous wall-free models in that the interaction between the mass
transport processes ongoing in both domains can be studied. These also offer the
advantage of predicting the effects of haemodynamic conditions on the oxygen
concentration in the wall more accurately in comparison with using the Sh. The
disadvantage of these models is that there are many factors that affect the oxygen
consumption and diffusion within the wall which could lead to a lot of variability in the
oxygen levels in reality. For the purpose of analysis, the standard approach is to use

92

CHAPTER 4: Literature Survey

constant consumption and diffusion parameters for the arterial wall. The results
obtained in this case are only varied according to the set parameters, the haemodynamic
conditions, the thickness of the arterial wall and the boundary conditions. Thus the
effects of different cell composition, atherosclerotic lesion progression, inflammatory
cellular activity and vasa vasorum penetration are ignored.

Figure 4.5: (a) Model geometry and velocity vector plot for steady flow through the
stenosis (b) Local Sh and (c) dimensionless surface PO2, (PO2-PO2,w)/(PO2,in-PO2,w),
as a function of dimensionless axial position for all five cases with fluid side
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transport coupled to an oxygen consuming wall. Adapted from Moore and Ethier
(1997).162

Coupled wall-lumen models of oxygen transport have the advantage over wall-free
models in that they can provide information on the concentration profiles within the
arterial wall. Moore and Ethier (1997) analysed the oxygen transport within a 2D
geometry of a 89% area reduction axisymmetric stenosis under steady flow conditions,
as shown in Figure 4.5.162 The consumption of oxygen in the arterial wall is included
along with the non-linear oxygen binding properties of haemoglobin. As part of the
study the authors analysed the effects of simplifying the blood oxygen transport model
used, and of artificially decreasing Sc. As well as demonstrating the disadvantages of
simplifying the blood transport model, the authors concluded that further studies of
oxygen transport in large arteries must include the oxygen transport into an accurate
model of the arterial wall. This study is important for the work presented here because
the blood oxygen transport models, as described in Chapter 3, were based on those used
by Moore and Ethier. How their study differed was that they assumed a constant shearinduced RBC dispersion coefficient, 1.5×10-11m2/s, whereas the models used here
adopted a variable dispersion coefficient that was dependent on the shear rate. This is
more reflective of the range of shear rates experienced in the arteries modelled here. As
mentioned previously, many subsequent studies reference Moore and Ethier’s results
when simplifying their oxygen transport models, for instance neglecting the bound
oxygen. The validity of this is debated in the conclusions section of Chapter 7.
Perktold et al. (2002) modelled the oxygen transport, along with wall and suture
mechanics, in anatomically-correct bypass configurations.193 Three different types of
anastomosis were modelled: conventional, Taylor-patch and Miller-cuff with venous
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interposition grafts of different modifications. The haemodynamic conditions were
assessed for each geometry and it was found that there was a correlation between low
WSS and reduced oxygen flux into the arterial wall.
One particular study published by Banerjee et al. (2008) modelled the oxygen transport
in a simplistic 2D avascular arterial wall of a coronary artery stenosis before and after
angioplasty.7 The stenosis pre- and post-angioplasty was found to have a significant
impact on the luminal PO2 values along the arterial wall and the calculated flux into the
arterial wall. The geometries did not include stent struts, and the arterial wall was
assumed to be homogeneous and of constant thickness.
Tada (2010) continued his previous work modelling the oxygen transport and transient
blood flow in a carotid bifurcation model by including a homogeneous arterial wall and
neglecting the effects of a compliant arterial wall, as modelled previously by Tada and
Tarbell (2006).248,250 The geometry was constructed from averaged dimensions taken
from several previous studies: Ma et al. (1997), Bharadvaj et al. (1982), and Perktold
and Rappitsch (1995).15,142,194 Three PO2 profile locations were adopted for comparison
from in vivo measurement locations used by Santilli et al. in dog carotid arteries.217 One
simplification implemented was that the curvature of the ICA was ignored which would
produce a swirling flow within the ICA. This would not alter the WSS or oxygen flux
within the carotid sinus, where two of the three measurement locations are situated. The
region of low oxygen flux on the outer wall of the carotid sinus, as observed by
previous authors, was predicted in this study also. In addition, it was found that the
effect of oscillatory blood flow on the PO2 levels in the arterial wall was negligible. The
three PO2 profile plots exhibited a considerable difference when compared with Santilli
et al. as shown in Figure 4.6. A steep gradient at the luminal surface present in the
results presented by Santilli et al. was not reproduced in these results. Additionally, the
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results failed to predict the minima point in all three plots. The geometry used by Tada
was adapted for use in Test Case 1, as described in Chapter 6.

Figure 4.6: Transarterial wall PO2 profiles at three locations from Tada (2010).248

Caputo et al. (2013) conducted an analysis of the haemodynamic conditions and oxygen
transport in three geometries of stented coronary arteries with different centreline
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curvatures.23 Initially, a stainless steel, balloon-expandable stent was implanted in a
healthy RCA at a balloon-to-artery ratio of 1.4:1. After 14 days the stented artery was
harvested and the stent was imaged using high resolution micro-CT scans. The stent
geometry was then imported into a commercial FEA software where an idealised
arterial wall was over-expanded and allowed to relax onto the stent geometry. This was
done to obtain an accurate representation of the arterial wall prolapse without the
neointimal growth present. The resultant geometry had a straight centreline that
extended proximal and distal to the stented region. Two additional geometries were
constructed whereby the proximal and distal regions had a curved centreline. The two
radii of curvature were 36 and 20mm (labelled as CU36 and CU20 in Figure 4.7), which
corresponded to the range of curvatures of human and porcine RCAs obtained from
angiographic data. The simulations were steady-state and the bound oxygen was
ignored. When the predicted results were compared with the histological data, areas of
predicted low WSS (defined by Caputo as <0.4Pa) and low oxygen concentration were
found to match with areas of increased NIH, with some sample plots shown in Figure
4.7. This is the only 3D study of oxygen transport in stented arteries carried out to date
which incorporates the stent struts, which were found to have a considerable impact on
the local haemodynamics and oxygen transport. Because of the limitations in the
oxygen transport model adopted it is possible that the extent of the hypoxic regions in
the arterial wall was under-predicted.
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Figure 4.7: Qualitative comparison of the oxygen concentration between the
computational models: straight, and with a radius of curvature of 36 and 20 mm,
labelled as CU36 and CU20, respectively, as modelled by Caputo et al. (2013).23
Also shown on the right are the corresponding histological images at three selected
sections. Black arrows indicate the wall region with the lowest oxygen
concentration in the computational models and the greatest neointimal thickness in
the histologies.23
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4.3

Haemodynamic Analyses of Stented Arteries

The local haemodynamics present in arteries have been shown to affect the biological
processes which take place following stent implantation, as discussed in Chapter 2.
CFD simulations are required for analysing the local haemodynamics within a stented
artery because of the size of the arteries concerned and consequently, the difficulty in
analysing the blood flow in vivo or in vitro. Additionally, the incidence and severity of
ISR has been found to vary with stent type and therefore, comparison of stent types
using CFD is warranted. Throughout the relatively short history of CFD analysis of
stents there are three reoccurring themes: how stent design affects the local
haemodynamics within the stented region, how realistic are the geometries used, and
what haemodynamic variables are used to assess the designs. The first theme was
discussed in Chapter 2. The second theme is common to the oxygen transport studies
above and will also be apparent in relevant studies below. In reference to the third
theme the range of haemodynamic variables used in assessing stent geometries, which
endeavour to capture the flow features more accurately, is ever expanding and a select
amount will be mentioned throughout this section and Section 4.4.
LaDisa et al. (2003) were among the first to analyse the haemodynamic impact of
stenting a coronary artery using CFD.130 In their study the arterial wall surface was
modelled as a straight cylinder and the stent investigated was similar to the PalmazSchatz stent (Johnson & Johnson, Fremont, CA, USA). They compared the WSS
distribution within the stented geometry with that of an unstented geometry. The
simulations were based on previous in vivo measurements of canine LAD coronary
artery diameter and blood flow velocities before and after stent implantation.131 The
results of this study showed that the stent geometry had a dramatic effect on the WSS
distribution along the luminal surface including that the minimum WSS value decreased
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by 77% in comparison with an unstented artery, and stagnation zones were localised
around stent struts. Following this study LaDisa et al. conducted several more studies
into how stent designs and deployment ratios affect the WSS and spatial WSSG
distributions within stented coronary arteries. Following this, in a paper published in
2004, LaDisa et al. assessed the impact of deployment diameter and stent strut
properties including number, width and thickness, on the WSS distribution. Increasing
the deployment ratio from 1.1:1 to 1.2:1 increased the area of the stented luminal
surface exposed to low WSS (defined as <0.5Pa) 12-fold. Doubling the number of struts
from four to eight resulted in a 2.75-fold increase in the luminal surface area exposed to
low WSS. Reducing the strut thickness from 0.096 to 0.056mm caused the total area
exposed to low WSS to decrease by approximately 87%. A reduction in stent strut width
resulted in an increase of 9% of the stent area being exposed to low WSS. This study
confirmed that stent design properties and deployment ratio could influence the local
haemodynamic conditions and consequently, affect the biological processes post-stent
implantation.
In a paper published in 2005 LaDisa et al. assessed the impact of a more realistic
representation of the arterial wall deformation on the transient WSS. The hypothesis
was that in reality the arterial wall would straighten circumferentially between stent
struts and if modelled this would produce different WSS distributions in comparison
with idealised cylindrical stented arteries. To derive the circumferentially straightened
geometries an automated construction algorithm was used. The WSS and the WSSG
were assessed for two different geometries based on the Palmaz-Schutz stent and they
concluded that the arterial wall deformation is important in determining the WSS
distribution.
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He et al. conducted a parametric study, published in 2005, of stent strut geometries
using geometries comprising of just two stent struts in a flat configuration with and
without a link strut.93 The authors assessed the geometries in terms of the normalised
axial WSS and the percentage of the arterial wall luminal surface exposed to a low WSS
threshold value of <0.5Pa. This was done for a variety of stent strut configurations and
carried out under high and low flow conditions. The study confirmed that stent strut
configuration could influence the local haemodynamics and, specifically, that struts
should be, wherever possible, orientated parallel to the vessel axis to reduce flow
recirculation and low WSS zones.

Figure 4.8: Contour plots of the WSS magnitude on the arterial wall portion
delimited by the links and the stent struts at the diastolic peak (0.16s) for each
stent model, from Balossino et al. (2009).6

Balossino et al., in a paper published in 2008, compared the effects of four different
stent designs, similar to four commercially available stents, on the local haemodynamics
within stented coronary arteries. Single units of each stent design were expanded
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virtually using FEA in idealised arteries with simplified arterial plaque and the resultant
geometries were analysed using a transient velocity inlet boundary condition. Given that
the CFD geometries used were derived using FEA, and also included the presence of
plaque, they were more representative of what would happen in vivo. The percentage
area of the arterial wall luminal surface exposed to a low WSS threshold value of 0.5Pa
at six time instants during the cardiac cycle was used to compare the four different stent
designs, with the contour plots of the WSS magnitude at diastolic peak for each stent
shown in Figure 4.8. Additionally, the effect of stent strut thickness on the WSS was
assessed and interestingly, it was found that a thicker strut, in this instance, results in
less of the arterial wall being exposed to low WSS. The authors note that this
observation disagrees with previous studies and may be the result of modelling the
pulsatile flow with a FEA-derived geometry; i.e. more realistic geometries than
previous studies. The authors also analysed the peak WSS and noticed that the greater
the distance between stent struts the higher the peak WSS values are. This study further
confirmed the link between stent design parameters and the WSS distribution within a
stented coronary artery.
Murphy and Boyle in 2008 assessed the effects of increasing levels of physiological
realism on the WSS and WSSG in stented coronary arteries. Similar to LaDisa et al.
(2005), where the arterial wall was modelled with circumferentially straight sections
between stent struts, Murphy and Boyle developed a novel methodology to predict the
tissue prolapse occurring between stent struts to increase the accuracy of how the
arterial wall surface was represented. Using Young’s equation and distance between the
struts, a curved surface was generated to represent the tissue prolapse. Additionally, the
effect of stent oversizing, where stents are typically implanted with a stent-to-artery
diameter ratio of 1.1-1.2:1, was also assessed. Modelling the tissue prolapse and the
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stent oversizing were both shown to affect the WSS and WSSG distributions in the
stented coronary arteries in comparison with simplified straight cylindrical artery wall
models. Therefore, increasingly realistic arteries were deemed necessary to accurately
assess the haemodynamic conditions in stented coronary artery models. Following on
from this study, Murphy and Boyle in 2010 carried out a transient CFD comparison
study of three stent designs, as shown in Figure 4.9. The four variables used in the
comparison were WSS, WSSG, wall shear stress angel gradient (WSSAG), and
oscillatory shear index (OSI), and a detailed statistical analysis of the results was carried
out. One of the key conclusions of this study was that just applying the threshold
assessment technique to stent comparison was insufficient in elucidating the effects of
stent implantation on coronary artery haemodynamics and further studies should include
statistical analysis of the results.

Figure 4.9: Solid models of the LAD arteries implanted with (from left to right) the
PS stent, the GR-II stent and the Bx stent from Murphy and Boyle (2010).172
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In a paper published in 2010, Pant et al. compared the haemodynamic conditions
induced by five stent designs, similar to commercially available stents, in idealised
stented coronary arteries. All simulations had a transient inlet velocity, the arterial wall
was modelled as a straight cylinder and the only a quarter of the stented domain was
modelled to exploit the periodic symmetry of the stents to reduce computational
expense. The WSS and the modified oscillatory shear index (MOSI) were assessed and
it was found that the length of the link struts in the cross-flow direction and their
alignment with the main flow were critical factors in the haemodynamic performance of
the stent designs.
In terms of the generation of the geometries required for the CFD simulations of stented
arteries there have been a variety of avenues pursued by different studies. Gundert et al.,
in a paper published in 2011, described a rapid and computationally inexpensive method
to virtually implant stents in patient-specific artery models rendered from medical
imaging data. According to this method, a parameterised version of the stent is
geometrically flexed until its centreline follows the centreline of the implanted artery.
This gives an idealised stent geometry which includes the stent struts in a patientspecific model but neglects the stent and vessel deformation. Morlacchi et al. in a paper
published in 2011 utilised a sequential approach of FEA followed by CFD to investigate
the final kissing balloon technique for stenting a coronary bifurcation. A stent model
was virtually expanded in an idealised atherosclerotic bifurcation model using FEA and
the resultant geometry was analysed using CFD. Additionally, Chiastra et al. in two
papers in 2012 and 2013 continued this work with a similar CFD analysis of stented
coronary bifurcation models. The stents were virtually expanded using FEA within
artery models constructed from pre-operative computed tomography angiography and
conventional coronary angiography images. Transient CFD simulations were then
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carried out and the TAWSS, relative residence time and OSI were assessed. In these
studies the feasibility of virtually implanted patient-specific coronary bifurcation
geometries for haemodynamic assessment was demonstrated. In terms of assessing the
impact of using more realistic stented geometries, Martin et al. (2014) compared the
transient haemodynamics within three stented geometries generated using FEA or
purely idealised. The authors found that stent and vessel deformation had a significant
impact on the local haemodynamics within a stented artery. Critically though, the
computational cost of virtually expanding stent geometries using FEA is significant and
therefore, in most instances the hardware and time expense would make this method
unfeasible, at least for the time being.
4.4

Helical Flow

Experiments conducted by Caro on the dispersion of indicator flowing in simplified
models of the circulatory system showed that large secondary motions were induced by
bends in the models.25 It was postulated that these secondary motions had particular
physiological importance in circulation, listing possible advantages as being the
prevention of stagnation zones and flow separation at the arterial walls. Inspired by
observations of spiral folds on the inner endoluminal surface of arteries using fibreoptic angioscopy by Stonebridge and Brophy,241 postulated by Caro et al. as being
helical distributions of lesions due to low WSS zones,27 Stonebridge et al. went on to
show that blood flows in the right common and distal superficial femoral and the left
common femoral arteries with a secondary rotational motion which produces an overall
spiral (helical) flow. This was detected using Doppler ultrasound with the probe aligned
perpendicular to the axial flow, as shown in Figure 4.10 along with a sample ultrasound
image.245
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(a)

(b)

Figure 4.10 (a): The Doppler ultrasound set up used in the experiment described
by Stonebridge et al.245 (b): This sample image clearly shows the characteristic
red/blue split signifying helical flow as observed in vivo.244 Reproduced with
permission from Vascular Flow Technologies.

The terms spiral flow and helical flow are used interchangeably in the literature, but for
the purpose of this literature survey, helical flow is the term used. The helical flow in
arteries is induced by their non-planar curvature and the heart itself. It has been
proposed that the secondary motion, i.e. the rotational motion, of the blood flow is
induced by the twisting of the left ventricle during contraction,149 and then accentuated
upon entering the aortic arch.63,119 This twisting is, in part, due to the structure of the
ventricular myocardial band of the heart which has been found by Torrent-Guasp to be
spatially orientated in the form of a helix.257 Brecher also observed that there existed a
continuous negative pressure within the ventricle21 which Marinelli cited as evidence of
a perpetual vortex within the ventricle,148 which provides the ventricular suction during
the diastolic period, and possibly incites the initial helical flow. Helical flow had been
observed before in the human aorta by Segadel and Matre222 and again by Kilner and
Yang using magnetic resonance imaging (MRI),119 and by Frazin et al. in canine
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thoracic and abdominal aortae using Doppler ultrasound,63 but the studies by
Stonebridge et al. were the first to show that the helical flow was maintained in the
peripheral arteries also. Suo concluded, following MRI and CFD analysis, that helical
flow in the aorta could only be produced by including the specific aortic motion caused
by the beating heart.247 Caro et al. published observations from MRI data of flow
through healthy human arteries with non-planar curvature and branching which showed
how these features appeared to significantly affect the haemodynamics, including
WSS.27
Many of the beneficial effects of helical flow in the arteries were originally only
postulations by researchers in the area; however, there is growing evidence which
support these postulations. Stonebridge et al. discuss how there are theoretical
advantages to helical flow, including rotationally-induced stability, reduced turbulence,
and a beneficial effect on mechanisms of endothelial damage.245 In a paper by Caro et
al. it was highlighted that greater mixing and more uniform WSS was expected in the
cardiovascular system which was found to be commonly non-planar.27 Doorly et al.
found through CFD analysis that a simple modification to the geometry of an end-toside anastomosis, where the graft is rendered approximately helical, produced a
profound effect on the flow, enhancing the swirling motion of the flow downstream.52
Zabielski and Mestel concluded from a CFD analysis into helical flow around arterial
bends that the non-planar curvature limits the severity of flow separation at the inner
bend and reduces variation of the WSS.271 This was confirmed in a CFD analysis by
Papaharilaou et al. of planar and non-planar end-to-side anastomoses where it was
found that the introduction of an out-of-plane curvature produced a significant change in
the spatial distribution of WSS and a 10% reduction in the time-averaged peak WSS
magnitude.189 The spatial extent of the elevated oscillatory WSS regions was reduced in
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the non-planar model in comparison with the planar model and, given that Ku et al.
found a correlation between elevated oscillatory WSS and NIH, there are effectively
less areas exposed to unfavourable, in terms of disease progression or ISR, flow
conditions in the non-planar geometry.128 In a numerical study of vortical flow
identification and flow transport in arterial graft geometries, Doorly et al. found that
significantly greater particle mixing was prevalent in the non-planar geometry compared
with the planar geometry, with continual transport of particles away from the wall, thus
lessening near-wall particle residence times.53 Stonebridge et al. compared helical and
non-helical flow patterns through stenoses using MRI in vitro and CFD modelling.243 In
this study it was found that near-wall turbulence energy was considerably less with
helical flow (0.025m2/s2) than non-helical flow (0.16m2/s2) beyond the stenosis, with
turbulence being associated with substantial WSS fluctuations in both space and time.146
The degree of helical flow has been found by Houston et al. to be reduced in
atherosclerotic arteries, although a direct relationship between atherosclerotic lesions
and the absence of helical flow has not been proven, and within these arteries the
turbulent nature of the resulting flow encourages further development of the disease.103
A study by Morbiducci et al. indicated that helical flow dampened WSS temporal
gradients in aortocoronary bypass grafts.164 Morbiducci et al. also conducted an in vivo
investigation into the helical flow patterns in the aortic region of five healthy humans
using 4D phase-contrast MRI, and CFD analyses of the reconstructed aortic geometries.
It was found that helical-blood-flow dynamics is common to healthy individuals, and
that helical flow might be caused by natural optimisation of fluid transport processes in
the cardiovascular system, aimed at obtaining efficient perfusion of blood and nutrients
therein to the organs and tissue.166 In predicting these transport processes, and also those
involved in atherogenesis, a paper by Chiastra et al. highlighted that flow properties
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such as velocity, helicity and vorticity are primarily responsible, and that researchers
should consider these bulk flow properties in addition to the WSS variables.39 Liu et al.
conducted a CFD study of the transport of LDL in four models of human aortae and
found that the helical flow induced in the aortic arch had a beneficial effect on LDL
concentration at the arterial wall.141 Helical flow has also been shown to be instrumental
in moderating shear-induced activation of platelets, which is a problem for some
cardiovascular implants.155,165,191,273 Massai et al. found through CFD simulations of a
reconstructed model of a left carotid bifurcation that an inverse relationship existed
between the helical flow index (a variable for measuring the helical structure of the
flow) and the probability of shear-induced activation of platelets.155
An analysis by Paul and Larman using CFD of helical flow downstream of a 75%
stenosis found that turbulent kinetic energy was reduced post stenosis.191 The helical
motion provides rotational stability to the flow, reducing flow disturbance and
turbulence, which is a beneficial effect. Conversely, as noted by Paul and Larman,
helical flow also produced oscillating WSS in the post-stenosis model,191 which is
considered a detrimental effect possibly causing damage to the endothelium. In addition
to this, other researchers have speculated on whether the effects of helical flow are
entirely beneficial. Frazin et al. considered that although the rotational element of the
flow may be important physiologically for organ perfusion, pathologically, there may be
a relation between the shear forces induced by helical flow and plaque deposition.62 A
paper by Texon showed that “serpentine flow” in relatively straight vessels may also
produce zones of diminished lateral pressure and atherosclerosis.256 A CFD study of
helical grafts by Zheng et al. found that along with the benefits of increased WSS and
swirling flow, there was also an enlarged pressure drop and low velocity concentrated in
one area in a helical graft model which could lead to increased NIH or thrombosis.274
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Pressure drop was found to be proportional to the helicity of an inlet flow into an
idealised stented artery in a CFD study by Chen et al.36 CFD simulations conducted in
this study showed pressure drops for the stent with swirling flow to be 164, 167 and 173
Pa for inlet helicities of 3.5, 6.4 and 14.5 m/s2, respectively, whereas for the stent with
normal inlet flow the pressure drop was 163 Pa. Beneficial effects of helical flow also
noted in this paper were that the average lengths of the recirculation zones between the
stent struts and OSI, a measure of the change in direction and magnitude of the WSS
vectors during the cardiac cycle, were reduced with increasing helicity of the inlet flow,
which enhanced the average WSS in comparison with normal flow.36
Considering the correlation between adverse flow conditions and increased
NIH,10,74,91,97,122,188 and the effects of the local haemodynamics on the other biological
processes leading to ISR, discussed in Section 2, there are two particular stents which
are embracing the beneficial theoretical effects of helical flow, i.e. increasing particle
mixing, reducing areas of disturbed flow and providing a more uniform WSS, and
endeavouring to restore this natural blood flow pattern in a stented artery.

4.4.1

BioMimics 3D Helical Stent

The BioMimics 3D helical stent, as shown in Figure 4.11, is being developed by Veryan
Medical Ltd which has its head office in Horsham, West Sussex, UK and research and
development based in Galway, Ireland. This stent appears to have evolved from a
helical bypass graft, marketed as SwirlGraft, which incorporated Small Amplitude
Helical Technology (SMAHT), developed at Imperial College London. The theory
behind this technology is that a normal planar bend induces two equal but opposite
Dean vortices within the flow, whereas in a non-planar bend, as found in SMAHT, one
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of the vortices begins to dominate the other as the flow progresses through the bend,
producing helical flow.

Figure 4.11: BioMimics 3D helical stent. Reproduced with permission from Veryan
Medical Ltd.
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polytetrafluorethylene (ePTFE) arteriovenous shunts in two pigs.26 Even though the
experiment was limited by the number of pigs employed, the results of this study were
still positive with consistently less thrombus formation and NIH in SwirlGraft devices
compared with the conventional devices. Interestingly, when the porcine arterial
sections were analysed, two seemingly helical ribbons of NIH were found which
seemed to match with the predicted areas of low WSS in a CFD model of SwirlGraft. A
clinical trial was carried out by Huijbregts et al. in which 20 patients requiring vascular
access grafts were implanted with SwirlGraft.107 It was found that the graft was prone to
thrombosis, possibly due to the loss of the helical geometry of the graft upon
implantation. It was concluded by Huijbregts et al. that with modifications to
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implantation techniques and the SwirlGraft design that the product might advance to a
randomised controlled trial.107
Veryan Medical has taken this same SMAHT technology and applied it to peripheral
stent design in the form of the BioMimics 3D helical stent, shown in Figure 4.11. In
addition to the helical flow benefits, the stent also includes design features such as
tapered radial stiffness and collinear stent ends which, in theory, help in providing a
more gradual change in the wall stress and luminal area between the unstented and
stented portion of the artery, as opposed to a dramatic change which could form a
stagnation zone in the flow, encouraging thrombus and neointimal formation. For
peripheral stent implantation, in the femoral artery particularly, as the leg bends the
stent must be flexible enough to allow movement and longitudinal slackening of the
artery without stent fracture or the infliction of damage on the arterial wall. The
BioMimics 3D helical stent has been assessed in this regard through a human cadaver
study as stated on the company website (http://www.veryanmed.com/). In this study the
BioMimics 3D stent and control straight stents were implanted in the lower and mid
superficial femoral artery and the upper popliteal fossa of three cadavers and the knee
joint was flexed over a range of angles. It was observed that the BioMimics 3D helical
stent could increase its helicity and thus take up the slack in the artery upon flexion of
the knee, while also avoiding permanent deformation, unlike the straight stents. This
ability is deemed a valuable characteristic which could prolong the life of a peripheral
stent by absorbing stresses which ordinarily could cause fracture.
As mentioned earlier, studies by Lee et al. into the effects of supplemental oxygen on
NIH and by Tarbell into mass transport of molecules, e.g. oxygen, into arterial walls
and localisation of atherosclerosis and NIH, highlight the importance of flow conditions
and oxygen flux into the arterial wall on the development of NIH.135,252 Coppola and
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Caro, citing Tarbell and the link between a local lack of oxygen and both atherosclerosis
and NIH, used CFD to examine the effects of arterial three-dimensionality on the
distribution of WSS and the mass transport of oxygen from the blood flow into the
arterial wall in a U-bend by modelling the blood vessels as either a cylindrical or helical
conduit.44 It was shown that a helical geometry can reduce both the range and extent of
low WSS regions and substantially increase the oxygen flux through the walls.

Figure 4.12: Angiograph showing the BioMimics 3D helical stent and the
conventional straight stent inserted in the contralateral (left) and common carotid
artery (right) respectively.228 Reproduced with permission from Veryan Medical
Ltd.

Shinke et al. presented results from a pilot porcine trial where two pigs were implanted
with a conventional stent in one common carotid artery and the BioMimics 3D helical
stent in the contralateral artery, as shown in the angiograph in Figure 4.12.228
Comparisons were made between the histological sections taken at three locations in the
two arteries, as shown in Figure 4.13. As can be seen from these sections the extent of
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NIH with the helical stent was far less than with the conventional one and thus it was
concluded that the helical stent’s improved flow regime helped in minimising NIH.

Figure 4.13: Histological sections of the stented arteries for the straight (control)
stent and the BioMimics 3D helical stent one month post implantation. The
sections shown correspond to proximal, middle and distal locations to the stented
region.228 Reproduced with permission from Veryan Medical Ltd.

The in vivo results from this porcine study were compared with CFD predictions by
Coppola and Caro and the effects of varying the geometrical parameters, i.e. the
amplitude and frequency of the helical shape, on the flow pattern, WSS, and oxygen
flux to the arterial wall were studied.45 It was expected that the increased mixing effects
of the geometry-induced secondary flows would modify the distribution of WSS and
produce higher oxygen flux levels to the arterial wall. Results showed that increasing
the amplitude of the helical geometry increased the WSS and oxygen flux to the vessel
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wall, and that increasing the frequency increased the WSS but had no effect on the
oxygen flux.45 Oddly, the results indicated that the inner curvature regions of the helical
model are exposed to lower oxygen flux than in the corresponding straight stent case,
and yet the development of NIH is lower in these regions, as shown by the porcine trial.
The reasons for this were inconclusive; however, the overall results of the study were
positive.

Figure 4.14: Diagram of the helical geometry employed by Cookson et al. in a CFD
analysis of the mixing behaviour in a helical pipe with two different helical
geometries.42

Cookson et al. conducted a CFD investigation of the mixing behaviour of a small
amplitude helical pipe incorporating two different helical geometries, as shown in
Figure 4.14.42 Helix A has an amplitude of 0.2 times the diameter of the pipe and Helix
B has an amplitude of 0.5 times the diameter. This investigation was based on the
hypothesis that increased mixing, induced by helical geometries, reduced thrombosis in
grafts incorporating SMAHT and that by joining together two helical geometries of
different amplitudes the mixing effect could be enhanced further without an excessive
pressure loss across the device. This study followed on from a previous numerical study
of single helical geometries by Cookson et al.41 The results of the investigation
indicated that the mixing effect was improved upon in the combined helical geometry in
comparison with the single helical geometry and that the pressure drop was found to be
less in the combined helical geometry. These results show a possible improvement in
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the original SMAHT design on which SwirlGraft and the BioMimics 3D helical stent
are based.

4.4.2

Vascular Flow Technologies Ltd Stent

The BioMimics 3D helical stent induces a helical flow by imposing a helical geometry
on the treated artery, while another stent technology, currently in development at
Vascular Flow Technologies Ltd (VFT) based in Dundee, Scotland, induces helical flow
through the use of a helical ridge placed on the inner surface of the stent. VFT (formerly
Tayside Flow Technologies) is a spin-out company set up in 1998 from Tayside
University Hospitals NHS Trust. The stent technology being developed by VFT is based
on research by Stonebridge et al. into the naturally occurring helical flow found in
studies of the cardiovascular system using Doppler ultrasound, as mentioned
previously.241,242,245 The benefits of helical flow, discussed earlier, led VFT to design a
bypass graft, which was similar to SwirlGraft in that its goal is to induce helical flow;
however, instead of shaping the graft in a helical form which could be lost on
implantation, this bypass graft incorporated a helical ridge at the distal end of the graft,
which restored helical flow. Early clinical results from a first-in-man study were
presented by Vermassen and Stonebridge in which 40 patients with peripheral arterial
disease had the graft implanted.263 10 patients were assessed for the presence of helical
flow at six months and in all 10 helical flow was evident, confirming that the graft
induced helical flow. In addition, a patency-rate of 88% at one year follow-up was
found for the 40 patients treated.263
The company is currently developing a helical-ridge insert for stents, similar to the graft
design, in order to induce helical flow in a stented artery. Two patents which have been
filed give some details of this technology: European Patent EP1314406 (B1) and US
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Patent US7721767 (B2).104,105 The former describes a partially helical-shaped ridge
insert for a stent as shown in Figure 4.15, while the latter gives details of a method for
determining the helix angle of a helical formation for a conduit.

Figure 4.15: Axial and longitudinal views of the proposed helical-ridge insert for
stents, adapted from European Patent EP1314406 (B1).105 Reproduced with
permission from Vascular Flow Technologies.

A conduit, as described in the US Patent, includes natural blood-flow tubing, stents, and
artificial industrial equipment, e.g. a hose or pipe.104 The method described in this
patent allows the determination of the optimum helix angle through the use of two
characteristic curves. As shown in Figure 4.16, for a given mass flow rate in a given
conduit the experimentally determined non-dimensional pressure drop and turbulent
kinetic energy are plotted against the helix angle. The optimum helix angle would
normally correspond to the angle at which the non-dimensional pressure drop and the
non-dimensional turbulent kinetic energy are equal to zero, in this case at approximately
7.5 degrees (notated as 52 in Figure 4.16); however, this may not always be the case.104
In a preclinical porcine study by Houston et al., an unmodified control stent and a
modified stent incorporating the helical-ridge insert were compared in a 45 day carotid
cuff stenosis model.102 The cuff model is designed to mimic lesions that may occur
downstream of a stent and to induce cell proliferation and ECM synthesis, both of
which contribute to neointimal thickening. There was a statistically significant reduction
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in intima/media ratios distal to the implanted region in the modified stent porcine
models, with a high ratio indicating significant neointimal thickening, in comparison
with the control stent porcine models. Using Doppler ultrasound it was confirmed that
the modified stent maintained the natural helical flow within the arteries of all eight
pigs, whereas, the control stent did not. An idealised plain-wall tube was compared with
a tube with a helical ridge using CFD and results obtained predicted a reduction in
turbulent kinetic energy downstream of a 50% stenosis in the helical-ridge model.

Figure 4.16: Graph taken from US Patent US7721767. The variation of nondimensional pressure drop with the helix angle is notated as 50 and the variation of
non-dimensional turbulent kinetic energy with the helix angle is notated as 51. The
helix angle when both variables are equal to zero is notated as 52.104 Reproduced
with permission from Vascular Flow Technologies.
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4.5

Summary

In this chapter a review of the existing literature was presented on the relevant topics for
this study. The topics reviewed were oxygen transport analyses, haemodynamic
analyses of stented arteries, and helical flow. Oxygen transport analyses vary in
complexity with computationally-cheap wall-free analyses and simplified blood oxygen
transport models that do not incorporate the bound oxygen common within the
literature. Coupled blood-arterial wall analyses allow accurate assessment of the
resultant oxygen distribution within the arterial wall, as also achieved in the test cases
presented in Chapters 6, 7, and 8. Haemodynamic analyses of stented arteries are
generally limited to WSS variables, but by analysing the oxygen transport also, one of
the secondary effects of the abnormal haemodynamics within a stented artery can be
investigated. In theory, helical flow, as reviewed here, could have beneficial effects on
both the local haemodynamics and oxygen transport within stented arteries.
Key points from this chapter include:


In vivo measurements with oxygen microelectrodes in animals are needed to
learn more about the variations in oxygen transport.



Shear-dependent wall permeability model adopted by Rappitsch et al. (1997)
was noted to not be valid for oxygen transfer through the wall.



Areas of predicted low mass transfer were found to correlate strongly with areas
prone to intimal thickening in humans.143



Some previous studies neglected the bound oxygen transport and reasoned that
the Sh with the bound oxygen would be 2.5 times the predicted Sh without the
bound oxygen. This assumption will be assessed in Chapter 9.
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Moore and Ethier (1997) previously concluded that further studies of oxygen
transport in large arteries must include the oxygen transport into an accurate
model of the arterial wall.162



Several previous studies have noted that accurate representations of the arterial
geometries is essential in order to predict the mass transfer.



Neglecting the compliance of the arterial wall and the pulsatility of the flow in
simulations of oxygen transport in arteries is justifiable.



Helical flow is theorised to produce more uniform WSS, reduced high
oscillating flow regions, greater particle mixing, reduced near-wall particle
residence times, dampened WSS temporal gradients, and increased oxygen
transport. Further analysis of this is presented in Chapters 8 and 9.
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5

Prelude to Test Cases

5.1 Introduction
As discussed in Section 3.4, Model 1 is the most advanced blood oxygen transport
model which incorporates the oxygen bound within RBCs, the non-linearity of the
oxygen exchange between the free and bound oxygen, and a variable shear-induced
RBC dispersion coefficient. There are four additional models which have varying
degrees of simplifications with the most simple of these, Model 5, most commonly used
in the literature. To compare the five different models, two separate test cases were
devised. Test Case 1 compared the transarterial wall PO2 profiles predicted in an
idealised carotid bifurcation using the five models with measurements recorded by
Santilli et al. in dog carotid bifurcations.217 In Test Case 2 the maximum and minimum
transarterial wall PO2 profiles in a stented coronary artery predicted using the five
models were compared with measurements from a separate study by Santilli et al. In
this separate study transarterial wall PO2 profile measurements were taken within rabbit
aortae, of similar size to human coronary arteries, which had been implanted with 3mm
diameter stents.218 Additionally, the PO2 and the local Sh on the stented artery luminal
surface predicted by each model were compared, along with the percentage volume of
the arterial wall exposed to low and hypoxic levels of PO2.
Following these two test cases a third test, Test Case 3, was constructed in which the
most advanced model, Model 1, was applied to three sample stents to demonstrate how
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different stent designs can impact the oxygen transport within a stented coronary artery.
Finally, in Test Case 4 the predicted oxygen transport in a variety of helical stent
geometries were assessed using Model 1. The goal of this test case was to elucidate the
effects of increasing helical radius on the PO2 levels within the arterial wall of idealised
stented coronary arteries. This will further build on previous studies on helical flow by
analysing its impact on the local haemodynamics and oxygen transport within a stented
artery, and assess helical flow in terms of its theoretical benefits, as reviewed in Chapter
4.

5.2 Modelling the Blood Flow
For all simulations carried out as part of this study the meshes, generated in ANSYS
ICEM meshing software (ANSYS Inc., Canonsburg, PA, USA), were imported into the
CFD commercial software ANSYS CFX 15 (ANSYS Inc., Canonsburg, PA, USA)
where the Navier-Stokes equations were solved to predict the blood flow within the
luminal domain. All simulations were steady state as pulsatility has been shown to have
a minimal effect on oxygen transport to the arterial wall.124 The density of blood was
taken as 1060kg/m3 and the non-Newtonian nature of blood was modelled using the
non-Newtonian Bird-Carreau model, with assigned values based on experimental data
from Jung et al.115 The continuity and momentum equations were solved with a high
resolution advection scheme and the convergence criteria were set to a maximum
residual tolerance of 1×10-6 .
All simulations were carried out on the Irish Centre for High-End Computing (ICHEC)
Fionn supercomputer using a maximum of five nodes, each with 2×12 2.4GHz Intel Ivy
Bridge core processors and 64GB of RAM. The computer processor unit (CPU) time to
reach convergence for each model in Test Cases 1 & 2 are given in Table 5.1 and there
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is a clear pattern whereby Model 5 almost halves the CPU time required on the same
meshes. This may be significant when computational resources are an issue, although,
as will be demonstrated by these test cases simplification of the oxygen transport model
has considerable limitations. The CPU run times for each stent in Test Case 3 are
4.13×106 s, 6.55×106 s and 5.17×106 s for Stent A, B and C, respectively, and for Test
Case 4 the typical CPU time was ~5.0×106 s.

Test Case
Model

1

2

1

1.90×106 s

4.13×106 s

2

1.07×106 s

4.56×106 s

3

1.73×106 s

4.49×106 s

4

1.09×106 s

4.50×106 s

5

6.49×106 s

2.62×106 s

Table 5.1: CPU run times in seconds for each simulation to reach convergence for
all five models in Test Cases 1 & 2.

5.3 Modelling the Oxygen Transport
The PO2 in the blood and the arterial wall is modelled in ANSYS CFX 15 using an
additional variable. Additional variables are defined in ANSYS CFX as non-reacting
scalar components that are transported through a flow field but do not affect the
continuity or momentum equations. The transport of the PO2 within the blood flow is
governed by Equation 3.47 with flow variables affecting the transport through the
substantial derivative term ( PO2

t ). The diffusivity coefficient, D’, is represented

by Equation 3.48 and the source term is controlled by Equation 3.49. Both D’ and the
source term are evaluated explicitly, based on the previous time-step value for PO2, and
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a time-step independence study found no difference in the predicted PO2 results at
smaller time-step increments. The PO2 is transported via diffusion only in the arterial
wall with a fixed diffusivity coefficient, DT, and consumption modelled via a source
term. The advection/diffusion equation for PO2 in the lumen domain was solved with a
high resolution advection scheme, in line with recommendations by Carroll et al.,29 and
the convergence criteria were set to a maximum residual tolerance of 1×10-6 in all
domains.
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CHAPTER
Chapter 6.
6.1

Test Case 1 – Carotid Bifurcation

Introduction

To assess the accuracy of the oxygen transport models, as described in Chapter 3 and
summarised in Table 3.1, experimental measurements are needed for comparison.
Santilli et al. used an oxygen microelectrode to measure the transarterial wall PO 2
profiles in 11 dog carotid bifurcations.217 An idealised human carotid bifurcation
geometry was constructed from detailed measurements taken from several
studies.128,142,248 A dog carotid bifurcation geometry would be ideal for comparison;
however, Santilli et al. reported that they used mongrel dogs, and only the wall
thicknesses were reported with no luminal diameters given.217 The size of the arteries
and the oxygen transport parameters within the arterial wall would vary according to
different breeds of dogs. Therefore, the PO2 measurements by Santilli et al. are used
here, as done previously by other researchers,248–250 for comparison with the predicted
results for a human with the distance through the arterial wall scaled according to the
thickness of the human artery. The five different models were used to simulate the
oxygen transport in an idealised human carotid bifurcation, shown in Figure 6.1,
adapted from Tada with, for the first time, the addition of a heterogeneous arterial
wall.128,142,248 The carotid bifurcation offers two advantages for this study: there are
different flow patterns present in it which will affect the oxygen transport, and because

125

CHAPTER 6: Test Case 1 – Carotid Bifurcation

the carotid sinus is prone to atherosclerotic plaque build-up it is an area of interest for
oxygen transport modelling.

6.1.1

Geometry Creation

The geometry was constructed in Rhinoceros 3-D (McNeel, Indianapolis, IN, USA) and
comprised of the common carotid artery (CCA) which bifurcates into the internal
carotid artery (ICA) and the external carotid artery (ECA). To reduce computational
expense half of the geometry was used with symmetry assumed along the centreline of
the carotid arteries, thus ignoring the secondary curvature of the ICA.248 The secondary
curvature has the greatest effect downstream of the measurement locations and
therefore, would have no consequence on the results presented here. The thickness of
the arterial wall in the carotid arteries, particularly the intima in the carotid sinus, has
been shown to vary with location in human subjects.128 Accordingly, a variable intimal
thickness ranging from 0.10 to 0.63mm was used, as shown in Figure 6.1. The intimal
thicknesses correspond to the mean values of measurements from bi-planar angiographs
from 57 patients, as listed in Table 6.1 with reference to Figure 6.2 (which shows the
orientation of the polar coordinates in each arterial segment), adopted from Ku et al.128
The media was assumed not to experience any thickening and was assigned a constant
thickness of 0.60mm.
The predicted and measured transarterial wall PO2 profiles were then compared at three
of the six measurement locations as outlined by Santilli et al.217 One of the benefits of
these locations numbered 1 - 3, in terms of assessing the blood oxygen transport
models, is that they cover three distinct flow patterns: straight shear flow parallel to a
wall, low shear recirculation flow and high shear flow directed towards the wall,
respectively.
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Figure 6.1: (a) Plan of the carotid bifurcation model with (b) cross-section X-X’
and (c) cross-section Y-Y’. The intima thickness is approximately 0.12mm
throughout the common carotid artery (CCA) and the internal carotid artery
(ICA), except in the outer wall of the carotid sinus and proximal to the ICA where
it gradually increases to a maximum of 0.63mm in accordance with Ku et al.128
This can be seen clearly in the cross-section X-X’.
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Figure 6.2: Schematic representation of the locations at which the intimal
thickness data from human carotid arteries were recorded along with the polar
coordinate orientation used in each artery segment. It should be noted that in
keeping with the original data from Ku et al. the orientation of the polar
coordinates is different at location E compared with all other locations.128
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Polar Position
(°)

Intimal Thickness
(mm)

A. CCA

0
90
180
270

0.10 ±0.02
0.15 ±0.03
0.12 ±0.03
0.10 ±0.02

B. Proximal ICA

0
90
180
270

0.14 ±0.05
0.47 ±0.13
0.63 ±0.17
0.37 ±0.10

C. Midpoint Carotid Sinus

0
90
180
270

0.19 ±0.07
0.24 ±0.05
0.49 ±0.10
0.31 ±0.07

D. Distal Internal Carotid

0
90
180
270

0.07 ±0.02
0.06 ±0.01
0.08 ±0.04
0.09 ±0.04

E. External Carotid

0
90
180
270

0.27 ±0.15
0.08 ±0.02
0.12 ±0.05
0.15 ±0.05

Cross-Section Location

Table 6.1: Intimal thicknesses as adopted from Ku et al.128 Only half of the
bifurcation geometry used and therefore, only the measurements at 270° were used
normal to the plane of symmetry. The polar positions for each segment are shown
in Figure 6.2.

6.1.2

Geometry Discretisation

The mesh for Test Case 1 was generated using ANSYS ICEM meshing software
(ANSYS Inc., Canonsburg, PA, USA). It comprised of hexahedral elements and was
inflated into the luminal domain from the arterial wall surface with the height of the
initial element set at 3μm in order to accurately capture the MTBL. This is in line with
both the Validation Test Case 2 presented in Appendix A and from previous literature in
the area of oxygen transport modelling.203,248 Following a mesh convergence study, as
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discussed in Appendix B, the resultant mesh had a total of 973121 nodes broken down
as follows: 501546 in the lumen domain, 295075 in the intima domain and 176500 in
the media domain.

6.1.3

Boundary Conditions

A mass flow rate boundary condition of 0.00375kg/s, taken from a study by Tada,248
was placed at the inlet of the CCA which corresponds to the averaged mass flow rate
over the cardiac cycle, divided by two for the half geometry. Additionally, at the inlet
PO2,in=100mmHg, which corresponds to the typical arterial value found in human
arteries,200 and also the average luminal value recorded by Santilli et al.217 At both
outlets PO2,out=0mmHg, a boundary condition that allows ANSYS CFX to
automatically replace this value with the value attained iteratively from the solution
process, and an entrainment boundary condition was imposed with a zero relative
pressure. The mass flow rates at the two outlets were compared with the calculated
transient mass flow rates from Tada and found a maximum difference of 5.68% in the
averaged flow rate over the cardiac cycle at the ECA outlet. At the external wall
boundary, which corresponds to the medial/adventitia interface, a constant
PO2=75mmHg was imposed, which was the averaged PO2 value recorded at the
adventitia by Santilli et al. At the arterial wall surfaces located at the inlet and outlets a
zero flux PO2 boundary condition was imposed.
6.2

Results and Discussion

Figure 6.3 shows the predicted PO2 levels on the luminal surface for each of the models.
The flow patterns are the exact same in each simulation; however, the predicted PO2
levels clearly vary significantly depending on which blood oxygen transport model is
adopted. In the following sections the results at the three prescribed locations are
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compared with experimental results from Santilli et al., specifically, the transarterial
wall PO2 profiles. The oxygen MTBL at each location was analysed in detail for each of
the five models.

Figure 6.3: Predicted PO2 levels along the luminal surface using the five different
models, as summarised in Table 3.1.
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Figure 6.4: Locations of transarterial wall PO2 profiles along with the predicted
PO2 levels on the luminal surface using Model 1.

For reference, Figure 6.4 shows the luminal surface PO2 levels as predicted by Model 1
along with the locations of the three transarterial wall PO2 profiles. Location 1 is within
a developing MTBL with a uniform distribution of PO2 circumferentially around the
luminal surface with no flow disturbances. Location 2 is in a recirculation zone within
the carotid sinus where the PO2 levels are significantly depleted. Looking at Figure 6.3
it is clear that this low PO2 region is present in each simulation with all five models
except for Model 3 where it is imperceptible because most of the luminal surface is
exposed to low/hypoxic PO2 levels. Location 3 is adjacent to a high PO2 region at the
bifurcation divide. A detailed analysis of each location for each model follows.
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6.2.1

Location 1

Location 1 is situated in the CCA where the flow is parallel to the luminal surface and
within a developing MTBL, as shown in Figure 6.4. Figure 6.5 shows a cross-sectional
slice at Location 1 with a contour plot of the predicted velocity magnitude. As shown,
the blood flow at this location is undisturbed and is flowing parallel to the luminal
surface. This means that the oxygen transport is predominantly diffusive perpendicular
to the luminal surface at this location. For Models 1 and 2 D’ is affected by the local
shear rate through the variable Dc. Figure 6.6 shows the predicted shear rate and Dc at
Location 1. The shear rate is a typical shape for developing pipe flow with a maximum
value of 437s-1 at the luminal surface. The Dc value correspondingly varies between a
minimum value of 8.0×10-12m2/s within the centre of the lumen and a maximum value
of 1.2×10-10m2/s within the MTBL at the luminal surface.

Figure 6.5: Cross-sectional slice at Location 1 showing a contour plot of the
predicted velocity magnitude.
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The effect of a relatively high Dc value within the MTBL can be seen by comparing the
results of both Models 1 and 3, and Models 2 and 4. Figure 6.7 shows the predicted
PO2, dS/dPO2 , D’, and S along a line at Location 1 for each model. Looking at Figure
6.7(c) there is a clear difference in the predicted D’ values within the MTBL for Models
1 and 3 where the only difference between the two models is that a variable Dc value is
used for Model 1, and Dc=0m2/s for Model 3 (essentially ignoring the dispersion of
RBCs). For Model 3, ignoring the dispersion of RBCs leads to lower PO2 values within
the MTBL, and at the luminal surface, which is compounded by resultant higher
dS/dPO2 values within the MTBL. This is also seen when comparing Models 2 and 4;
however, the effect of neglecting the dispersion of RBCs is not as pronounced because
the dS/dPO2 value is constant. Completely ignoring the contribution of the
oxyhaemoglobin contained within the RBCs, i.e. Model 5, results in a higher D’ value
and consequently, a higher luminal surface PO2 value compared with the other four
models. The saturation of the oxyhaemoglobin, S, is shown in Figure 6.7(d) to follow a
similar trend to the PO2 for each model with Model 3 showing the largest decrease.
Interestingly though, S begins to decrease much closer to the luminal surface than PO2
because of the slope of the oxygen disassociation curve is relatively low until PO2
begins to fall below 60mmHg, Figure 6.7(b), as demonstrated best with Model 3. A
high dS/dPO2 means that for a relatively large change in PO2 there is a corresponding
large change in S; whereas, if dS/dPO2 is low, then a similarly large change in PO2 will
only produce a small change in S.
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Figure 6.6: Predicted (a) shear rate and (b) Dc along a line within the blood flow
from the centre of the artery to the luminal surface at Location 1.

Figure 6.7: Predicted (a) PO2, (b) dS/dPO2 , (c) D’ and (d) S values along a line
within the blood flow from a radius of 2.90mm to the luminal surface at a radius of
3.00mm at Location 1.
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Figure 6.8 shows the cross-sectional slice at Location 1 with a contour plot of the
predicted PO2 levels using Model 1 which shows the PO2 levels within the arterial wall
are circumferentially uniform due to the uniformity of the flow in this region. In terms
of the transarterial wall PO2 profiles for Model 1 at Location 1, the predicted PO2 values
show reasonable agreement with the experimental results in capturing the overall trend,
as shown in Figure 6.9. The radial position of the predicted nadir in the PO2 levels is
different to the nadir of the Santilli et al. experimental results. This may be due to
different diffusion and consumption parameters within the dog arterial wall compared
with the adopted values based on human arteries. Crucially though, at this location at
least, the predicted PO2 levels do not fall below the hypoxic or low PO2 levels of
10mmHg and 30mmHg. The predicted results using the other four models show a broad
variation in comparison with Model 1. Model 2 gives a higher luminal surface value
than Model 1 and consequently, overall higher PO2 values across the arterial wall. The
predicted PO2 profile from Model 4 is very close to that predicted by Model 1 because
taking Dc=0m2/s decreases the D’ value within the MTBL, and conversely, taking a
constant value for dS/dPO2 at this location has the opposite effect of increasing the D’.
This results in a D’ value for Model 4 adjacent to the luminal surface which is close to
the D’ value predicted by Model 1, as shown in Figure 6.7(c). Model 3 predicts the
lowest PO2 values on the luminal surface, and consequently, across the arterial wall.
Model 5, on the other hand, predicts the highest PO2 values on the luminal surface and
across the arterial wall. Crucially, it fails to predict the high PO2 gradient within the
MTBL that is seen with Models 1-4. This will be discussed in greater detail separately
in Section 6.2.4.
From analysing the results at Location 1, where the blood flow is parallel to the wall,
laminar and undisturbed, it can be concluded that inclusion of the bound oxygen has a
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significant effect on the predicted PO2 levels within the MTBL. Counterintuitively,
inclusion of the bound oxygen predicts lower PO2 levels when compared with a simpler
model, Model 5. In addition, both neglecting the dispersion of RBCs and the variability
of the slope of the oxygen disassociation curve also significantly impact the predicted
results.

Figure 6.8: Cross-sectional slice at Location 1 showing a contour plot of the
predicted PO2 levels in all three domains.
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Figure 6.9: Comparison of predicted and measured transarterial wall PO2 profiles
at Location 1. Measurements adapted from Santilli et al. are shown for
comparison and the distances through the arterial wall for these have been scaled
to the size of a human carotid artery.

6.2.2

Location 2

Location 2 is situated on the outer side of the carotid sinus within the ICA where the
flow is considerably different to that at Location 1. As shown in Figure 6.10, the
velocity magnitude peak value is offset to the bifurcation side of the sinus with a
relatively large low velocity recirculation zone present on the side of Location 2. The
tangential velocity vectors on the slice surface are also shown in Figure 6.10 to
highlight the presence of secondary motion within the sinus. This secondary motion is
similar to that seen in previous studies of flow patterns in the human carotid bifurcation
such as experimental work by Motomiya and Karino (1984) using transparent segments
prepared from a human subject post-mortem.168 This is also demonstrated in Figure 6.11
using streamtraces coloured according to PO2 levels which highlights how previously
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oxygen depleted blood is turned over towards the outer surface of the carotid sinus
where it enters a low velocity recirculation zone and further depleted.

Figure 6.10: Cross-sectional slice at Location 2 showing a contour plot of the
predicted velocity magnitude. The velocity vectors tangential to the slice plane are
shown, with arbitrary length, to highlight the secondary motion present within the
sinus.
As mentioned before, D’ is affected by the local shear rate through the variable Dc for
both Models 1 and 2. Figure 6.12 shows the predicted shear rate and Dc along a line at
Location 2. The shear rate is maximum, for Location 2, at the centre of the artery with a
value of 140s-1 and minimum adjacent to the luminal surface with a value of 9s-1. The
Dc value correspondingly varies between a maximum value of 6.4×10-11m2/s within the
centre of the lumen and a minimum value of 9.4×10-12m2/s within the MTBL adjacent to
the luminal surface. Consequently, there is no significant increase in D’ caused by the
shear rate and Dc. Physiologically, this means that the shear-induced dispersion of
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RBCs does not increase the effective diffusivity of oxygen within the low velocity zone
on the outer side of the carotid sinus, as would be expected. Note: the change in the
slope of the plot of Dc at Location 2, Figure 6.12(b), is a reflection of the change in
governing equation for Dc for values above and below a shear rate value of 100s-1.

Figure 6.11: Streamlines passing through the cross-sectional slice at Location 2
and 3 coloured according to predicted PO2 values using Model 1 along the
streamlines.

The effect of a relatively low Dc value within the MTBL can be seen by comparing the
results of both Models 1 and 3, and Models 2 and 4. Figure 6.13 shows the predicted
PO2, dS/dPO2 , D’, and S along a line at Location 2 for each model. Looking at Figure
6.13(c) Models 1 – 4 all predict very low D’ values within the MTBL and consequently,
low luminal surface PO2 values. For Models 3 and 4, which ignore the dispersion of
RBCs, show no difference in luminal surface PO2 values in comparison with Models 1
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and 2 because Dc, as modelled in Model 1, has little effect on D’ as seen in Figure
6.13(c). This is opposite to Location 1, as demonstrated by Figure 6.7(b), where a
considerable difference was visible between the D’ values within the MTBL between
the models that included Dc (Models 1 & 2) and those that did not (Models 3 & 4).
Completely ignoring the contribution of the oxyhaemoglobin contained within the
RBCs, i.e. Model 5, again here at Location 2 results in a significantly higher D’ value
and consequently, a higher luminal surface PO2 value compared with the other four
models. The saturation of the oxyhaemoglobin, S, is shown in Figure 6.13(d) to follow a
similar trend to the PO2 for each model where it is included (Models 1 - 4). As seen at
Location 1 as shown in Figure 6.7, S begins to decrease much closer to the luminal
surface than PO2; however, unlike Location 1, all four models predict a significant drop
in the S within the MTBL. Physiologically, this means that the bound oxygen content
has a particularly significant contribution to the oxygenation of the arterial wall at this
location; although because of the low velocity of the flow the PO2 levels fail to be kept
sufficiently high to maintain the required supply to the arterial wall.

Figure 6.12: Predicted (a) shear rate and (b) Dc within the blood flow at Location 2
from centre of artery to the luminal surface.
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Figure 6.13: Predicted (a) PO2, (b) dS/dPO2 , (c) D’ and (d) S values along a line
within the blood flow from a radius of 2.80mm to the luminal surface at a radius of
3.29mm at Location 2.

Figure 6.14 shows the cross-sectional slice at Location 2 with a contour plot of the
predicted PO2 levels using Model 1. Because of the low velocity and recirculation zone
in the sinus on the side of Location 2 the PO2 levels are hypoxic across the intima and a
substantial portion of the media. Looking at Figure 6.15 there is a considerable
difference between the predicted PO2 values and the experimental results from Santilli
et al. There are several reasons for this, all stemming from the fact that the carotid
bifurcation geometry used here is based on measurements from humans and the
experimental results from Santilli et al. are from dog carotid arteries. In humans this
location is commonly a site of intimal thickening, caused by atherosclerotic plaque
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build-up, as included here with the total arterial wall thickness varying between 1.09mm
and 0.84mm within the cross-sectional slice shown in Figure 6.14. Conversely, in dogs,
as studied by Santilli et al., the wall thicknesses recorded were considerably thinner at
154.0 ±4μm at Location 2.217 The effect of the intimal thickening in humans on the
oxygenation of the arterial wall can be seen here with extensive hypoxic regions where
cells would express VEGFs resulting in the penetration of vasa vasorum into the medial
layer to increase the oxygen supply to the cells at this site.262

Figure 6.14: Cross-sectional slice at Location 2 showing a contour plot of the
predicted PO2 levels in all three domains.

Analysing Figure 6.15, there is no significant difference between Models 1 and 3
because the relatively low Dc has a negligible effect on the D’ within the MTBL for
Model 1. This is also true for the small difference between Models 2 and 4. Model 5
again predicts a much higher luminal surface PO2 value, although there is still a portion
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of the arterial wall exposed to low and hypoxic PO2 levels. Interestingly, because all
five models reach a nadir of 0mmHg the extent of the influence of the oxygen diffusing
in from the adventitia is noticeable with the PO2 levels rising from a radius of 3.7mm up
to the medial/adventitial interface at 4.35mm. This gives an effective range of oxygen
diffusion at this location of 0.65mm; however, the PO2 levels become hypoxic at
approximately half this distance. A similarly high PO2 gradient is observed at the
location also which Models 1 – 4 predict but Model 5 does not.

Figure 6.15: Comparison of predicted and measured transarterial wall PO2
profiles at Location 2. Measurements adapted from Santilli et al. are shown for
comparison and the distances through the arterial wall for these have been scaled
to the size of a human carotid artery.
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6.2.3

Location 3

Lastly, Location 3 is situated on the inner side of the carotid sinus within the ICA where
the flow is different to both previous locations. Figure 6.16 shows a cross-sectional slice
at Location 3 with a contour plot of the predicted velocity magnitude and Figure 6.17
shows the predicted shear rate and Dc at Location 3. The velocity magnitude peak value
is offset to the inner side of the sinus, as shown in Figure 6.16, which has a noticeable
effect on the shear rate as shown in Figure 6.17(a). The tangential velocity vectors on
the slice surface are again shown in Figure 6.16 to highlight the presence of secondary
motion within the sinus that has the effect of replenishing the oxygen at this location.
This means that the oxygen transport has a greater contribution from the advection term
of the transport equation in comparison with Locations 1 and 2. Additionally, for
Models 1 and 2, D’ is affected by the local shear rate through the variable Dc. The shear
rate is a reflection of the rate of change of velocity so looking at Figure 6.17(a) in
combination with Figure 6.16 gives an understanding of why the shear rate along the
line at Location 3 has a particular shape. In Figure 6.16 the closeness of the velocity
contours reflect the rate at which the velocity is changing in a given region of flow.
Within the first 1.0mm, going from the centre out, the shear rate is consistently above
100s-1 which is reflective of the relatively gradual change in velocity in this region of
flow. Moving radially out along the line the next 1.5mm sees very little change in the
velocity as the line passes through the region of flow coloured according to the velocity
range of 0.30 to 0.35m/s. The shear rate dips to a nadir value of 50s-1 within this region.
Following this, with the peak velocity skewed towards the inner side luminal surface,
the velocity changes rapidly from approximately 0.30m/s down to 0.00m/s at the
luminal surface. This relatively rapid transition is reflected in the closeness of the
velocity contours in Figure 6.16. The shear rate correspondingly rises to a peak value of
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547s-1 and then drops to a value of 336s-1 at the luminal surface. The Dc value similarly
varies between a minimum value of 3.2×10-11m2/s within the low shear rate region and a
maximum value of 1.4×10-10m2/s at the peak shear rate point. Importantly, the Dc value
drops to a value of 1.0×10-10m2/s within the MTBL at the luminal surface.
Physiologically, this means that the dispersion of RBCs has a significant effect on the
oxygen transport at this location.

Figure 6.16: Cross-sectional slice at Location 3 showing a contour plot of the
predicted velocity magnitude. The tangential velocity vectors are shown, with
arbitrary length, to highlight the secondary motion present within the sinus.
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Figure 6.17: Predicted (a) shear rate and (b) Dc within the blood flow at Location 3
from centre of artery to the luminal surface.

Figure 6.18: Predicted (a) PO2, (b) dS/dPO2 , (c) D’ and (d) S values along a line
within the blood flow from a radius of 3.23mm to the luminal surface at a radius of
3.29mm at Location 3.
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Figure 6.18 shows the predicted PO2, dS/dPO2 , D’, and S along a line at Location 3 for
each model. The relatively high Dc value increases D’ within the MTBL which can be
seen by comparing the D’ values of both Models 1 and 3, and Models 2 and 4. Looking
at Figure 6.18(c) there is almost no difference in the predicted D’ values within the
MTBL for Models 1 and 2 (a minimum of 1.78×10-10m2/s and 1.79×10-10m2/s,
respectively, at the luminal surface), that results in similar luminal surface PO2 values
(74mmHg and 79mmHg, respectively). This is also the case with their respective
dS/dPO2 values at the luminal surface (0.0022mmHg-1 and 0.0019mmHg-1, Model 1
and 2 respectively). Model 3 again predicts a relatively low luminal surface PO2 value
(39mmHg) with high dS/dPO2 and low D’ values within the MTBL. Model 4 predicts a
lower luminal surface PO2 value (69mmHg) than Model 1. Completely ignoring the
contribution of the oxyhaemoglobin contained within the RBCs, i.e. Model 5, again
results in a higher D’ value and consequently, a higher luminal surface PO2 value
(93mmHg) compared with the other four models. The saturation of the
oxyhaemoglobin, S, as shown in Figure 6.18(d), is very similar in Models 1, 2, and 4
because the PO2 levels are very similar and are all in a region on the oxyhaemoglobin
curve that has a low slope and consequently, there is little change in S over small
changes in PO2. Model 3 again predicts a greater drop in S, similar to the drop in PO2.
Physiologically, this means that the bound oxygen content has less of an effect on the
oxygenation of the arterial wall at this location in comparison with the other two
locations, but the dispersion of the RBCs does play a crucial part in the overall oxygen
transport at this location.
At Location 3 the predicted PO2 value (66mmHg) for Model 1 just within the arterial
wall matches well with the experimental results from Santilli et al. (64mmHg), as
shown in Figure 6.19; however, the PO2 values across the arterial wall differ with those
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recorded experimentally, which again are due to differences in consumption, diffusion
and solubility of the oxygen in humans and dogs. Looking at Figure 6.20 it is clear how
thin the MTBL is at Location 3 in comparison with Location 2 (approximately 0.05mm
vs 0.5mm, respectively), which is caused by the off-centre velocity profile. There is
little difference between the transarterial wall PO2 profiles predicted by Models 1 and 2
because the dS/dPO2 value predicted by Model 1 adjacent to the luminal surface is
similar to the constant value taken for Model 2. Model 3 again predicts a very low
transarterial wall PO2 profile at this location. The transarterial wall PO2 values predicted
by Model 4 are lower than those predicted by Model 1 because of the effect of the
increased Dc value, as modelled by Model 1, is not included. Model 5 again predicts a
much higher luminal surface PO2 value. As with the other two locations a high PO2
gradient is observed at Location 3 using Models 1 – 4 but not with Model 5.

Figure 6.19: Comparison of predicted and measured transarterial wall PO2
profiles at Location 3. Measurements adapted from Santilli et al. are shown for
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comparison and the distances through the arterial wall for these have been scaled
to the size of a human carotid artery.

Figure 6.20: Cross-sectional slice at Location 2 showing a contour plot of the
predicted PO2 levels using Model 1 in all three domains.

6.2.4

High PO2 Gradient in MTBL

The results of each model at Locations 1, 2 and 3 within the human carotid bifurcation
are presented in Figure 6.9, Figure 6.15 and Figure 6.19 respectively, along with
experimental values recorded by Santilli et al. in dog carotid bifurcations. Models 1 - 4,
which include the bound oxygen, predict a high gradient within the MTBL at all three
locations that is also observed between the luminal and first arterial wall PO2 values in
the experimental results from Santilli et al. Model 5, which does not include the bound
oxygen, fails to predict this steep gradient. Previous studies have hypothesised that this
high gradient in PO2 between the lumen and arterial wall is due to high oxygen
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consumption by the endothelium,259 and this is currently an unresolved controversy in
this field because it is not corroborated by in vitro studies. This controversy is covered
in depth by both Vadapalli et al. and Tsai et al.258,261 In the results presented here,
predictions by Model 1 show that the high gradient seen experimentally could be due to
the complex balance between the free and bound oxygen contained within the MTBL,
and the consumption within the arterial wall. This could be a very important
consideration for future oxygen transport studies.
To analyse this phenomenon in further detail the PO2, dS⁄dPO2 , D’ and S values for
each model at Location 1, as shown in Figure 6.7, are referred to again. Model 1 and 3
include the varying gradient of the dissociation curve, dS⁄dPO2 , in the calculation of
D’. As shown in Figure 6.7(b), dS⁄dPO2 , increases rapidly within the boundary layer
which numerically results in a decreased D’ within this region for both Model 1 and 3.
What this means physiologically is that there are two exchanges taking place: the
exchange of oxygen between the blood and the arterial wall, and the exchange of
oxygen between the RBCs and the plasma, i.e. the bound and free oxygen. The free
oxygen only constitutes 1.5% of the total oxygen contained within the blood,200 and
therefore, the bound oxygen can have a significant effect on the exchange of oxygen
between the blood and the wall by either acting as a large PO2 reservoir. This is
exemplified by the difference in PO2 between the models that include the bound
oxygen, Models 1 - 4, and the one that does not, Model 5. It is clear from the results that
the high gradient is not a result of modelling just the RBC dispersion (Models 1 and 2)
or by assigning a variable dS⁄dPO2 value within the domain (Models 1 and 3), but just
by including the bound oxygen only.
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6.3

Conclusion

This test case was undertaken to assess the five blood oxygen transport models in an
idealised artery and to compare the predicted results to experimental measurements at
three locations taken in dog carotid arteries. When the results were analysed the most
significant observation was that the most advanced model, Model 1, predicted a high
PO2 gradient at the luminal surface. This is the first time that this has been observed in
computational models and matches well with experimental measurements. Critically,
this may help settle a controversial issue in the area of oxygen transport modelling
which is explained in a paper by Tsai et al. (2010).258 Specifically, the high gradient in
the PO2 levels adjacent to the arterial wall luminal surface were observed
experimentally which led to some researchers to assume that the endothelium consumes
vastly more oxygen than the typical VSMCs in the arterial wall. This assumption is not
backed up by experimental data on cultured ECs. Here, for the first time, the high PO 2
gradient has been predicted and appears to be a consequence of the balance between the
free and bound oxygen, and the consumption within the arterial wall.
In addition to the above conclusion, this test case also confirms that simplifying the
blood oxygen transport model leads to significant differences in the predicted PO2
levels on the luminal surface and also within the arterial wall. Critically, Model 5, the
most commonly used blood oxygen transport model in the literature, failed to predict
the steep PO2 gradient adjacent to the luminal surface and significantly over-predicted
the amount of oxygen diffusing into the arterial wall. This will be further demonstrated
in Test Case 2 in the following chapter.
Finally, an obvious limitation of this work is evident in the results, namely that the
arterial wall oxygen transport model is not accurate with predicted PO2 values across
the arterial wall falling below the experimental measurements. This may be in part due
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to the difference between physiological differences between dogs and human arteries.
Also, the intima and media are modelled as homogeneous materials with different
consumption, diffusivity and oxygen solubility. In reality, macrophages, plaques and
penetrating vasa vasorum which could exist in vivo would alter these values
significantly. Certainly, at Location 2, an area which is prone to lesion development,
could have a cellular composition and consequently, oxygen transport governing
parameters very different to those which exist in a healthy artery.
6.4

Summary

In this test case the oxygen transport within an idealised geometry of a human carotid
bifurcation was predicted using five different oxygen transport models with varying
degrees of simplification. The results were compared with experimental results from a
study of oxygen levels across the arterial wall of carotid arteries at three locations in 11
mongrel dogs.
The results indicate that:


Simplifying the blood oxygen transport model has significant effects on the
predicted arterial wall oxygen levels.



Further work is needed in deriving crucial parameters for the oxygen diffusion
and consumption within the arterial wall to vacillate more accurate prediction of
oxygen levels.



A high PO2 gradient observed in experimental studies was recreated here for the
first time using the oxygen transport models that incorporate both bound oxygen
and free oxygen. This may have important implications for future work in this
area.
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The next chapter describes Test Cases 2, where the same five models were used in
analysing the oxygen transport in a stented coronary artery, and Test Case 3, where
Model 1 is used to compare three different stent designs.
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CHAPTER
Chapter 7.
7.1

7

Test Cases 2 & 3 – Stented Coronary Arteries

Introduction

ISR is a continuing problem for coronary artery stent design. NIH is one of the key
biological processes that can result in ISR, and has been found to be exacerbated by
hypoxia and disturbed haemodynamics within the stented region.134,135 Test Case 2
assesses the predicted PO2 levels and Sh using the five blood oxygen transport models,
as summarised in Table 3.1, within a realistically-deformed stented coronary artery. As
part of this assessment the maximum and minimum PO2 transarterial wall profile plots
within the stented region are compared with in vivo experimental measurements from
stented rabbit aortas of similar size from Santilli et al.218 Test Case 3 then compares the
predicted PO2 levels and Sh, as modelled using the most advanced blood oxygen
transport model, within the realistically-deformed stented coronary arteries of three
different stent designs.
7.2

Geometry Creation

Three different stent designs, shown in Figure 7.1, were investigated in this study and
are referred to as Stent A, Stent B and Stent C with their differing geometrical
properties listed in Table 7.1.153 Stent A resembles the BX Velocity stent (Cordis of
Johnson & Johnson, Fremont, CA, USA), Stent B resembles the S7 AVE stent
(Medtronic, Fridley, MN, USA) and Stent C resembles the thick strut Multilink RX
Ultra stent (Abbott Laboratories, Lake Bluff, IL, USA). The tri-folded balloon-tipped
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catheter, used in the structural analysis described below, resembles the configuration of
the Raptor balloon-tipped catheter (Johnson & Johnson).

Stent

A

B

C

Stent configuration

Closed-cell

Open-cell

Open-cell

Strut thickness

0.14 mm

0.10 mm

0.13 mm

Strut width

0.13 mm

0.10 mm

0.10 mm

Link configuration

Peak-to-peak

Peak-to-peak

Peak-to-valley

Link type

Flexible

Non-flexible

Non-flexible

Link shape

N-shaped

Straight

Straight

Link width

0.10 mm

0.08 mm

0.10 mm

Table 7.1: Geometrical properties of the three investigated stents.153

The realistically-deformed stented artery geometries were obtained from non-linear
finite element analyses (FEA) carried out using ABAQUS (Dassault Systèmes,
Providence, RI, USA). These structural analyses consisted of the expansion of the
sample stents using the realistic model of a tri-folded balloon-tipped catheter within an
idealised coronary artery as shown in Figure 7.2. Each of the three stents were assumed
to be manufactured from 316L stainless steel and a rate-independent elastic-plastic
material model with isotropic hardening was adopted to describe their mechanical
behaviour. The elastic-plastic response was modelled on the basis of data reported by
Murphy et al., who conducted uniaxial tension tests of 316L stainless steel struts.170
Likewise, the mechanical behaviour of the guide wire, catheter shaft, and angioplasty
balloon was described using isotropic linear elastic material models with their linear
elastic response described using data from Mortier et al., who employed a realistic
model of the Raptor balloon-tipped catheter to evaluate the mechanical impact of stent
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deployment within a bifurcated coronary artery.167 The thicknesses of the intima, media
and adventitia were 0.24, 0.32, and 0.34mm respectively, and their mechanical
behaviour was described using isotropic hyperelastic material models with their nonlinear elastic response adopted from data reported by Holzapfel et al.100 Holzapfel et al.
carried out experimental analysis of 13 human LAD coronary arteries harvested within
24 hours of death.
The computational domain was 20mm long with the arterial lumen set at a stent-free
diameter of 2.7mm and external arterial wall diameter of 4.5mm. The stents had an
8.0mm unexpanded length and were expanded using a pressure load, which varied with
each stent design, within the balloon to achieve a deployment ratio of 1.1:1. Once
expanded, depending on the stent strut configuration, the overall length of the stent
changes: Stent A 7.7mm, Stent B 7.4mm, and Stent C 8.3mm. This can be seen clearly
in Figure 7.3 where Stent C is noticeably longer than the other two stents when
completely expanded. As a side note, also noticeable in Figure 7.3 is the apparent
corrugation of the arterial wall luminal surface, i.e. the surface is not completely
smooth. This is because of the mesh size and type used for discretising the arterial wall
for the FEA, and has a perceptible effect on the variables of interest which use gradients
in their calculation, namely WSSG and Sh. For the purpose of this study though the
overall distributions are still clear for both variables.
The mechanical behaviour of the coronary arterial wall is highly non-linear,
predominantly because of the collagen fibres within, which stiffen the arterial wall at
higher stress levels.72 This non-linearity is accounted for by using third-order Ogden
hyperelastic material models for each layer of the arterial wall. These hyperelastic
material models were fit to the appropriate experimental data from Holzapfel et al. with
different hyperelastic material constants adopted for each layer, which showed good
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agreement with experimental data, as described by Martin.150 The FEA solution was
carried out using ABAQUS/Explicit solver with multiple contact surfaces and friction
included. As shown in Figure 7.2(b), as the pressure load is increased the ends of the
stent begin to expand first. This is referred to as dog-boning, because of the shape, and
is commonly observed in the literature.152,236,251 Once the fully expanded configuration
is reached, as in Figure 7.2(c), the balloon was deflated, Figure 7.2(d), and the stent
recoils slightly and settles into its final expanded configuration. Further details of these
analyses are discussed elsewhere.150,153 The final expanded configuration of both the
stent and the arterial wall was then exported from ABAQUS to Rhinoceros 3-D where
the geometry was adapted for CFD analysis. This adaption involved removal of small
sliver regions, which would disrupt the mesh generation, where the stent surface would
be malapposed to the luminal surface that are caused largely by mismatched mesh
patterns. Entry and exit regions, 32mm in length, were added proximal and distal to the
stented region to ensure that the haemodynamics were not affected by the boundary
conditions. These regions also included 4mm length of intima and media to ensure that
the oxygen MTBL had developed adequately. Only the intima and media layers of the
arterial wall were needed for the oxygen transport analysis as the adventitia is supplied
with oxygen by vasa vasorum within it, as discussed in previous chapters. The stented
region itself for each stent was defined as the 12mm long region where the diameter of
the artery at the extremities has returned to its unstented value. The stented region for
each stent is shown in Figure 7.3.
Only Stent A was used for comparison of the five different blood oxygen transport
models in Test Case 2. All three stents were compared using the most advanced model,
i.e. Model 1, in Test Case 3 for the purpose of demonstrating the effects of different
stent designs on the PO2 values on and within the arterial wall.
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Figure 7.1: The three stents analysed. The final deformed configuration is shown.
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Figure 7.2: FEA-predicted deployment of Stent A, as carried out by Martin et al. (2014), using a tri-folded balloon-tipped catheter
within an idealised coronary artery with a heterogeneous multi-layered arterial wall incorporating an intima, media and adventitia.153
(a) Initial configuration with a pressure load=0.00MPa, (b) expansion of balloon with a pressure load=0.50MPa, (c) maximum expansion
with a pressure load=1.10MPa, and (d) the final deformed configuration with a pressure load=-0.01MPa.
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Figure 7.3: The stent and luminal surface within the stented region for the three
stents analysed.

7.2.1

Geometry Discretisation

Similar to Test Case 1 the geometry was imported into ANSYS ICEM meshing
software for discretisation. An unstructured mesh topography was adopted for all three
stented artery geometries comprising of tetrahedral and prism elements. The mesh
inflation parameters established in the validation test case were taken as a basis for the
mesh convergence studies of the stented coronary artery geometry. The surface mesh
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was generated using the Octree Method which was used as a basis for the volume mesh
created using the Delauney Method. Finally, prism layers were added at the luminal
surface (eight layers) and within the media (eight layers). This meshing procedure is
recognised for its generation of good quality meshes for CFD using ANSYS ICEM
mesh generation software. The Octree Method is a robust method that is reliable for
complicated geometries and the Delauney Method produces a volume mesh which has a
smoother volume mesh transition between adjacent elements. This smoother transition
results in improved aspect ratios, which in turn helps with solution convergence. The
prism layers are required for accurate prediction of both the haemodynamics and the
PO2 boundary layer at the luminal surface. Recommendations by previous researchers
in this area were taken into account in the mesh generation and also confirmed by the
mesh convergence study, the results of which are presented in Appendix B. For
instance, it was found that for accuracy in predicting the oxygen transport at the luminal
surface at least three layers of prisms off the luminal surface within the MTBL are
required. This is in agreement with previous work by Tada, and Coppola and Caro in
this area.43,248 For the meshes generated here eight prism layers were used because areas
of flow disturbance resulted in a thickened MTBL which required additional prism
layers, in comparison with previous authors, for it to be accurately captured. Figure 7.4
shows a cross-section of the mesh employed for Stent A.
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Figure 7.4: Cross-section of mesh employed for Stent A at mid-point of stented
region. Refinement was applied on the stent surface and prism layers were used on
the luminal surface, and also within the arterial wall, to ensure accurate capture of
both the haemodynamic and PO2 transport features.

7.2.2

Boundary Conditions

For the stented artery models the following boundary conditions were implemented. At
the inlet of the fluid domain a fully developed Hagen-Poiseuille velocity profile was
imposed with Vmean=0.2313m/s, which results in an average volume flow rate of
40ml/min which is within the range of typical basal values seen in human LAD
coronary arteries in vivo.112 Also, at the inlet PO2,in=100mmHg, which is normal arterial
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blood PO2.200 At the outlet an entrainment boundary condition with a zero relative
pressure was set with PO2,out=0mmHg. PO2 was free to transfer across the
luminal/arterial wall surface, and across the intima/media interface surface. On the stent
surface a PO2 zero-flux condition was imposed. On the media/adventitia interface
surface PO2=45mmHg, as used by Richardson,206 and on the wall surfaces located either
end of the arterial wall section a zero flux boundary condition was imposed.
7.3

Results and Discussion - Test Case 2

Figure 7.5(a) and (b) show the maximum and minimum PO2 transarterial wall profile
plots within the stented domain for all five models which were taken at the position of
maximum and minimum luminal surface values. For comparison the measurements by
Santilli et al. from rabbit aortic arteries on day 1 following stent implantation with 3mm
internal-diameter stents are also shown.218 The stents used by Santilli et al. were
manufactured by Cordis, although it was not stated specifically that the BX Velocity
stent was used. The balloon used was a 3.0mm outer diameter balloon, which was also
used in the FEA simulations presented here. In their study, the exact measurement
location within the stented domain is not provided and therefore, the maximum and
minimum profiles for each model are presented here alongside the experimental results.
Assuming the experimental results are taken as being reflective of the PO2 values
present in a similar size human coronary artery, as modelled here, then Model 1 is again
shown to produce the steep PO2 gradient and is within the range of luminal surface PO2
values observed experimentally. Model 5 again over-predicts the amount of oxygen
being transported to the luminal surface and there is an absence of the steep PO2
gradient at both locations. Models 2 and 4 also over-predict the oxygen flux into the
arterial wall, and Model 3 again significantly under-predicts it. Both Models 1 and 3,
and Models 2 and 4 are quite similar at the minimum location because the minimum
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luminal surface PO2 values for all five models are within a low velocity recirculation
(almost stagnate) zone next to a stent strut and the shear rate is low which consequently
means the Dc value is also low, i.e. almost negligible in this case. The uneven section of
the transarterial curves within the lumen in Figure 7.5(b) are also attributed to this
recirculation zone downstream of the stent strut at this location.
Differences in the PO2 transarterial wall profile predicted by the simulations and the
experimental results from Santilli et al. are attributed to differences in arterial wall
properties of different species. For example, looking in more detail at the PO2
transarterial wall profiles it would appear that the diffusion of oxygen through the
intima of the rabbit aortae may be higher than in the human coronary arteries as
modelled here. This would be supported by looking specifically at the maximum PO2
transarterial wall profile of Model 1 which shows the closest luminal surface PO2 value
to the experimental results. A higher diffusivity would shift the curve (in red in Figure
7.5(a)) over towards the experimental measurements by Santilli et al.; additionally, the
consumption value would also vary. Further work would need to be carried out to
confirm this and could again highlight the differences in arterial wall tissue properties
observed across different species.
The effect of the higher consumption value for the human coronary artery as adopted in
the intima domain in these simulations is clearly distinguishable in Figure 7.5(a) with a
considerably steeper curve in the first approximately 0.15mm (less than 0.24mm set for
the intima because of stretching caused by the stent implantation) from the luminal
surface to an approximate radius of 1.70mm in comparison with the slope of the PO2
transarterial wall profile from this point to the outer boundary.
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Figure 7.5: (a) Maximum and (b) minimum transarterial PO2 profiles for each
model applied to the deformed coronary artery geometry virtually implanted with
Stent A. Measurements adapted from Santilli et al. are shown for comparison and
the distances through the arterial wall for these have been scaled to the size of a
human coronary artery.218 The minimum PO2 luminal surface value for each
model is located within a recirculation zone immediately downstream of a stent
strut which produces a severe drop and variable slope in PO 2 profile in Figure
7.5(b). The luminal surface is shown as a vertical dashed-dotted line. Note:
locations of maximum and minimum PO2 transarterial profiles for each model are
shown in Figure 7.6.
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Figure 7.6: Locations of predicted maximum and minimum luminal surface PO 2
values within the stented region for each model which were used for the profile
plots in Figure 7.5. To give an indication of the gradient of the PO2 along the
surface at the maximum locations Figure 7.8 shows a line plot of the PO2 along line
A-A’.

Contour plots of the PO2 and Sh are shown in Figure 7.7(a) and (b) respectively. When
analysed in conjunction with the line plots along the axial cross-section A-A’ (Figure
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7.8) the effects of each model become apparent. The difference between Model 1 and
the simpler models is striking. Firstly, the plots of the PO2 values along the luminal
surface in Figure 7.7(a) show quite a large variability across the five models with the
extent of the difference clear in the PO2 line-plot in Figure 7.8. The areas of low PO2
values (<30mmHg) around the stent struts which are apparent with Model 1 do not
appear with Models 2, 4 and 5, with Model 5 predicting very little variation in PO2 on
the luminal surface with the lowest value being 64mmHg. Model 3, which neglects the
RBC dispersion, predicts very low PO2 levels on the luminal surface that translate into
very little oxygen diffusing into the arterial wall. Interestingly though, Model 3 predicts
very high Sh values along the surface because the Sh is based on the gradient of PO 2
normal to the surface, which is very high for Model 3 as seen previously in Figure 7.5.
This highlights a possible disadvantage in using the Sh as a basis for analysis in the
form adopted here as it uses the PO2 gradient normal to the wall.
Hypoxic PO2
(<10mmHg)

Low PO2
(<30mmHg)

D'min

D'max

Model 1

12.6%

72.8%

1.12E-11

3.51E-10

Model 2

0.0%

14.3%

9.05E-11

2.56E-10

Model 3

36.6%

80.8%

6.13E-12

2.08E-10

Model 4

0.0%

33.9%

8.58E-11

8.58E-11

Model 5

0.0%

0.0%

1.20E-09

1.20E-09

Table 7.2: Percentage volume of the arterial wall exposed to hypoxic and low PO2
within the stented region for each model along with the minimum and maximum
D’ values present within the blood flow.

The relatively small variation in PO2 values observed along the luminal surface for
Model 5 translates to very little variation predicted in the local Sh also. For Models 1 –
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4 there is a similarity in the regions of low and high Sh, with low Sh (values tending
towards the calculated Da≈17) predicted in regions where the flow is separating away
from the luminal surface and high Sh predicted in regions where the flow is reattaching,
i.e. where the flow is directed towards the wall and oxygen transport through convection
is high. The peaks of high Sh observed with Models 1 – 4 are dampened considerably
for Model 5 to the extent that the reattachment points are unrecognisable on the luminal
surface plots. Da itself could not be used as a threshold value in this case since none of
the models actually predicted the local Sh to drop below 17 on the luminal surface even
though significant portions of the arterial wall were predicted to be exposed to hypoxic
PO2 levels. This may highlight a limitation of using Da as a threshold value for low Sh.
Greater amounts of neointimal thickening have been shown to occur in areas with PO2
values of less than 30mmHg, and hypoxia exists where the PO2 levels drop to below
10mmHg.34,218 Thus, how much of the arterial wall is exposed to PO2 values below
these two thresholds is of importance in predicting the possibility of excessive
neointimal thickening and potential ISR. As shown in Table 7.2, the five models studied
here predict a broad range of percentage volumes of the arterial wall exposed to low
PO2 (<30mmHg). For example, Model 5 predicts that none of the stented arterial wall is
exposed to low PO2, as opposed to Model 1 predicting 72.8% of the stented arterial wall
is exposed to low PO2 with 12.6% exposed to hypoxic conditions. Model 2, which
neglects the non-linearity of the oxygen disassociation curve, differs significantly in the
amount of hypoxic and low PO2 regions (0% and 14.3% respectively) within the arterial
wall compared with Model 1. Model 3, which neglects the shear-dependent dispersion
of RBCs, predicts extensive hypoxic and low PO2 regions within the stented region
(36.6% and 80.8% respectively). The PO2 levels drop off severely within the MTBL for
Model 3 because the slope of the oxygen disassociation curve, dS/dPO2 , increases
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significantly, reducing the D’, as demonstrated in the analysis at each location in Test
Case 1. This results in the lowest D’ value of the five models, as shown in Table 7.2,
which in turn results in the lowest PO2 luminal surface values throughout the stented
region, as shown in Figure 7.7. Model 4 is similar to Model 2 in the regard that it
predicts that none of the arterial wall within the stented region is exposed to hypoxic
PO2 levels. Critically, this broad variability in predicted hypoxic and low PO2 regions
within the stented region again highlights the disadvantages of simplifying the blood
oxygen transport model.
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Figure 7.7: Predicted (a) PO2 and (b) Sh on the luminal surface within the stented region.
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Figure 7.8: Predicted PO2 and Sh along line A-A’.
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7.4

Results and Discussion - Test Case 3

Investigating the results from all three stented arteries requires first to analyse the
haemodynamics, and then the oxygen transport within each domain and how it’s
affected by the haemodynamics and arterial wall deformation. Finally, the predicted
haemodynamics and oxygen transport results are compared alongside the restenosis
rates for each stent.

7.4.1

Haemodynamics

Figure 7.9 shows the predicted WSS and WSSG within the stented region for each stent.
Table 7.3 shows the percentage luminal area of the stented region which is exposed to
low WSS <0.5 Pa. Low WSS is correlated with increased NIH.127 As reviewed in
Chapter 2, previous studies have shown that increased expression of pro-thrombotic
agents, inflammatory cell adhesion molecules, and VSMC growth factors by ECs occurs
in response their exposure to WSS below 1.0 – 1.2 Pa, although the effects are
considered more severe below 0.5 Pa. Also, as mentioned in Chapter 2, a study of stent
implantation in rabbits showed that ECs are still present adjacent to stent struts
immediately post-implantation. This is crucial here because as shown in Figure 7.9(a)
the areas that experience WSS values below 0.5 Pa are predominantly adjacent to stent
struts. Stent A is predicted to perform the best of the three stents with 31.3% of the
luminal area within the stented region exposed to low WSS, in comparison with 35.4%
and 36.3% for Stent B and Stent C, respectively. Where the endothelial layer is
destroyed within the stented region, in interstices between stent struts, VSMCs can be
exposed to the blood flow.208 According to the predicted WSS distributions for each
stent here, as shown in Figure 7.9(a), any areas where VSMCs may be exposed to the
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blood flow the WSS is below physiological WSS values, ranging from 0.5 – 1.0 Pa,
which encourages VSMCs to proliferate.
The WSSG is also plotted for each stent in Figure 7.9(b). High WSSG (>0.85 Pa/mm)
has been shown to increase endothelial permeability that causes increased
macromolecule uptake.195 It is assumed here that the endothelium offers no resistance to
oxygen transport; however, increased endothelial permeability could lead to increased
uptake of leukocytes causing increased inflammation in areas predominately around
stent struts. The percentage of the luminal surface within the stented region which is
exposed to WSSG values above 0.85 Pa/mm are shown in Table 7.3 for each stent.
Significantly less of the luminal area is exposed to high WSSG values for Stent A
(42.0%) than both Stent B (53.1%) and Stent C (53.9%). Therefore, the ECs within the
stented region for Stent A would experience, in theory, less endothelial permeability in
comparison with Stent B and Stent C.
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Stent

A

B

C

Low PO2 (<30mmHg)

72.8%

74.2%

68.9%

Hypoxic PO2 (<10mmHg)

12.6%

14.3%

5.3%

62.7%

64.1%

57.2%

11.9%

5.0%

2.4%

Low WSS (<0.5Pa)

31.3%

36.3%

35.4%

High WSSG (>0.85Pa/mm)

42.0%

53.1%

53.9%

Interface Area

99.75mm2

95.43mm2

99.11mm2

Restenosis Rate

31.4%

10.1%

25.8%

Luminal Low PO2
(<30mmHg)
Luminal Hypoxic PO2
(<10mmHg)

Table 7.3 Percentage volume of the arterial wall exposed to low and hypoxic PO 2
within the stented region for each stent along with the lumen/arterial wall interface
area within the stented region and restenosis rate, as taken from the following
clinical trials at 6-month follow-up: Stent A, ISAR-STEREO-II, Stent B,
DISTANCE and Stent C, ISAR-STEREO-I, and discussed in Section 7.4.3.
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Figure 7.9: Predicted (a) WSS and (b) WSSG on the stented artery luminal surface for the three stents analysed.
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7.4.2

Oxygen Transport

Comparing the three stent designs by concentrating solely on the percentage luminal
area exposed to low WSS or high WSSG does not give sufficient detail on how the
haemodynamics can affect the biological processes taking place within the arterial wall
post-implantation. In this study here the inclusion of the oxygen transport allows
analysis of the effects of the haemodynamics post-stent implantation on one aspect that
can directly affect the cells within the arterial wall, not just on the luminal surface.
Table 7.3 lists the predicted percentage volume of the arterial wall for each stent
exposed to low and hypoxic PO2 values. Stent C is predicted to perform the best of the
three stents with only 68.9% of the arterial wall exposed to low PO2 and only 5.3%
exposed to hypoxic conditions. For Stent A 72.8% exposed to low PO2 and 12.6% of
the arterial wall is predicted to be exposed to hypoxic conditions. Stent B has the
highest percentage volume exposed to low PO2 at 74.2% and 14.3% of the arterial wall
is exposed to hypoxic PO2 levels. Figure 7.10(a), (b), and (c) show the distribution of
the percentage volume of the arterial wall within the stented region exposed to PO2
values in bins of 5 mmHg. Comparing the three stents, it is predicted that none of the
arterial wall for Stent C is exposed to PO2 values below 5 mmHg, compared with 1.1%
and 3.1% of the arterial wall for Stent B and Stent A, respectively. Included in these
histograms are the percentage volume of the arterial wall that is present in the intima for
each PO2 bin range. This analysis shows that in the case of these idealised arterial walls,
with no plaque present, only the intima experiences hypoxic PO2 levels, with the
assumption that the intima remains intact. This would be in agreement with previous
studies that found that the media is predominantly supplied with oxygen from the
adventitial vasa vasorum. In this case, with hypoxia present within the intima,
penetration of the media by the vasa vasorum would be induced.
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To ascertain why each stent performs differently, in terms of oxygen transport, further
investigation is warranted. Looking again at the WSS and WSSG luminal surface plots
presented in Figure 7.9, along with the PO2 and Sh luminal surface plots, and PO2 axial
cross-sectional plots for Stents A, B and C, as shown in Figure 7.11, and Figure 7.12.
When Figure 7.12 is analysed it becomes apparent that the design of Stent C, with stent
struts that are well-spaced out and link struts which are aligned with the flow, results in
reduction in the size of the low and hypoxic PO2 zones. Interestingly, the prolapse of the
arterial wall between the struts allows increased oxygen convection into the wall
downstream of each strut, which is apparent in Figure 7.11(b) with high Sh in these
regions. This detail would not have been captured effectively with an idealised nondeformed arterial wall. Immediately apparent in Figure 7.11(a) and Figure 7.12 is that
the N-shaped link struts in Stent A, which are predominantly aligned perpendicular to
the flow, cause an extended region of recirculation zones and consequently low PO2
values on the luminal surface. This further suggests the dominance of the augmented
haemodynamic environment caused by stent implantation on the oxygen flux. For Stent
B, the smaller interstrut areas relative to Stents A and C mean that the arterial wall does
not prolapse into the lumen to the same extent as with the other two stents, as seen in
Figure 7.13 and Figure 7.14. Additionally, the lumen/arterial wall interface area, i.e. the
area exposed to the blood flow within the stented region, for Stent B is less than both
Stents A and C because of the greater number of stent struts. It would appear that these
particular design features of Stent B cause more of the arterial wall to be exposed to low
and hypoxic PO2 levels in comparison with Stent C.
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Figure 7.10: (a, b & c) Predicted percentage volume of the arterial wall and intima,
both normalised with respect to the arterial wall volume within the stented region,
exposed to PO2 values in bins of 5mmHg for each stent. (d, e & f) Predicted
percentage area of the stented luminal surface exposed to WSS values in bins of
0.125Pa normalised with respect to the total luminal area within the stented region
for each stent.
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Figure 7.11: Predicted (a) PO2 and (b) Sh on the stented artery luminal surface for the three stents analysed.
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Figure 7.12: Axial cross-section of predicted PO2 in both the arterial wall and lumen within the stented region for the three stents
analysed. The interfaces between all three domains are clearly outlined.
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Although, it is clear that it is not simply a case of decreased lumen/arterial wall interface
area which impinges the PO2 flux into the arterial wall since Stent A has a similar
interface area to Stent C, as shown in Table 7.3, but produces low and hypoxic PO2
percentage volumes only marginally better than Stent B. Therefore, there are additional
factors involved. Particular to this study here, the realistically-deformed arterial wall is
different for each stent, specifically the medial and intimal thicknesses vary within the
stented region for each stent.
Figure 7.13 and Figure 7.14 show these thicknesses along two axial cross-sections for
each stented artery geometry. When these are analysed it is clear that the arterial wall
stretches when the stent is implanted, and that this stretching reduces the thickness of
the arterial wall within the stented region to different extents depending on the stent
design. The stretching acts circumferentially and axially, and for Stent C, which
elongates in the axial direction from a length of 8.0mm crimped to a length of 8.3mm in
final deployment configuration, it appears that the axial stretching thins the arterial wall,
specifically the media, within the stented region. The percentage change in the volume
of the arterial wall within the stented region for Stent A is -0.2%, for Stent B -2.5% and
for Stent C -7.0%. Therefore, for Stent C there is a significant difference in the amount
of the arterial wall that requires oxygen delivery. The media shows a -11.6% reduction
for Stent C compared with -0.4% and -4.7% for Stents A and B, respectively. This
comparative reduction is clear in Figure 7.13 and Figure 7.14 where Stent C shows a
much lower medial thickness along two different axial cross-sections. This hypothesis is
supported by the fact that the luminal surface PO2 threshold percentage values, as
shown in Table 7.3, do not directly match the arterial wall PO2 threshold values. For
instance Stent B has 5.0% of the luminal surface exposed to hypoxic PO2 levels,
compared to 11.0% and 2.4% for Stents A and C respectively. Yet, Stent B has the
182

CHAPTER 7: Test Cases 2 & 3 – Stented Coronary Arteries

highest percentage volume of the arterial wall exposed to hypoxic PO2 levels (14.3%)
compared with 12.6% and 5.3% for Stents A and C respectively. Note: the arterial wall
volume displaced out of the stented region is still present in the computational domain
as the arterial wall is modelled in the structural analysis as almost incompressible, it is
just pushed out of the stented region. This is indicated by the slightly higher thickness
of the media (0.33mm) on the extremities of the stented region in Figure 7.14. This
would not be captured by a non-deformed idealised geometry.
On inspection of Figure 7.15, Figure 7.16, and Figure 7.17 it can be seen that higher
values of Sh coincide with reattachment zones where both the WSSG is high and the
WSS is increasing in the direction of flow. It is possible that within these reattachment
zones increased infiltration of cytokines, mitogens, leukocytes, and thrombotic elements
into the arterial wall could also occur leading to increased NIH. Therefore, increased
oxygen transport by convection may come at a price of increased convection of prorestenotic agents within the blood stream into the arterial wall at these locations. Also
clear from Figure 7.15, Figure 7.16, and Figure 7.17 is that the predicted PO2 luminal
surface values are closely related to the WSS; however, the percentage volumes
exposed to low and hypoxic PO2 levels in the arterial wall do not match the percentage
luminal areas exposed to low WSS, as shown in Table 7.3 and is also clear by
comparing the histograms in Figure 7.10. This draws the conclusion that even though
the WSS and luminal PO2 values seem to follow similar trends along the luminal
surface in Figure 7.15, Figure 7.16, and Figure 7.17, the percentage of low WSS cannot
act as a predictor of the extent of low and hypoxic PO2 levels within the arterial wall.
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Figure 7.13: Line plots of the medial and intimal thicknesses within the stented
region for each stent along an axial cross-section with the corresponding predicted
PO2 values within the arterial wall. Cross-sections are taken at same location as AA’, B-B’ and C-C’ as shown in Figure 7.15, Figure 7.16, and Figure 7.17,
respectively.
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Figure 7.14: Line plots of the medial and intimal thicknesses within the stented
region for each stent along an axial cross-section with the corresponding predicted
PO2 values within the arterial wall. These cross-sections were taken perpendicular
to the previous set in Figure 7.13.
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Figure 7.15: Predicted PO2 and WSS, and Sh and WSSG along line A – A’.
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Figure 7.16: Predicted PO2 and WSS, and Sh and WSSG along line B – B’.
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Figure 7.17: Predicted PO2 and WSS, and Sh and WSSG along line C – C’.
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7.4.3

Comparison with Restenosis Rates

The angiographic restenosis rates for each commercially available coronary stent that
resemble the three stents are presented in Table 7.3, along with the percentage volume
of the arterial wall exposed to low and hypoxic PO2 levels. These rates were taken from
the following clinical trials at 6-month follow-up: Stent A, ISAR-STEREO-II, Stent B,
DISTANCE and Stent C, ISAR-STEREO-I. Stent B is predicted to perform the worst,
in terms of volumetric percentages of low (74.2%) and hypoxic (24.3%) PO2 within the
arterial wall, but shows the lowest restenosis rate (10.1%). Stents A has slightly lower
percentage volumes of low (72.8%) and hypoxic (12.6%) PO2 within the arterial wall
and has the highest restenosis rate (31.4%). Stent C is predicted to have significantly
less percentage volume of the arterial wall exposed to low (68.9%) and hypoxic (5.3%)
PO2 levels but has a lower restenosis rate (25.8%) in comparison with Stent A, but
significantly higher than Stent B (10.1%). Looking solely at the amount of the arterial
wall exposed to low and hypoxic PO2 levels Stent C is predicted to perform the best out
of the three stents; however, this does not match with the restenosis rates. Considering
ISR is a multifactorial process, there may be some other issue with this stent, e.g.
structural damage of the arterial wall or areas of low wall shear stress, which is not
captured by oxygen transport models alone. With all these elements that can affect the
biological processes within an implanted artery, it is difficult to determine which
element dominates.
Possibly the extent of damage inflicted on the arterial wall by stent implantation may
also play a role in the risk of ISR. Martin (2014) analysed the equivalent stress (ES),
time-averaged WSS, OSI and RRT using the same three stent geometries (along with an
additional three). Of the three stents presented here, Stent A had the highest maximum
ES (83.84 kPa) and the highest mean ES (10.7 kPa). Stent B was predicted to exert a
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maximum ES of 58.98 kPa and a mean ES of 8.83 kPa on the arterial wall, and Stent C
a maximum ES of 74.37kPa and a mean ES of 9.21kPa. Plots of the ES distribution
within the arterial wall and on the luminal surface are shown in Figure 7.18. For Stent
A, for example, which is predicted to perform the worst in terms of ES, the area
exposed to the highest ES is around the N-shaped link struts. This area is also shown to
experience hypoxic PO2 levels, low WSS and high WSSG. Possibly the combined
effects of the high stress exerted on the arterial wall, the adverse local haemodynamics
and hypoxic PO2 levels within a focussed area of the stented region for Stent A leads to
higher restenosis rates. This is conjecture at this point and for significant statistical
power more geometries would need to analysed than just the three presented here.
One difference between Stents A and C, and Stent B is that Stent B is predicted to
create a more uniformly circular luminal cross-section, as opposed to more polygonal
cross-section with Stents A and C. A typical transverse cross-section is shown for each
stent in Figure 7.19. In a study by Garasic et al. the authors found that stent geometries
with 12 struts per cross-section had 50% to 60% less mural thrombus, and two-fold less
neointimal area than identical stents with only eight struts after 28 days in rabbits. 69 The
authors also observed increased macrophage numbers in the 12-strut stented arteries
which was explained by the observation that leukocytes cluster around stent struts.69
This would support the theory that the leukocyte adhesion is increased in regions of
recirculation and low WSS which are generally located adjacent to stent struts.
Interestingly, in their study the increased macrophage cell count in the 12-strut stented
arteries did not translate into increased NIH at 28 days. Possibly, the inflammatory cells
impact is only noticeable after the 28 day period in rabbits as noted by the authors.
Given that factors, in addition to the oxygen transport and the local haemodynamics,
that also affect the biological processes that can result in ISR, possibly a more complete
190

CHAPTER 7: Test Cases 2 & 3 – Stented Coronary Arteries

and comprehensive assessment methodology is necessary in predicting the implications
of stent designs on the adverse outcomes post-implantation. Such a methodology would
need to incorporate most of the factors discussed here, although the extent to which
each factor affects the overall result is debateable and currently unknown.

Figure 7.18: Equivalent stress (ES) for each stent design as predicted by Martin. 150
Note: the adventitia layer is also included in these plots.
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Figure 7.19: Transverse cross-sectional plots for each stent.
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7.5

Conclusions

Test Case 2 confirms the limitations of simplifying the blood oxygen transport model,
as discussed in Chapter 6, with some additional points to note. The steep PO2 gradient
observed adjacent to the luminal surface at all three locations in Test Case 1 is also
visible here in the PO2 profile plots in Figure 7.5 and significantly, Model 5 fails to
predict it again in this test case. Critically, this test case shows that adopting the Sh as a
measure of the oxygen flux into the arterial wall can be problematic if using a simplified
blood oxygen transport model. This is vividly portrayed in both Figure 7.7 and Figure
7.8. In Figure 7.7 a stark difference is visible between the Sh predicted by Model 1
compared with Model 5 with none of the sharp peaks in Sh downstream of the stent
struts predicted by Model 1 visible when Model 5 is used. This is further demonstrated
in Figure 7.8 where the line graph of the predicted Sh for Model 5 is flattened in
comparison with all the other four models. Therefore, a simplified blood oxygen
transport model, as adopted in most oxygen transport studies in the literature, fails to
predict these peaks in Sh observed downstream of stent struts. Additionally, some
researchers have used the results presented by Moore and Ethier (1997) to justify the
use of a correction factor of 2.5 to the Sh when applying a simplified blood oxygen
transport model which ignores the bound oxygen.44,203 As shown clearly in Figure 7.8
this would not suffice in accounting for the use of a simplified model.
Test Case 3 demonstrates that the oxygen transport can be significantly affected by stent
design with the three stent designs exhibiting significantly different percentages of the
arterial wall exposed to hypoxic PO2 levels. This is not simply a case of how much of
the luminal area is exposed to the blood as shown by the fact that the hypoxic volume
percentages do not correlate with the luminal surface interface areas for each stent. Stent
struts angled perpendicular to the flow can significantly affect the amount of oxygen
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transferred into the arterial wall from the blood flow, which is clearly seen for Stent A
in Figure 7.11. Critically, this test case shows the value of an accurate oxygen transport
model in improving designs of cardiovascular devices. Additionally, the benefit of using
realistically-deformed stented artery geometries, as generated here using FEA, is
demonstrated here because some features, such as prolapse and stretching of the arterial
wall, which would not be generated accurately otherwise are shown to affect the
predicted results. Further investigation is warranted possibly incorporating plaque
within the arterial wall or by using a patient-specific geometry which provides an
avenue for future study.
7.6

Summary

In Test Case 2, presented here, the five blood oxygen transport models were compared
within a realistically-deformed stented geometry.
The results showed that:


The models that incorporate the bound oxygen again predicts a steep gradient in
the PO2 transarterial profile at the luminal surface that matches well with the
experimental data from Santilli et al.



Model 1 shows the best agreement with regard to the luminal surface value with
the experimental data from Santilli et al.



There are some differences observed in the arterial wall oxygen transport
properties possibly because of dissimilarities between species.



Simplifying the blood oxygen transport model, by ignoring non-linearities and
the oxy-haemoglobin, have significant effects on the accuracy of the results
generated.
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In Test Case 3 the most advanced blood oxygen transport model was used to compare
three different stent designs. The results demonstrated that


There were significant differences between the three stent designs assessed in
terms of the oxygen transport into the arterial wall.



Therefore, stent design affects the amount of oxygen reaching cells within the
arterial wall.



One stent, Stent C, had significantly less of the arterial wall predicted to be
exposed to hypoxic PO2 levels which was caused in part by the stretching of the
arterial wall upon implantation as predicted by FEA.



Another consequence of this was that the amount of the arterial wall exposed to
hypoxic PO2 levels was not correlated with the amount of the luminal surface
exposed to hypoxic PO2 levels.



This highlights one of the advantages in using realistically-deformed geometries,
although computational expense may be an issue.

In the next chapter, the haemodynamics and the oxygen transport, modelled using
Model 1, are analysed in helical-flow-inducing stent designs and compared with a
straight stent of similar length.
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Chapter 8.

8

Test Case 4 – Helical-Flow-Inducing Coronary
Stents

8.1

Introduction

The local haemodynamics and oxygen transport can both, in theory, affect the long-term
outcome of stent implantation, as discussed in Chapter 2, and helical flow has been
theorised to improve both, as discussed in Chapter 4. In this chapter Test Case 4
assesses the effects of inducing helical flow on the haemodynamics and oxygen
transport in stented coronary arteries. First, the background and justification for a
helical-flow-inducing coronary stent are discussed. Second, the methodology for
geometry and mesh creation is described briefly. Finally, in the results section both the
haemodynamics and the oxygen transport are analysed.
8.2

Background

Helical flow has been theorised to provide several haemodynamic benefits for the
reduction of ISR in stented arteries. As described previously in Section 4.4.1 the
BioMimics 3D stent is a self-expanding nitinol stent, developed for the treatment of
peripheral artery disease, which induces helical flow in a treated artery. Helical-flowinducing stents have not yet been deployed in coronary arteries; however, there is
justification for the use of a similar stent for the treatment of CAD. In theory, a helicalflow-inducing BMS may offer a viable alternative to a DES in cases where it is not
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suited and may give additional benefits compared with a conventional BMS, as
discussed below.
When a patient is diagnosed with CAD there are recommendations on the best treatment
options or pathways. Depending on the severity of the disease a change of diet or statins
may be prescribed; however, in cases of acute coronary syndromes, stable angina and
myocardial infarction with ST-segment elevation, CABG and angioplasty with stenting
are both appropriate treatment options.180 CABG is generally only undertaken in cases
of multi-vessel disease; although, it may not be suitable if the patient is quite frail.
When deciding on what stent to implant, DESs are generally recommended given their
superior performance in clinical trials when compared with BMSs.70,181 Clinical
scenarios favoring a BMS over a DES are when non-elective surgery is required,
expected

poor

compliance

clopidogrel/prasugrel/ticagrelor,

with

DAPT,

bleeding

intolerance/allergy

risk,

and

indication

to
for

aspirin

or

long-term

anticoagulation.14 Patients who have a high bleeding risk are those with a history of
congestive heart failure, cerebrovascular disease, hepatic or renal disease, and diabetes
mellitus, or simply that they are of advanced age.229 Both those who have a high
bleeding risk and those who will undergo a surgical procedure within the following year
may not be able to comply with the one year DAPT required for DES implantation (a
BMS only requires one month).68 Also, in relation to expected poor compliance with
DAPT, when an interventional cardiologist is making the decision between a BMS and
a DES it is prudent to predict the likelihood that the patient will comply with the longterm DAPT. Current guidelines also recommend avoiding DES implantation in the
presence of financial barriers to prolonged DAPT or social barriers that may limit
patient compliance.33 A BMS is seen as a valuable alternative to a DES for large
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vessels, for patients with myocardial infarction with ST-elevation, and for saphenous
vein graft stenosis.14 Therefore, there is still a role for BMSs in the treatment of CAD.
In addition to ISR, and late and very late stent thrombosis, neoatherosclerosis is a
relatively new observed phenomenon which occurs more frequently and earlier with
DESs than with BMSs.190 One study where the authors reviewed histology findings
from 299 autopsy cases (197 BMS and 209 DES lesions) found that the incidence of
neoatherosclerosis was greater in DES lesions (31%) than in BMS lesions (16%),
although thin-cap fibroatheromas or plaque rupture were more frequent with BMSs than
DESs.177 This is significant because plaque rupture can cause a thrombotic event
leading to myocardial infarction. Therefore, beyond the elution period of a DES there is
an argument for having a stent in place which not only combats ISR but also produces
flow characteristics which are atheroprotective. Additionally, the BioMimics 3D stent is
a self-expanding stent and although most current coronary stents are balloon-expandable
there are reasons for the use of self-expanding stents in the coronary arteries. Selfexpanding stents can have a smaller cross-sectional profile, which can offer an
advantage for tortuous vessels, they experience reduced foreshortening in comparison
with balloon-expandable stents,220 and also they can decrease rates of stent
malapposition.19
Therefore, a self-expanding BMS which is atheroprotective by inducing helical flow
would be beneficial for angioplasty procedures in the coronary arteries, particularly for
long lesions that are considered a risk factor for ISR.120 With this justification in mind
the following test case was undertaken to see if there are any advantages, in terms of
haemodynamics and oxygen transport, to the implantation of a helical-flow-inducing
stent in the left coronary artery and to assess the previously theorised benefits of helical
flow in this context.
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8.3

Methodology

The geometries developed for the assessment of helical-flow-inducing stent designs
were based on the BioMimics 3D stent which induces helical flow by imposing a helical
shape on the artery. This is different to the other method of a helical ridge within the
stented region, as described previously in Section 4.4.1. The BioMimics 3D stent is a
self-expanding nitinol stent developed for the treatment of peripheral artery disease,
with specific application to the femoral artery. In the case of the popliteal femoral
artery, a typical diameter and length of stent required are 6.0mm and 100.0mm,
respectively. The BioMimics 3D stent is described as having a central helical region
with transition regions either end to help merge the helical region with the straight
artery, as shown in Figure 8.1.

Figure 8.1: Schematic of a typical BioMimics 3D stent.264

The same stent configuration was adopted here for assessment of helical flow in a
stented coronary artery, with the diameter set at 3.0mm and the length of the stent
centreline set at 20.0mm. 20.0mm is considered a long coronary stent that could be used
for a correspondingly long atherosclerotic lesion, which is one of the risk factors for
ISR in coronary arteries.60 One straight stent geometry and five helical geometries were
constructed with the helical radius increasing from 0.2mm to 1.0mm. The helical
section length was set at 10mm with 5mm allowed for the transition regions at either
end of the helical section which serve to smoothly change the centreline from a straight
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line to a helical shape and visa-versa, as shown in Figure 8.2. The maximum helical
radius, given the restrictions on the length of stent, was found to be 1.0mm because any
further increase in the helical radius was found to result in an unrealistically deformed
outer arterial wall surface within the transition regions. Additionally, for the same
reason, the helical section itself consisted of one complete turn. The arterial wall
thicknesses adopted were the same as used in the previous coronary artery test cases
with the intima and media assigned thicknesses of 0.24 and 0.32mm, respectively, as
adopted from Holzapfel et al.99

Transition

Helical Section

Transition

1.0mm

Figure 8.2: Centrelines of the helical stent geometries constructed with a maximum
helical radius of 1.0mm. Note the helical section is highlighted in red.

One feature to note is that the length of the centreline was set at 20.0mm; therefore, as
the helical radius increased the straight-line distance between the proximal and distal
ends decreased accordingly. This can be seen clearly in Figure 8.2 and Figure 8.3. The
maximum change in the straight-line distance between the two ends is 2.3mm.
Additionally, the artery centreline is shifted by a maximum of 1.0mm from its original
position, assuming an initially straight artery. These two geometrical consequences of a
helical centreline would have the effect of straining the artery during and after stent
implantation and the question arises as to what is a reasonable amount of strain. To
answer this one would have to look at how much strain is placed on the arterial wall
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during stent implantation in a partially blocked coronary artery. For example, consider a
normally 4.0mm diameter coronary artery (luminal cross-sectional area of 12.6mm2)
with a 70% reduction in luminal cross-sectional area due to the presence of an
atherosclerotic lesion. The unstented luminal cross-sectional area is 3.8mm2 which,
assuming a circular cross-section, has an unstented diameter, Du, of approximately
1.1mm. With the further assumption that if the artery was stented the luminal diameter
increases to the previous 4.0mm (stented diameter, Ds), then the circumferential strain,
εc, is as follows:

c 

D 2.9

 266%
Du 1.1

(3.73)

Implantation of a helical stent and changing the overall length between the proximal and
distal ends by a maximum of 2.3mm (∆L) over a length of 20mm (Lo) would induce
considerably less strain, albeit longitudinal strain,

L 

 L , i.e.,

L 2.3

 11.5%
Lo 20

(3.74)

and consequently stress, on the arterial wall than the strain induced by the change in
luminal cross-sectional area. This issue may warrant further investigation using FEA,
but is beyond the scope of this work. In total six simulations, i.e one straight stent and
five helical stents, were carried out and numbered Stent 1 to Stent 6, with increasing
centreline helical radii of 0mm (straight stent), 0.2mm, 0.4mm, 0.6mm, 0.8mm and
1.0mm, respectively, as shown in Figure 8.3.
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Figure 8.3: Elevation and end views of the geometries of the six stents modelled.

The geometries were created in Rhinoceros 3D and were based on the Multilink Vision
(Abbott Laboratories, Lake Bluff, IL, USA) coronary stent strut configuration. This
strut configuration was used because the link struts allow for a degree of longitudinal
expansion, as needed by the helical stents, the strut configuration is used already in the
coronary arteries while the BioMimics 3D configuration is used in the peripheral
arteries, and also, exact dimensions of a coronary version of the BioMimics 3D stent are
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unknown. To create the stent geometries the strut configuration was first cut from a
planar surface, then wrapped into circular form, and finally aligned along the relevant
helical centreline. The arterial wall, and entry and exit regions were also created in
Rhinoceros 3D.
The completed geometries were imported into ANSYS ICEM, and the same mesh
parameters used in Test Cases 2 & 3 were adopted for computational domain
discretisation. The typical total node count for each mesh was approximately 14 million,
with approximately 2.5, 2.8 and 8.7 million nodes in the media, intima and lumen
domains respectively. As an example, Figure 8.4 shows the mesh density used for Stent
6 on the luminal surface and within the arterial wall. The boundary conditions used
were the same as those adopted in Test Cases 2 & 3. All simulations were again carried
out on the ICHEC Fionn supercomputer using two nodes, each with 2 × 12 2.4 GHz
Intel Ivy Bridge core processors and 64 GB of RAM. Approximate time to reach
convergence was 1770 CPU hours.
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Figure 8.4: Mesh density used for Stent 6 on (a) the luminal surface, and (b & c)
within the three volume domains.
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8.4

Results

The percentage volumes of the arterial wall within the stented region exposed to low
(<30mmHg) and hypoxic (<10mmHg) PO2 levels for each stent modelled, with helical
radii ranging from 0mm to 1.0mm, are plotted in Figure 8.5. It is clear from this graph
that there is a downward trend in the percentages as the centreline helical radius
increases. Overall, between Stent 1, the straight stent, and Stent 6, the helical stent with
a centreline helical radius of 1.0mm, the low PO2 percentage volume decreases from
75.0% to 68.7% and the hypoxic percentage volume decreases from 28.4% to 22.4%.
Although there is only a relatively small reduction, relative to the total amount, in the
volume of the arterial wall exposed to low PO2, the change in volume exposed to
hypoxic PO2 is significant, i.e. a 21.1% reduction within the stented region.

Figure 8.5: Percentage volume of the arterial wall exposed to low and hypoxic PO 2
levels versus helical radius of the stent centreline.
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Table 8.1 gives that the luminal-surface area-averaged values of the PO2, Sh and WSS
within the stented region of each stent. Again there is a clear trend in all three variables
in that the area-averaged PO2, Sh and WSS all increase with increasing centreline
helical radius. This preliminary analysis of the results appears positive, in terms of
reducing the amount of the arterial wall exposed to hypoxic PO2 levels and reducing
adverse WSS conditions; however, it does not give the complete story. Before further
analysing the oxygen transport the haemodynamics created by each stent are first
analysed, in particular the development of helical flow and its effects on the WSS and
WSSG within the stented region.

Area-Averaged over Stented Luminal Surface
Stent No

PO2
[mmHg]

Sh

WSS
[Pa]

1

21.1

119

0.60

2

21.3

119

0.60

3

22.1

120.1

0.60

4

24.1

124.4

0.62

5

26.4

131.3

0.64

6

27.9

135.9

0.68

Table 8.1: Area-averaged PO2, Sh and WSS for the six selected stents. These values
were obtained by area-averaging over the luminal surface within the stented
region.
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8.4.1

Analysis of Haemodynamics

Figure 8.6 and Figure 8.7 show the WSS and WSSG distributions for the six selected
stents. Stent 1 produces the lowest area-averaged WSS, as seen in Table 8.1, and in
comparison with the other five stents, has the most uniform distribution of WSS within
the stented region. As the helical radius increases two distinct ribbons of low and high
WSS develop, as shown in Figure 8.6. Also clearly visible in Figure 8.6 is that a large
area of low WSS (<0.5Pa) develops in the proximal transition region of Stents 4, 5, and
6, and also in the distal transition region of the three stents, as shown in Figure 8.14(a),
Figure 8.15(a), and Figure 8.16(a). These are caused by the sudden change in direction
of the flow in the transition regions. Once the helical flow is established between these
regions the secondary motion appears to increase the WSS. Physiologically, because
there is a concentrated area of the luminal surface exposed to low WSS this could lead
to increased NIH within this region.
The histograms presented in Figure 8.8 give a good insight into the change in WSS
induced by increasing the helical radius. For Stents 1 – 3 all, or at least 99%, of the
luminal surface is exposed to WSS values below the physiological value of 1.5Pa. For
Stent 1 particularly, 64% of the luminal surface is exposed to WSS values ranging
between 0.5 – 1.0Pa. As the helical radius increases with each successive helical stent
the WSS becomes less concentrated within this range as both the maximum WSS
increases and the amount of the luminal surface exposed to low WSS also increases.
Thus, the range of WSS values that the luminal surface is exposed to broadens when
helical flow is induced. This result contradicts the literature which lists a more uniform
WSS distribution as one of the benefits of helical flow.27 Notably, the percentage area
exposed to atheroprotective WSS values, i.e. >1.5Pa, increases with helical radius with
Stents 4, 5, and 6 exposed to 2.5%, 6.0%, and 7.9%, respectively, as shown in Table
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8.2. Conversely, the percentage luminal surface area exposed to low WSS increases
from 34.3% for Stent 1 and plateaus at approximately 43% for Stents 4, 5, and 6, as also
shown in Table 8.2.
This increase in the range of WSS from Stent 1 to Stent 6 predicted to occur on the
luminal surface also results in a relatively small increase in the amount of the luminal
surface exposed to high WSSG (>0.85 Pa/mm), as shown in Table 8.2 and Figure 8.7.
For the helical stents shown here increasingly high WSSG is present as the helical
centreline radius increases, as shown in the histograms in Figure 8.9, with the range of
WSSG values steadily rising. High WSSG is commonly observed within a stented
artery where the flow separates from and reattaches to the wall upstream and
downstream of the stent struts respectively (as demonstrated in Chapter 7). Here, the
flow within the helical stented arteries is directed more towards the arterial wall in the
high WSS ribbon region. Directing the blood flow towards the arterial wall clearly has
benefits in terms of increasing the oxygen transport into the arterial wall, as discussed
below; however, increased advection of other elements within the blood would also take
place. For instance there would be increased advection of platelets, cytokines and
mitogens in the blood towards the wall which could lead to increased NIH in this
region. Additionally, the increase in WSSG within the high ribbon could lead to
problems with re-endothelialisation and increased inflammation with high WSSG linked
to increased inflammatory marker expression by ECs.211,212
Helical flow is characterised by a secondary circular motion of the flow on a plane
perpendicular to the main flow direction. For the purpose of visualising helical flow the
LNH for each stent is presented which gives both a visual representation of the flow
vortices, and also an indication as to the degree that the helical flow extends beyond the
stented region, as seen in Figure 8.10. Additionally, the contour plots of the velocity
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magnitude with the secondary flow streamlines at five slice locations perpendicular to
the centreline are presented for each stent in Figure 8.11 to Figure 8.16.
First, in visually analysing the velocity contours and the streamlines at each of the slice
locations for Stent 1, see Figure 8.11(h – l), the maximum velocity is seen to remain
within the centre of the lumen throughout and the dominant flow disturbances are being
caused by stent struts that create small recirculation regions downstream. As the helical
centreline radius increases with each subsequent stent the induced secondary flow
becomes more prevalent. For Stent 2 there is the clear existence of two vortices on the
three slices within the stented region, see Figure 8.12(i – k). Normally these exist in
circular conduits with centrelines which curve along a plane where the momentum of
the flow carries it towards the outer wall of the curved conduit where it divides into two
counter-rotating vortices, known as Dean vortices. In the geometries presented here the
secondary flows are established in a different manner. The maximum velocity region
maintains its central alignment, with reference to a straight line between the entry and
exit regions, driven by its momentum through the helical section, and where the flow
deviates the most from this central maximum velocity region is where the secondary
flows are strongest, with the slower moving blood recirculating back into this faster
region. This secondary flow thus increases mixing within the blood flow which is
interpreted as a beneficial effect by not having the same blood within the low velocity
region continually along the length of the stent.
For Stent 3 these vortices are also visible in the velocity and streamline plots in Figure
8.13(i – k), and crucially one vortex begins to dominate over the other which is a sign of
developing helical flow. The domination of one vortex over the other is clear also in the
LNH plot in Figure 8.10, where the only vortex visible, due to its strength, is the
clockwise rotating one. Again the maximum velocity skews slightly more towards the
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outer surface which in turn further increases the WSS magnitude along this ribbon
within the stented region, as shown in Figure 8.13(a). Also visible, in terms of the WSS,
is that there is a ribbon of low WSS developing along the inner curve of the stented
region, see Figure 8.13(a), as a consequence of the skewed velocity profile, see Figure
8.13(i – k). For Stent 4 the clockwise rotating vortex begins to dominate earlier as the
flow transits through the stented region, although the anti-clockwise vortex becomes
more visible, and also extends further downstream, as seen in Figure 8.10 and Figure
8.14(i & j). This trend continues which each successive helical stent with the clockwise
rotating vortex becoming established earlier in the stented region and extending further
beyond it, see Figure 8.10, the velocity skewing more towards the outer wall of the
curved artery, and the values of WSS and WSSG increasing within the high ribbon
region, as shown in Figure 8.6 and Figure 8.7.
Helical flow is also thought to reduce the size of recirculation zones within a straight
stented artery, as discussed in Chapter 4.36 Recirculation zones are created upstream and
downstream of stent struts when the flow separates away from the arterial wall surface
and their effects in relation to the biological processes are summarised in Chapter 2.
Briefly, recirculation zones create conditions at the arterial wall surface that promote
increased thrombus formation, inflammation and NIH within the stented artery. To
quantify the volume of the blood within the stented region which undergoes
recirculation the volume of the luminal domain experiencing retrograde longitudinal
velocity was measured. The results are presented in Table 8.2 where it is apparent that
the volume of the stented region experiencing recirculation is doubled for Stent 6
relative to Stent 1. The percentage volume values are all extremely low; however, it
should be noted that these recirculation areas are all adjacent to the arterial wall luminal
surface and, therefore, could have a considerable effect on the biological processes
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within the arterial wall at these locations. This result contradicts the previous literature
on this subject which theorises that helical flow reduces recirculation zones.36

Stent
No

Retrograde
Flow
[×10-10m3]

Retrograde
Flow
[%]

Low WSS
(<0.5Pa)
[%]

WSS
(>1.5Pa)
[%]

WSSG
(>0.85Pa/mm)
[%]

1

1.5

0.11

34.3

0

68.5

2

1.51

0.11

35.2

0

67.6

3

1.53

0.11

38.5

0

68.4

4

1.63

0.12

42.2

2.5

67.0

5

1.99

0.14

43.8

6.0

71.0

6

3.05

0.22

43.6

7.9

75.4

Table 8.2: Volume and percentage of the stented lumen that experiences
retrograde longitudinal velocity, and the percentage of the luminal surface within
the stented region that experiences low (<0.5 Pa) WSS, atheroprotective (>1.5 Pa)
WSS, and high WSSG (>0.85 Pa/mm).
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Figure 8.6: Contour plots of WSS within stented region for the six selected stents.
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Figure 8.7: Contour plots of WSSG within stented region for the six selected stents
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Figure 8.8: Normalised area of the stented luminal surface exposed to a WSS range
of 0 – 2.5Pa in bins of 0.125Pa.
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Figure 8.9: Normalised area of the stented luminal surface exposed to a WSSG
range of 0 – 10.0Pa/mm in bins of 1.0Pa/mm.
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Figure 8.10: Iso-surface plots of LNH for the six selected stents.
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Figure 8.11: Results for Stent 1 – (a) WSS, (b) luminal PO2 and slice locations, (c-g) PO2 in lumen, intima and media at each slice
location, and (h-l) velocity contours and secondary flow streamlines at each slice location. Note that the main flow direction for slices is
towards the reader.
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Figure 8.12: Results for Stent 2 – (a) WSS, (b) luminal PO2 and slice locations, (c-g) PO2 in lumen, intima and media at each slice
location, and (h-l) velocity contours and secondary flow streamlines at each slice location. Note that the main flow direction for slices is
towards the reader.
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Figure 8.13: Results for Stent 3 – (a) WSS, (b) luminal PO2 and slice locations, (c-g) PO2 in lumen, intima and media at each slice
location, and (h-l) velocity contours and secondary flow streamlines at each slice location. Note that the main flow direction for slices is
towards the reader.
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Figure 8.14: Results for Stent 4 – (a) WSS, (b) luminal PO2 and slice locations, (c-g) PO2 in lumen, intima and media at each slice
location, and (h-l) velocity contours and secondary flow streamlines at each slice location. Note that the main flow direction for slices is
towards the reader.
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Figure 8.15: Results for Stent 5 – (a) WSS, (b) luminal PO2 and slice locations, (c-g) PO2 in lumen, intima and media at each slice
location, and (h-l) velocity contours and secondary flow streamlines at each slice location. Note that the main flow direction for slices is
towards the reader.
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Figure 8.16: Results for Stent 6 – (a) WSS, (b) luminal PO2 and slice locations, (c-g) PO2 in lumen, intima and media at each slice
location, and (h-l) velocity contours and secondary flow streamlines at each slice location. Note that the main flow direction for slices is
towards the reader.
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8.4.2

Analysis of Oxygen Transport

The changes in haemodynamics created by inducing helical flow have significant
influence on the oxygen transport from the blood into the arterial wall which is apparent
when the luminal surface PO2 and Sh contour plots in Figure 8.17 and Figure 8.18 are
analysed. As shown in Figure 8.5, between Stent 1 and Stent 6 the percentage volume of
the arterial wall exposed to low PO2 decreases from 75.0% to 68.7% and the percentage
volume exposed to hypoxic PO2 decreases from 28.4% to 22.4%. It is clear from Figure
8.17 that even though there is an overall reduction in the volume of the arterial wall
exposed to hypoxic PO2 levels the reduction is not uniform on the luminal surface;
instead, similar to the WSS, increased oxygen transport is observed in a helical ribbon
through the stented region. Looking again at Figure 8.17 there are essentially two
helical ribbons of opposing high and low PO2 levels distributed along the length of the
stented region. These high and low helical ribbons are also present in the Sh, WSS and
WSSG plots, and are a result of the helical centrelines governing the geometries of the
five helical stents, and the induced secondary motion of the flow towards the outside of
the curved lumen.
Figure 8.19 shows the percentage volume of the arterial wall exposed to PO2 values in
bins of 5mmHg and also the proportion of each bin that is within the intima. What is
clear from this figure is that the impact of helical flow affects the intima and the media
disproportionately. For Stent 1 28.4% of the arterial wall is exposed to hypoxic PO2
levels, but the media only accounts for 4.2% of that. For Stent 6 22.4% of the arterial
wall is exposed to hypoxic PO2 levels with the media proportion only reducing to 3.6%.
Conversely, the intima represents 24.2% of that total for Stent 1 and reduces to 18.8%
for Stent 6. In Figure 8.19 it can be seen that the percentage of the arterial wall within
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the intima that is hypoxic is significantly reduced with relatively slight increases in all
bins from 15 – 75mmHg. Contrary to this, the proportion of the arterial wall that is
within the media and also hypoxic is not significantly reduced by increasing the helical
centreline radius. This can be further seen in Table 8.3, where the individual
percentages of the intima, media, and the complete arterial wall exposed to hypoxic and
low PO2 are given. Most tellingly the percentage of the intima exposed to hypoxic PO2
levels reduces from 62.0% to 48.5%, and the percentage of the media exposed to
hypoxic PO2 levels reduces from 6.9% to 5.9%.
The flow disturbances caused by the stent struts limit the amount of oxygen diffusing in
from the lumen in all the stent geometries; however, with the helical stents there is
increased advection towards the arterial wall within the high PO2 ribbon, for example as
seen in Figure 8.14(b). Consequently, the high PO2 ribbon marks the region where the
underlying arterial wall experiences higher PO2 levels which can be seen in the crosssectional plots shown in Figure 8.14(c – g). Crucially, the low PO2 ribbon does not have
a significant effect on the amount of the arterial wall exposed to hypoxic PO2 levels for
one reason – only the intima is significantly affected by the luminal surface PO2 levels.
The media layer is predominantly supplied with oxygen through diffusion from the
outer interface, representing, physiologically, the interface with the adventitia, and the
intima layer is supplied through diffusion from the luminal surface, as demonstrated
previously in Test Case 3. Following on from this, the intima within the arterial wall in
the straight stent model already experiences a considerable amount of hypoxic PO2
levels (62.0% of the intima for Stent 1) within the stented region due to stent struts
disrupting the luminal blood flow. Finally, even though the luminal surface within the
high PO2 ribbon experiences PO2 levels that reach up to values as high as 80 – 90mmHg
in Stent 6, compared with 20 – 40mmHg in Stent 1, the low PO2 ribbon does not change
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to the same degree with a considerable amount of the luminal surface still experiencing
PO2 levels within the 20 – 30mmHg range, similar to the same area within Stent 1.
Therefore, helical flow does improve the oxygen transport into the arterial wall within a
stented artery, although not uniformly as it only improves it within a high PO2 helical
ribbon within the stented region. The question arises as to what this might mean
physiologically. This is similar to the results seen in the previous test cases where the
media remains relatively unaffected, in terms of oxygenation, by changes in
haemodynamics within the lumen because of the oxygen supply from the outer interface
with the adventitia (as expected). The intima though is affected considerably. Given that
in reality stents are placed within arteries that have experienced atherosclerotic plaque
build-up, the intima could already have been infiltrated by inflammatory cells and
undergone some degree of intimal hyperplasia before stent implantation. Decreasing the
percentage volume of the intima exposed to hypoxic PO2 levels could aid in the healing
of this crucial layer, particularly coupled with the potential haemodynamic benefits, as
discussed above. However, the degree to which it may aid the healing process poststent-implantation is debateable and would require further work to elucidate.
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Intima

Media

Arterial Wall

Stent

Hypoxic
[%]

Low
[%]

Hypoxic
[%]

Low
[%]

Hypoxic
[%]

Low
[%]

1

62.0

92.0

6.9

64.2

28.4

75.0

2

61.4

91.7

7.0

64.4

28.2

75.1

3

57.8

90.8

6.8

64.3

26.7

74.6

4

53.3

87.7

6.9

63.2

25.0

72.7

5

51.5

83.6

6.7

61.9

24.2

70.4

6

48.5

81.3

5.9

60.7

22.4

68.7

Table 8.3: The percentage volume of the intima, media, and arterial wall (both
intima and media together) exposed to hypoxic (<10mmHg) and low (<30mmHg)
PO2 levels for six selected stents.
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Figure 8.17: PO2 on the luminal surface within the stented region for the six
selected stents.
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Figure 8.18: Sh on the luminal surface within the stented region for the six selected
stents.
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Figure 8.19: Predicted percentage volume of the arterial wall and intima exposed
to PO2 values in bins of 5mmHg for the six selected stents.
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8.5

Discussion

Helical flow has been shown here to increase oxygen transport into the arterial wall
within a stented coronary artery with the volume of the arterial wall exposed to hypoxic
PO2 levels decreasing by 21.1% between a straight stent (Stent 1) and a stent with
helical centreline radius of 1.0mm (Stent 6). This reduction in hypoxic PO2 levels is not
uniform throughout the arterial wall with the region experiencing increased oxygen
transport only within a helical ribbon within the stented region that also experiences
high WSS and WSSG. Additionally, the intima is significantly more affected by the
change in haemodynamics and, consequently, the oxygen transport and reduction in
hypoxic PO2 levels, in comparison with the media. Given that physiologically the
intima experiences severe trauma during stent implantation, and also, prior
atherosclerotic lesion development, the fact that its oxygenation is also significantly
affected by changes in local haemodynamics gives added importance to improving these
local haemodynamics. When these local haemodynamics were analysed it was found
here that with increasing helical centreline radii the percentage of the luminal surface
exposed to atheroprotective WSS, and low WSS both increase. Unfortunately, the
region that experiences atheroprotective WSS also experiences high WSSG values that
are associated with increased inflammation and difficulties in re-endothelisation. The
transition regions within each helical stent geometry are areas that are prone to low
WSS due to the change in the flow direction in these regions. A more gradual transition
with a longer stent could result in more favourable WSS conditions within this region.
The LNH plots show that the helicity of the flow can extend to almost a full stent length
beyond the stented region for Stent 6.
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8.6

Conclusions

Helical flow, as induced here, is a double-edged sword with increased advection of
oxygen towards the luminal surface collocated with a ribbon of high WSSG.
Additionally, there is a diametrically opposite ribbon of low WSS which could lead to
increased NIH along the length of the stent in this region. Whether or not the added
benefit of atheroprotective WSS values and increased intima oxygenation out-weighs
the adverse effects of high WSSG is a question that these numerical models cannot
answer at present and instead may only come with further in vitro and in vivo work.
This is the first time the predicted oxygen transport within helical-flow-inducing stent
designs has been simulated using an advanced oxygen transport model which
incorporates both the free and bound oxygen. Additionally, this is the first time, to the
author’s knowledge, that the haemodynamics within several helical stents have been
analysed where the stent struts have been incorporated in the geometries, thus providing
a more realistic representation of a stented artery immediately post-implantation.
8.7

Summary

The results of Test Case 4 were presented here in which the effects of helical-flowinducing stents on the haemodynamics and oxygen transport within stented coronary
arteries were analysed. Six stented coronary artery geometries with increasing helical
centreline radii, from 0mm to 1.0mm, were modelled and the results compared. These
results indicate that helical flow has potentially beneficial and adverse effects on both
the WSS patterns and the oxygen transport within a stented coronary artery. Chapter 9
will summarise the conclusions drawn here from this test case, and those from the
previous three test cases, along with the novelty, limitations, and recommendations of
this work.

231

CHAPTER 9: Conclusions

CHAPTER
Chapter 9.
9.1

9

Conclusions

Introduction

Hypoxia in arterial walls contributes to the formation of foam cells and affects the
severity of inflammation in atherosclerotic lesions, causes VSMCs to express growth
factors which could lead to increased NIH, and can induce EC apoptosis. 20,134,215,216,252
Rabbits treated with supplemental oxygen following graft-to-artery anastomosis had
reduced NIH.135 The biological processes, thrombosis, inflammation, NIH and reendothelialisation, instigated following stent implantation can result in ISR and can
potentially all be influenced by the amount of oxygen reaching the cells within the
arterial wall. Therefore, predicting the amount of oxygen which will reach the tissue
cells within the walls of a stented vessel is of benefit in determining how well a stent
would perform post-implantation. In fact, predicting oxygen transport in the
cardiovascular system has applications beyond stents and could include the modelling
of atherosclerotic lesion development and the assessment of other cardiovascular
devices. Helical flow has been hypothesised to improve both the local haemodynamics
and the arterial wall oxygenation within stented arteries.
The aim of the research undertaken here was to develop an advanced oxygen transport
model that incorporates both the free oxygen dissolved in plasma and the bound oxygen
contained in RBCs, and also accounts for the shear-induced dispersion of RBCs, which
could be used to assess stent designs. As part of this over-arching aim, comparison of
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the results generated in 3D geometries using the advanced oxygen transport model and
the simpler models with experimental measurements from Santilli et al. was carried out.
Showing how this advanced oxygen transport model could then be used to assess three
different stent designs demonstrated the importance and viability of the methodology.
The advanced oxygen transport model was also used to assess the ability of helical flow
to improve oxygenation of the arterial wall in stented coronary arteries. In addition, the
effect of helical flow on the local haemodynamics within a stented coronary artery were
analysed.

9.2

Novelty

The work undertaken as part of this thesis has several novel aspects that deserve
mentioning:


It is the first time that an advanced blood oxygen transport model has been
developed that incorporates both free and bound oxygen, and a shear-dependent
RBC dispersion coefficient.



It is the first time that the simplifications of blood oxygen transport models,
which are prevalent in the literature, have been assessed in 3D geometries and
their effects on the PO2 profile within the arterial lumen and wall have been
analysed.



It is the first time that the oxygen transport has been modelled in three different
stent designs with the predicted low and hypoxic PO2 volumes within the arterial
wall assessed.



It is the first time that the oxygen transport within several helical-flow-inducing
stent designs has been predicted incorporating a heterogeneous arterial wall.
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Although many previous studies analysing the blood flow within a stented vessel have
analysed the haemodynamics, predominantly WSS-based variables, this study aimed to
elucidate how the haemodynamics affects the oxygen delivery to the arterial wall. Thus,
this study goes beyond the luminal surface and shows how the local haemodynamics
can have a significant impact on the biological processes within the arterial wall through
augmented delivery of oxygen to the cells contained within. For example, Test Case 3
shows how the oxygen transport into the arterial wall can be affected by different stent
designs and also, how the WSS, as plotted on the luminal surface within the stented
region, does not act as an accurate predictor of the extent of hypoxic regions within the
arterial wall. Test Case 4 demonstrates how the methodology developed can be applied
to improve coronary stent designs by studying the oxygen transport in several helicalflow-inducing stent designs. This may assist in the design of future cardiovascular
devices.

9.3

Limitations

Computational modelling of any sort when dealing with a real-world event/process
inevitably incorporates some degree of uncertainty and simplifications based on wellthought-out assumptions. In the case of computational modelling of oxygen transport
within the cardiovascular system there are some simplifications made for several
reasons, which include a lack of experimental data to confirm what parameter values to
adopt, inability of current software to accurately model some aspects of the problem,
and computational expense.
Lack of experimental data is an issue in predicting the oxygen transport within the
arterial wall which leads to some assumptions, for instance assuming a homogeneous
composition. The inability of current software to accurately model some aspects is
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exemplified by the fact that current CFD models of blood flow, which generally is
composed of several cellular constituents, assume a homogeneous medium (this also
falls under computational expense). Without more experimental data and more powerful
software and hardware there is little that can be currently done to avoid these limitations
and consequently the assumptions made.
In terms of limitations of the methodology presented here, and possible avenues for
future work, the shear-dependant dispersion of RBCs is a haemodynamic flow feature
that is not fully understood. Additionally, at low shear rates RBCs are known to form
rouleaux which could impact both their dispersion and the oxygen transport. Therefore,
future studies of this phenomenon may improve the predictive capability of the model.
This may be improved by particle based CFD software which could model all the
constituent cells of blood including the RBCs. All the simulations carried out as part of
this study were steady state with the assumption of rigid arterial walls. The assumption
of steady state was used because of the computational cost of transient simulations of
the geometries presented here would be extremely high and also, given how low the
diffusivity of oxygen is within plasma and within the arterial wall, the effect of
pulsatility has been shown to have a minimal effect.124 Also, the haematocrit is
considered to be constant throughout the fluid domain when in reality there is a reduced
haematocrit within the plasma skimming layer at the luminal surface. This could affect
the predicted steep gradient in the PO2 levels within the blood adjacent to the luminal
surface, although to what extent would need further investigation. Some numerical work
undertaken by Krüger (2016) modelling a suspension of deformable RBCs and nearly
rigid platelets using a combination of the lattice-Boltzmann, immersed boundary and
finite element methods produced results where the plasma skimming layer was
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observable.126 This type of work could serve as a basis for future work looking at the
effect of the plasma skimming layer on the oxygen transport into the arterial wall.
One aspect which was not varied was the parameters defining the oxygen transport
within the arterial wall. In reality, for stented arteries the presence of plaque, and
additionally, the structural damage caused to the arterial wall by stent implantation,
could result in a much higher oxygen demand within the arterial wall. Thus, the values
shown here in this study are conservative estimates of the PO2 levels and in reality the
situation could be significantly worse. Clearly, as shown by the results at Location 2 in
Test Case 1, more accurate representations of each layer of the arterial wall, including
plaque, and their diffusion/reaction parameters based on cellular composition would be
required for more patient-specific analysis; unfortunately, these are not available at
present. Additionally, given the complexity of the biological processes that can lead to
ISR, as described in Chapter 2, the power of the predictive models presented here is
limited. In truth they only present an idealised snap-shot of the stented artery. Thrombus
formation and inflammation begin to occur immediately upon stent implantation, but
given their scale at which they occur modelling them in the geometries presented here
would be extremely computationally expensive. As such the models presented here
assume uniform oxygen consumption throughout the arterial wall, when in reality with
leukocytes transmigrating into the arterial wall these would increase the oxygen
consumption.157 With this in mind the simulations presented here, even though they are
designed at a larger scale than the biological processes take place, do serve to give an
indication of the oxygen levels and highlight areas of potential hypoxia. This provides
an important step in reaching more accurate, patient-specific models that could be
improved with advanced imaging techniques such as optical coherence tomography and
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elastography which potentially could provide information at close to a cellular level in
patient-specific arteries that may aid in the design of future more discrete models.
The presence of malapposed struts was not considered in the test cases presented here.
Previous studies have found that malapposed struts can affect the local haemodynamics
within the stented region;12 therefore, consequently they would affect the oxygen
transport. This limitation may be addressed in future work using patient-specific
geometries. Additionally, although current medical imaging technology has allowed the
acquisition of patient-specific geometries, attaining the governing transport parameters
would be very challenging. Given the aforementioned correlations between hypoxia and
IH, with the addition of patient-specific geometries and parameters this methodology
could be a considerable aid to the both the design of future implantable devices and also
to the tailored analysis of the impact of these devices on individual patients.

9.4

Main Conclusions/Recommendations

The conclusions/recommendations of this study can be divided into two separate
categories:


Conclusions/recommendations for oxygen transport modelling



Conclusions/recommendations for stent design

9.4.1

Oxygen Transport Modelling

Three important conclusions for future analyses of oxygen transport modelling are
inferred by this study.
First, ignoring the oxyhaemoglobin content within the RBCs leads to large errors in the
PO2 gradient within the MTBL and, consequently, the prediction of hypoxic regions
within the arterial wall. The standard simplified model which ignores oxyhaemoglobin,
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i.e. Model 5, and is crucially the most commonly-used model in the literature, overpredicts the PO2 levels in both the carotid bifurcation and stented coronary artery test
cases presented here. It therefore presents an overly optimistic view of the risk of IH
caused by low and hypoxic PO2 levels.
Second, neglecting the shear-induced dispersion of RBCs also affects the accuracy of
the predicted results which is also shown in Test Cases 1 and 2.
Third, the use of a correction factor in the Sh results when neglecting the bound oxygen
in the blood oxygen transport model can lead to inaccurate results in comparison with a
more advanced model, i.e. Model 1.
The first conclusion deserves elaborating on further as the PO2 gradient within the
MTBL has been a source of controversy in the area of oxygen transport modelling
which remains unresolved at present. The steep PO2 gradient, seen in Figures 6.10, 6.16,
6.20, and 7.5, which has been observed in experimental measurements, has led to a
debate as to the role of the endothelium in oxygen transport as highlighted by Tsai et al.
(2010).258 In this study here the diffusion across the lumen/arterial wall interface has
been modelled with no resistance and no additional consumption in line with other
studies in oxygen transport in arteries.23,203,248 According to in vivo measurements of the
PO2 across the arteriole and arterial walls in animals, there is a high PO2 gradient at the
wall going from the lumen into the arterial wall.217,218 Previous studies have concluded
that this gradient is due to extremely high oxygen consumption by the endothelial cells,
for example in the study by Shibata et al.226, which have been thoroughly reviewed by
Tsai et al.259 However, when ECs have been cultured and studied in vitro the
consumption levels predicted have not matched with levels recorded by these
studies.169,192 Thus, the mismatch between in vivo and in vitro measurements has led to
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uncertainty as to what effect the endothelium has on PO2 gradients. The results
presented in this study would suggest that the endothelium does not consume a
significantly higher proportion of the oxygen being transferred into the wall than other
cells in arteries, in agreement with in vitro measurements using cultured ECs. Instead
the steep gradient is caused by the balance between the free and bound oxygen with the
bound oxygen acting a large store/sink for oxygen.

Figure 9.1: Artist’s representation of a transarterial wall PO2 profile as measured
using an electrode probe at Location 1 (in line with the locations described in
Chapter 6) within a dog carotid artery by Santilli et al.217

In addition, it is assumed by previous studies that the luminal measurements taken from
Santilli et al. are just inside the lumen as the probe is advanced through the arterial wall.
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In actuality, Santilli et al. give an artist’s representation of the transarterial wall oxygen
profile as recorded by the chart recorder from Location 1, as shown in Figure 9.1. In
their study it is mentioned that there is “a combination of respiratory movement,
pulsatile blood flow, electrode movement and electrical noise” which causes this sawtoothed pattern.217 These effects, combined with the accuracy of the electrode probe
used, i.e. its sphere of influence, is discussed by Tsai et al.259 In their review on the
subject, they suggest that it is doubtful that the PO2 value given is representative of the
actual value on the luminal surface and more likely an average of the PO2 value within a
volume around the probe which could include the MTBL.
From the results for Models 1 – 4 presented in Test Case 1 and 2, which include the
bound oxygen, the high PO2 gradient that is recorded by in vivo studies is reproduced in
the predicted PO2 transarterial profiles. This would lead to the conclusion that it is not
the consumption or resistance of the endothelium which creates the high gradient seen
in vivo, but the properties of the blood itself. Specifically, because of the slope of the
oxyhaemoglobin curve between 10 and 40mmHg, the RBCs act as both a sizeable
source and a sink for free oxygen. Thus, physiologically, the interaction between both
the free and bound oxygen within the MTBL can significantly affect how much oxygen
is delivered to the arterial wall.
Critically, in the studies which conclude that the endothelium must consume vastly
higher amount of oxygen than what is seen in vitro, this conclusion is based on
evaluation of oxygen mass transport from the lumen into the arterial wall using simple
diffusion calculations similar to Model 5, as presented in Chapter 3. Additionally, a
study by Vadapalli et al. concluded that most of the reported values of intravascular
oxygen flux are overestimated, which could explain some of the differences seen in
vivo.261 Additionally, it should be noted that many of the studies which support the high
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oxygen consumption of the endothelium were carried out in arterioles and capillaries,
and possibly the endothelium consumption would vary with the size of the vessel.
Therefore, consideration of the findings presented here may be important for future
studies of this area. This is clearly an area where future study is needed to fully
understand the processes taking place and more work, which would include in vivo, in
vitro, and numerical simulation, could shed light on these issues.
The second and third conclusions are related to the simplifications made in the blood
oxygen transport model, as detailed in Chapter 3, in previous studies. These are made to
reduce the computational expense of the simulations. For instance, by neglecting the
bound oxygen, and consequently, the shear-dependent nature of the RBC dispersion,
reduces the complexity and ensures convergence of simulations with larger timesteps,
and therefore, are less computationally expensive. However, as demonstrated here in
Test Cases 1 and 2 neglecting the bound oxygen in the blood oxygen transport model
leads to large errors which cannot be accounted for using a simple correction factor.
Therefore, some of these long-standing simplifications must be called into question
when the results generated could be significantly different from the actual physiological
process. More work is needed in this area.

9.4.2

Stent Design

From Test Case 3 it is clear that stent strut configuration can have a considerable impact
on the amount of oxygen reaching the underlying arterial wall cells. Stent A was
predicted to perform the worst which is predominantly caused by the N-shaped link
struts. These link struts, which are aligned perpendicular to the main blood flow, create
large volumes of hypoxic zones adjacent to the recirculation zones upstream and
downstream of the struts. Stent B suffers slightly from a decreased interface area caused
by the amount of struts present in the design. Stent C has the combination of both large
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intra-strut areas and also less low WSS zones caused by struts aligned perpendicular to
the main blood flow. It is clear from the results of Test Case 3 that the predicted
oxygenation levels within the arterial wall are not predictable by the interface area
presented to the luminal blood or by the WSS values plotted on the luminal surface
within the stented region. Additionally, in terms of assessing stent designs the benefit of
realistically-deformed stented arteries, as derived using FEA, is demonstrated in this test
case because some features, such as prolapse and stretching of the arterial wall, which
would not be generated accurately otherwise are shown to affect the predicted results.
Helical flow has been hypothesised to help reduce ISR when induced within a stented
region, as reviewed in Chapter 4. It presents certain theoretical benefits such as reduced
recirculation zones, more uniform WSS, and increased oxygen transport into the arterial
wall. Test Case 4 aimed to assess these benefits for a specific well-defined application,
i.e. a 20mm stent with a 10mm one-turn helical section. Briefly, the results presented in
Chapter 8 indicate that helical-flow-inducing stents do increase the overall amount of
oxygen transfer into the arterial wall; although, only in a helical ribbon within the
stented region. This is also true in relation to the WSS with two diametrically-opposite
ribbons; one high, one low, present within the stented region. The WSSG shows a
similar distribution which could lead to adverse consequences in terms of reendothelialisation and inflammation. Additionally, the amount of the blood flow
experiencing retrograde flow, which would signify recirculation zones, is shown to
increase with increasing helical centreline radius. Therefore, helical flow in stent
designs is beneficial to some extent for oxygen transfer into the arterial wall, but could
have adverse effects with increased WSSG and recirculation zones. How influential one
aspect is in comparison to the other would require further research. Because of the
specific restraints placed on the geometry, for instance the length and only one helical
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turn, some of the benefits of helical flow found by other researchers may not exist in
this specific test case but may appear with the longer stents that are used in peripheral
arteries.

9.5

Future Work

As detailed in the limitations section above, the parameters defining the oxygen
transport within the arterial wall need to be better defined with more experimental work.
Specifically, the effects of an atherosclerotic lesion on the parameters governing oxygen
transport would be beneficial for predicting necrosis in affected arteries. The blood
oxygen transport model needs further validation with simple comparison test cases
between in vitro measurements and in silico results. A comparison of the effects of
geometry simplifications used commonly in CFD studies on the predicted oxygen
transport within stented arteries would be of benefit. This study would take a similar
form to a study by Martin et al. (2014) whereby the arterial wall oxygenation predicted
using realistically-deformed stent geometries, as presented here in Chapter 7, could be
compared with the arterial wall oxygenation predicted using non-deformed, simplified
stent geometries.153

243

Bibliography

Bibliography
1.

Al-Roubaie S, Jahnsen ED, Mohammed M, Henderson-Toth C, Jones EA V.
Rheology of embryonic avian blood. Am J Physiol Heart Circ Physiol. 301,
H2473-81, 2011.

2.

Ammirati E, Moroni F, Magnoni M, Camici PG. The role of T and B cells in
human atherosclerosis and atherothrombosis. Clin Exp Immunol. 179, 173-187,
2015.

3.

Anderson JM, Rodrigruez A, Change DT. Foreign body reaction to biomaterials.
Semin Immunol. 20, 86-100, 2008.

4.

ANSYS Inc. ANSYS Acadenmic Research, Release 15, Help System, Linear
Equation Solution.

5.

Back LH, Radbill JR, Crawford DW. Analysis of oxygen transport from
pulsatile, viscous blood flow to diseased coronary arteries of man. J Biomech. 10,
763-774, 1977.

6.

Balossino R, Gervaso F, Migliavacca F, Dubini G. Effects of different stent
designs on local hemodynamics in stented arteries. J Biomech. 41, 1053-1061,
2008.

7.

Banerjee RK, Kwon O, Vaidya VS, Back LH. Coupled oxygen transport analysis
in the avascular wall of a coronary artery stenosis during angioplasty. J Biomech.
41, 475-479, 2008.

8.

Barth T, Jespersen D. The design and application of upwind schemes on

244

Bibliography

unstructured meshes. American Institute of Aeronautics and Astronautics; 1989, .
9.

Bassiouny HS, Song RH, Kocharyan H, Kins E, Glagov S. Low flow enhances
platelet activation after acute experimental arterial injury. J Vasc Surg Off Publ
Soc Vasc Surg [and] Int Soc Cardiovasc Surgery, North Am Chapter. 27, 910918, 1998.

10.

Bassiouny HS, White S, Glagov S, Choi E, Giddens DP, Zarins CK. Anastomotic
intimal hyperplasia: mechanical injury or flow induced. J Vasc Surg. 15, 708716, 1992.

11.

Bayes-Genis a, Camrud a R, Jorgenson M, et al. Pressure rinsing of coronary
stents immediately before implantation reduces inflammation and neointimal
hyperplasia. J Am Coll Cardiol. 38, 562-568, 2001.

12.

Beier S, Ormiston J, Webster M, et al. Hemodynamics in Idealized Stented
Coronary Arteries: Important Stent Design Considerations. Ann Biomed Eng. 44,
315-329, 2015.

13.

Beijk MAM, Klomp M, Verouden NJW, et al. Genous endothelial progenitor cell
capturing stent vs. the Taxus Liberté stent in patients with de novo coronary
lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot
study. Eur Heart J. 2009.

14.

Ben-Dor I, Waksman R, Pichard AD, Lindsay J, Satler LF. The Current Role of
Bare-Metal Stents. Card Interv Today. , 40-46, 2011.

15.

Bharadvaj BK, Mabon RF, Giddens DP. Steady flow in a model of the human
carotid bifurcation. Part I--flow visualization. J Biomech. 15, 349-362, 1982.

245

Bibliography

16.

Bharadvaj BK, Mabon RF, Giddens DP. Steady flow in a model of the human
carotid bifurcation. Part II--flow visualization. J Biomech. 15, 349-362, 1982.

17.

Bhargava B, Reddy NK, Karthikeyan G, et al. A novel paclitaxel-eluting porous
carbon–carbon nanoparticle coated, nonpolymeric cobalt–chromium stent:
Evaluation in a porcine model. Catheter Cardiovasc Interv. 67, 698-702, 2006.

18.

Biasetti J, Spazzini PG, Hedin U, Gasser CT. Synergy between shear-induced
migration and secondary flows on red blood cells transport in arteries:
considerations on oxygen transport. J R Soc Interface. 112014.

19.

Boddu AR, Balmuri AR, Kamalesh M. Clinical utility of self-expanding stents in
coronary artery disease. Res Reports Clin Cardiol. 6, 117-122, 2015.

20.

Boström P, Magnusson B, Svensson PA, et al. Hypoxia converts human
macrophages into triglyceride-loaded foam cells. Arterioscler Thromb Vasc Biol.
26, 1871-1876, 2006.

21.

Brecher GA. Experimental evidence of ventricular diastolic suction. Circ Res. 4,
513-518, 1956.

22.

Bricker JM. Rheology fo noncolloidal suspensions of spheres in oscillatory shear
flow and the dynamics of suspensions of rigid fibers. 2007.

23.

Caputo M, Chiastra C, Cianciolo C, et al. Simulation of oxygen transfer in
stented arteries and correlation with in-stent restenosis. Int j numer method
biomed eng. 29, 1373-1387, 2013.

24.

Caro CG. Discovery of the role of wall shear in atherosclerosis. Arterioscler
Thromb Vasc Biol. 29, 158-161, 2009.
246

Bibliography

25.

Caro CG. The dispersion of indicator flowing through simplified models of the
circulation and its relevance to velocity profile in blood vessels. J Physiol. 185,
501-519, 1966.

26.

Caro CG, Cheshire NJ, Watkins N. Preliminary comparative study of small
amplitude helical and conventional ePTFE arteriovenous shunts in pigs. J R Soc
Interface. 2, 261-266, 2005.

27.

Caro CG, Doorly DJ, Tarnawski M, Scott KT, Long Q, Dumoulin CL. NonPlanar Curvature and Branching of Arteries and Non-Planar-Type Flow. Proc
Math Phys Eng Sci. 452, 185-197, 1996.

28.

Caro CG, Pedley TJ, Schroter RC, Seed WA. Mechanics of the Circulation.
Oxford University Press; 1978, .

29.

Carroll GT, Devereux PD, Ku DN, McGloughlin TM, Walsh MT. Experimental
validation

of

convection-diffusion

discretisation

scheme

employed

for

computational modelling of biological mass transport. Biomed Eng Online. 9, 34,
2010.
30.

Cha W, Beissinger RL. Evaluation of shear-induced particle diffusivity in red cell
ghosts suspensions. Korean J Chem Eng. 18, 479-485, 2001.

31.

Chandran KB, Yoganathan AP, Rittgers SE. Biofluid Mechanics: The Human
Circulation. Vol 1st ed. CRC Press; 2006, .

32.

Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH.
Role of endothelial shear stress in the natural history of coronary atherosclerosis
and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll

247

Bibliography

Cardiol. 49, 2379-2393, 2007.
33.

Chavez JF, Doll JA, Mediratta A, et al. Factors Associated with the Use of DrugEluting Stents in Patients Presenting with Acute ST-Segment Elevation
Myocardial Infarction. Cardiol Res Pract. 2015.

34.

Cheema AN, Hong T, Nili N, et al. Adventitial microvessel formation after
coronary stenting and the effects of SU11218, a tyrosine kinase inhibitor. J Am
Coll Cardiol. 47, 1067-1075, 2006.

35.

Chen HY, Hermiller J, Sinha AK, Sturek M, Zhu L, Kassab GS. Effects of stent
sizing on endothelial and vessel wall stress: potential mechanisms for in-stent
restenosis. J Appl Physiol. 106, 1686-1691, 2009.

36.

Chen Z, Fan Y, Deng X, Xu Z. Swirling flow can suppress flow disturbances in
endovascular stents: a numerical study. ASAIO J. 55, 543-549, .

37.

Cheng C, Helderman F, Tempel D, et al. Large variations in absolute wall shear
stress levels within one species and between species. Atherosclerosis. 195, 225235, 2007.

38.

Chiastra C, Morlacchi S, Gallo D, Morbiducci U, Cárdenes R, Migliavacca F.
Computational fluid dynamic simulations of image-based stented coronary
bifurcation models. 2013.

39.

Chiastra C, Morlacchi S, Pereira S, Dubini G, Migliavacca F. Computational
fluid dynamics of stented coronary bifurcations studied with a hybrid
discretization method. Eur J Mech - B/Fluids. 35, 76-84, 2012.

40.

Chow MJ, Turcotte R, Lin CP, Zhang Y. Arterial extracellular matrix: A
248

Bibliography

mechanobiological study of the contributions and interactions of elastin and
collagen. Biophys J. 106, 2684-2692, 2014.
41.

Cookson AN. Computational Investigation of Helical Pipe Geometries From a
Mixing Perspective. 2009.

42.

Cookson AN, Doorly DJ, Sherwin SJ. Using coordinate transformation of
Navier–Stokes equations to solve flow in multiple helical geometries. J Comput
Appl Math. 234, 2069-2079, 2010.

43.

Coppola G, Caro CG. Oxygen mass transfer in a model three-dimensional artery.
J R Soc Interface. 5, 1067-1075, 2008.

44.

Coppola G, Caro CG. Oxygen mass transfer in a model three-dimensional artery.
J R Soc Interface. 5, 1067-1075, 2008.

45.

Coppola G, Caro CG. Arterial geometry, flow pattern, wall shear and mass
transport: potential physiological significance. J R Soc Interface. 6, 519-528,
2009.

46.

Coughlin MF, Schmid-Schönbein GW. Pseudopod projection and cell spreading
of passive leukocytes in response to fluid shear stress. Biophys J. 87, 2035-2042,
2004.

47.

Depaola N, Gimbrone MA, Davies PF, Dewey CF. Vascular endothelium
responds to fluid shear stress gradients [published erratum appears in Arterioscler
Thromb 1993 Mar;13(3):465]. Arterioscler Thromb Vasc Biol. 12, 1254-1257,
1993.

48.

Dichek D a, Neville RF, Zwiebel J a, Freeman SM, Leon MB, Anderson WF.
249

Bibliography

Seeding of intravascular stents with genetically engineered endothelial cells.
Circulation. 80, 1347-1353, 1989.
49.

Ding Z, Friedman MH. Dynamics of Human Coronary Arterial Motion and Its
Potential Role in Coronary Atherogenesis. J Biomech Eng. 122, 488-492, 2000.

50.

Ding Z, Friedman MH. Quantification of 3-D coronary arterial motion using
clinical biplane cineangiograms. Int J Card Imaging. 16, 331-346, 2000.

51.

Ding Z, Zhu H, Friedman MH. Coronary Artery Dynamics In Vivo. Ann Biomed
Eng. 30, 419-429, 2002.

52.

Doorly DJ, Peiró J, Sherwin SJ, et al. Helix and model graft flows: MRI
measurement and CFD simulations. FEDSM. 1997.

53.

Doorly DJ, Sherwin SJ, Franke PT, Peiró J. Vortical flow structure identification
and flow transport in arteries. Comput Methods Biomech Biomed Engin. 5, 261273, 2002.

54.

Dotter CT, Judkins MP. Transluminal Treatment of Arteriosclerotic Obstruction:
Description of a New Technic and a Preliminary Report of Its Application.
Circulation. 30, 654-670, 1964.

55.

Dumoulin C, Cochelin B. Mechanical behaviour modelling of balloonexpandable stents. J Biomech. 33, 1461-1470, 2000.

56.

Duraiswamy N, Cesar JM, Schoephoerster RT, Moore JJE. Effects of stent
geometry on local flow dynamics and resulting platelet deposition in an in vitro
model. Biorheology-Oxford-. 45, 547-562, 2008.

250

Bibliography

57.

Esmon CT. Inflammation and thrombosis. J Thromb Haemost. 1, 1343-1348,
2003.

58.

Faller D V. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol
Physiol. 26, 74-84, 1999.

59.

Farb a, Sangiorgi G, Carter a J, et al. Pathology of acute and chronic coronary
stenting in humans. Circulation. 99, 44-52, 1999.

60.

Farooq V, Gogas BD, Serruys PW. Restenosis: Delineating the numerous causes
of drug-eluting stent restenosis. Circ Cardiovasc Interv. 4, 195-205, 2011.

61.

Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronarystent placement and balloon angioplasty in the treatment of coronary artery
disease. N Engl J Med. 331, 496–501, 1994.

62.

Frazin LJ, Lanza G, Vonesh M, et al. Functional chiral asymmetry in descending
thoracic aorta. Circulation. 82, 1985-1994, 1990.

63.

Frazin LJ, Vonesh MJ, Chandran KB, Shipkowitz T, Yaacoub AS, McPherson
DD. Confirmation and Initial Documentation of Thoracic and Abdominal Aortic
Helical Flow: An Ultrasound Study. ASAIO J. 42, 951-956, 1996.

64.

Friedman MH, Ehrlich LW. Effect of spatial variations in shear on diffusion at
the wall of an arterial branch. Circ Res. 37, 446-454, 1975.

65.

Fukuda S, Yasu T, Predescu DN, Schmid-Schönbein GW. Mechanisms for
regulation of fluid shear stress response in circulating leukocytes. Circ Res. 86,
e13–e18, 2000.

251

Bibliography

66.

Fung YC. Biomechanics: Circulation. Springer New York; 1996, .

67.

Gaglia M a, Torguson R, Xue Z, et al. Insurance type influences the use of drugeluting stents. JACC Cardiovasc Interv. 3, 773-779, 2010.

68.

Gara PTO, Kushner FG, Ascheim DD, et al. ACCF / AHA Guideline 2013
ACCF / AHA Guideline for the Management of ST-Elevation Myocardial
Infarction : Executive Summary A Report of the American College of Cardiology
Foundation / American Heart Association Task Force on Practice Guidelines. ,
529-555, 2016.

69.

Garasic JM, Edelman ER, Squire JC, Seifert P, Williams MS, Rogers C. Stent
and artery geometry determine intimal thickening independent of arterial injury.
Circulation. 101, 812-818, 2000.

70.

Garg S, Serruys PW. Coronary stents: current status. J Am Coll Cardiol. 56, S142, 2010.

71.

Garg S, Serruys PW. Coronary stents: looking forward. J Am Coll Cardiol. 56,
S43-78, 2010.

72.

Gasser CT, Ogden RW, Holzapfel GA. Hyperelastic modelling of arterial layers
with distributed collagen fibre orientations. J R Soc Interface. 3, 15-35, 2006.

73.

Geary RL, Clowes AW, Cannon CP. Epidemiology and Pathogenesis of
Restenosis. Vol (Duckers HJ, Nabel EG, Serruys PW, eds.). Humana Press;
2007, .

74.

Geary RL, Kohler TR, Vergel S, Kirkman TR, Clowes a W. Time course of
flow-induced smooth muscle cell proliferation and intimal thickening in
252

Bibliography

endothelialized baboon vascular grafts. Circ Res. 74, 14-23, 1994.
75.

van der Giessen WJ, Lincoff AM, Schwartz RS, et al. Marked Inflammatory
Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in
Porcine Coronary Arteries. Circ . 94, 1690-1697, 1996.

76.

Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ.
Compensatory Enlargement of Human Atherosclerotic Coronary Arteries. N Engl
J Med. 316, 1371-1375, 1987.

77.

Go AS, Mozaffarian D, Roger VL, et al. Heart Disease and Stroke Statistics 2014 Update: A Report from the American Heart Association. Vol 129. 2014, .

78.

Goldman D. Theoretical models of microvascular oxygen transport to tissue.
Microcirculation. 15, 795-811, 2008.

79.

Goldsmith H. Red cell motions and wall interactions in tube flow. Fed Proc. 30,
1578-1590, 1971.

80.

Goldsmith H., Marlow J. Flow behavior of erythrocytes. II. Particle motions in
concentrated suspensions of ghost cells. J Colloid Interface Sci. 71, 383-407,
1979.

81.

Gorbet MB, Sefton M V. Biomaterial-associated thrombosis: roles of coagulation
factors, complement, platelets and leukocytes. Biomaterials. 25, 5681-5703,
2004.

82.

Grotendorst GR, Chang T, Seppä HEJ, Kleinman HK, Martin GR. Plateletderived growth factor is a chemoattractant for vascular smooth muscle cells. J
Cell Physiol. 113, 261-266, 1982.
253

Bibliography

83.

Grüntzig A. Transluminal dilation of coronary-artery stenosis. Lancet. 311, 263,
1978.

84.

Grüntzig A, Kumpe DA. Technique of percutaneous transluminal angioplasty
with the Gruntzig ballon catheter. Am J Roentgenol. 132, 547-552, 1979.

85.

Grüntzig A, Vetter W, Meier B, Kuhlmann U, Lüolf U, Siegenthaler W.
Treatment of renovascular hypertension with percutaneous transluminal dilation
of a renal-artery stenosis. Lancet. 311, 801-802, 1978.

86.

Gyongyosi M, Yang P, Khorsand A, Glogar D, on behalf of the Austrian Wiktor
Stent Study Group, European Paragon Stent Investigators. Longitudinal
straightening effect of stents is an additional predictor for major adverse cardiac
events. J Am Coll Cardiol. 35, 1580-1589, 2000.

87.

Habib RH, Dimitrova KR, Badour SA, et al. CABG Versus PCI: Greater Benefit
in Long-Term Outcomes With Multiple Arterial Bypass Grafting. J Am Coll
Cardiol. 66, 1417-1427, 2015.

88.

Hamilton C, Steinlechner B, Gruber E, Simon P, Wollenek G. The oxygen
dissociation curve: quantifying the shift. Perfusion. 19, 141-144, 2004.

89.

Han CI, Campbell GR, Campbell JH. Circulating Bone Marrow Cells Can
Contribute to Neointimal Formation. J Vasc Res. 38, 113-119, 2001.

90.

Harnek J, Zoucas E, Carlemalm E, Cwikiel W. Differences in Endothelial Injury
After Balloon Angioplasty, Insertion of Balloon-Expanded Stents or Release of
Self-Expanding

Stents:

An

Electron

Microscopic

Cardiovasc Intervent Radiol. 22, 56-61, 1999.

254

Experimental

Study.

Bibliography

91.

Haruguchi H, Teraoka S. Intimal hyperplasia and hemodynamic factors in arterial
bypass and arteriovenous grafts: a review. J Artif Organs. 6, 227-235, 2003.

92.

Haude M, Erbel R, Issa H, Meyer J. Quantitative analysis of elastic recoil after
balloon angioplasty and after intracoronary implantation of balloon-expandable
Palmaz-Schatz stents. J Am Coll Cardiol. 21, 26-34, 1993.

93.

He Y, Duraiswamy N, Frank AO, Moore JJE. Blood Flow in Stented Arteries: A
Parametric Comparison of Strut Design Patterns in Three Dimensions. J Biomech
Eng. 127, 637-647, 2005.

94.

Helmlinger G, Geifer R V, Schreck S, Nerem RM. Effects of pulsatile flow on
cultured vascular endothelial cell morphology. J Biomech Eng. 113, 123-131,
1991.

95.

Heppner BT, Morgan LW. Plasma oxygen permeability may be a factor in
atherosclerosis. J Atheroscler Thromb. 11, 49-55, 2004.

96.

Hill A V. The possible effects of the aggregation of the molecules of
haemoglobin on its dissociation curve. J Physiol. 41,1910.

97.

Hofer M, Rappitsch G, Perktold K, Trubel W, Schima H. Numerical study of
wall mechanics and fluid dynamics in end-to-side anastomoses and correlation to
intimal hyperplasia. J Biomech. 29, 1297-1308, 1996.

98.

Holmes Jr DR, Kereiakes DJ, Garg S, et al. Stent Thrombosis. J Am Coll
Cardiol. 56, 1357-1365, 2010.

99.

Holzapfel GA, Ogden RW, Lally C, Prendergast PJ. Simulation of In-stent
Restenosis for the Design of Cardiovascular Stents. Springer Berlin Heidelberg;
255

Bibliography

2006, pp. 255-267.
100. Holzapfel GA, Sommer G, Gasser CT, Regitnig P. Determination of layerspecific

mechanical

properties

of

human

coronary

arteries

with

nonatherosclerotic intimal thickening and related constitutive modeling. Am J
Physiol Heart Circ Physiol. 289, H2048-H2058, 2005.
101. Hong M-K, Park S-W, Lee CW, et al. Long-term outcomes of minor plaque
prolapsed within stents documented with intravascular ultrasound. Catheter
Cardiovasc Interv. 51, 22-26, 2000.
102. Houston JG, Bonneau M, Kang C, Stonebridge PA, Dick J. Reducing intimal
thickening and arterial wall stresses downstream to a spiral flow inducing stent in
a carotid arterial stenosis porcine model. CIRSE 2008. 2008.
103. Houston JG, Gandy SJ, Milne W, Dick JBC, Belch JJF, Stonebridge PA. Spiral
laminar flow in the abdominal aorta: a predictor of renal impairment deterioration
in patients with renal artery stenosis? Nephrol Dial Transplant. 19, 1786-1791,
2004.
104. Houston JG, Hood RG, Stonebridge PA, Thomson A. Method of determining the
helix angle of a helical formation for a conduit. May 2010.
105. Houston JG, Stonebridge PA, Dick JBC, et al. An insert for a stent. July 2007.
106. Hsu P-P, Li S, Li Y-S, et al. Effects of Flow Patterns on Endothelial Cell
Migration into a Zone of Mechanical Denudation. Biochem Biophys Res
Commun. 285, 751-759, 2001.
107. Huijbregts HJTAM, Blankestijn PJ, Caro CG, et al. A Helical PTFE
256

Bibliography

Arteriovenous Access Graft to Swirl Flow Across the Distal Anastomosis:
Results of a Preliminary Clinical Study. Eur J Vasc Endovasc Surg. 33, 472-475,
2007.
108. Inoue T, Croce K, Morooka T, Sakuma M, Node K, Simon DI. Vascular
inflammation and repair implications for re-endothelialization, restenosis, and
stent thrombosis. JACC Cardiovasc Interv. 4, 1057-1066, 2011.
109. Inoue T, Sata M, Hikichi Y, et al. Mobilization of CD34-Positive Bone MarrowDerived Cells After Coronary Stent Implantation. Circulation. 115, 553-561,
2007.
110. Jang IK, Tearney G, Bouma B. Visualization of tissue prolapse between coronary
stent struts by optical coherence tomography: comparison with intravascular
ultrasound. Circulation. 104, 2754, 2001.
111. Jiménez J, Davies PF. Hemodynamically Driven Stent Strut Design. Ann Biomed
Eng. 37, 1483-1494, 2009.
112. Johnson K, Sharma P, Oshinski J. Coronary Artery Flow Measurement Using
Navigator Echo Gated Phase Contrast Magnetic Resonance Velocity Mapping at
3.0 Tesla. 41, 595-602, 2008.
113. Joner M, Finn A V, Farb A, et al. Pathology of drug-eluting stents in humans:
delayed healing and late thrombotic risk. J Am Coll Cardiol. 48, 193-202, 2006.
114. Joner M, Nakazawa G, Finn A V., et al. Endothelial Cell Recovery Between
Comparator Polymer-Based Drug-Eluting Stents. J Am Coll Cardiol. 52, 333342, 2008.

257

Bibliography

115. Jung H, Choi JW, Park CG. Asymmetric flows of non-Newtonian fluids in
symmetric stenosed artery. Korea Aust Rheol J. 16, 101-108, 2004.
116. Kaazempur-Mofrad MR, Ethier CR. Mass transport in an anatomically realistic
human right coronary artery. Ann Biomed Eng. 29, 121-127, 2001.
117. Kaazempur-Mofrad MR, Wada S, Myers JG, Ethier CR. Mass transport and fluid
flow in stenotic arteries: Axisymmetric and asymmetric models. Int J Heat Mass
Transf. 48, 4510-4517, 2005.
118. Kastrati A, Mehilli J, Dirschinger J, et al. Restenosis after coronary placement of
various stent types. Am J Cardiol. 87, 34-39, 2001.
119. Kilner PJ, Yang GZ, Mohiaddin RH, Firmin DN, Longmore DB. Helical and
retrograde secondary flow patterns in the aortic arch studied by three-directional
magnetic resonance velocity mapping. Circulation. 88, 2235-2247, 1993.
120. Kim MS, Dean LS. In-stent restenosis. Cardiovasc Ther. 29, 190-198, 2011.
121. Kleinstreuer C. Biofluid Dynamics: Principles and Selected Applications. Taylor
& Francis Group ; 2006, .
122. Kleinstreuer C, Hyun S, Buchanan JR, Longest PW, Archie JP, Truskey GA.
Hemodynamic parameters and early intimal thickening in branching blood
vessels. Crit Rev Biomed Eng. 29, 1-64, 2001.
123. Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and
rupture. Arterioscler Thromb Vasc Biol. 27, 15-26, 2007.
124. Kolandavel MK, Fruend E-T, Ringgaard S, Walker PG. The effects of time

258

Bibliography

varying curvature on species transport in coronary arteries. Ann Biomed Eng. 34,
1820-1832, 2006.
125. Krone RJ, Rao S V, Dai D, et al. Acceptance, panic, and partial recovery the
pattern of usage of drug-eluting stents after introduction in the U.S. (a report
from the American College of Cardiology/National Cardiovascular Data
Registry). JACC Cardiovasc Interv. 3, 902-910, 2010.
126. Krüger T. Effect of tube diameter and capillary number on platelet margination
and near-wall dynamics. Rheol Acta. 55, 511-526, 2016.
127. Ku DN. Blood flow in arteries. Annu Rev Fluid Mech. 29, 399-434, 1997.
128. Ku DN, Giddens DP, Zarins CK, Glagov S. Pulsatile flow and atherosclerosis in
the human carotid bifurcation. Positive correlation between plaque location and
low oscillating shear stress. Arteriosclerosis. 5, 293-302, 1985.
129. Kute SM, Vorp DA. The effect of proximal artery flow on the hemodynamics at
the distal anastomosis of a vascular bypass graft: computational study. J Biomech
Eng. 123, 277-283, 2001.
130. LaDisa Jr. JF, Guler I, Olson L, et al. Three-Dimensional Computational Fluid
Dynamics Modeling of Alterations in Coronary Wall Shear Stress Produced by
Stent Implantation. Ann Biomed Eng. 31, 972-980, 2003.
131. LaDisa Jr. JF, Hettrick D a, Olson LE, et al. Stent implantation alters coronary
artery hemodynamics and wall shear stress during maximal vasodilation. J Appl
Physiol. 93, 1939-1946, 2002.
132. LaDisa Jr. JF, Olson LE, Guler I, et al. Stent design properties and deployment
259

Bibliography

ratio influence indexes of wall shear stress: a three-dimensional computational
fluid dynamics investigation within a normal artery. J Appl Physiol. 97, 424-430,
2004.
133. LaDisa Jr. JF, Olson L, Hettrick D, Warltier D, Kersten J, Pagel P. Axial stent
strut angle influences wall shear stress after stent implantation: analysis using 3D
computational fluid dynamics models of stent foreshortening. Biomed Eng
Online. 4, 59, 2005.
134. Lee ES, Bauer GE, Caldwell MP, Santilli SM. Association of artery wall hypoxia
and cellular proliferation at a vascular anastomosis. J Surg Res. 91, 32-37, 2000.
135. Lee ES, Caldwell MP, Tretinyak a S, Santilli SM. Supplemental oxygen controls
cellular proliferation and anastomotic intimal hyperplasia at a vascular graft-toartery anastomosis in the rabbit. J Vasc Surg Off Publ Soc Vasc Surg [and] Int
Soc Cardiovasc Surgery, North Am Chapter. 33, 608-613, 2001.
136. Lei M, Kleinstreuer C, Truskey GA. A focal stress gradient-dependent mass
transfer mechanism for atherogenesis in branching arteries. Med Eng Phys. 18,
326-332, 1996.
137. Leung DY, Glagov S, Mathews MB. Cyclic stretching stimulates synthesis of
matrix components by arterial smooth muscle cells in vitro. Science (80- ). 191,
475-477, 1976.
138. Li Y, Neoh KG, Kang E-T. Plasma protein adsorption and thrombus formation
on surface functionalized polypyrrole with and without electrical stimulation. J
Colloid Interface Sci. 275, 488-495, 2004.

260

Bibliography

139. Lima R, Ishikawa T, Imai Y, Takeda M, Wada S, Yamaguchi T. Radial
dispersion of red blood cells in blood flowing through glass capillaries: the role
of hematocrit and geometry. J Biomech. 41, 2188-2196, 2008.
140. Liu X, Fan Y, Deng X. Effect of Spiral Flow on the Transport of Oxygen in the
Aorta: A Numerical Study. Ann Biomed Eng. 38, 917-926, 2010.
141. Liu X, Pu F, Fan Y, Deng X, Li D, Li S. A numerical study on the flow of blood
and the transport of LDL in the human aorta: the physiological significance of the
helical flow in the aortic arch. Am J Physiol Hear Circ Physiol. 297, 163-170,
2009.
142. Ma P, Li X, Ku DN. Convective mass transfer at the carotid bifurcation. J
Biomech. 30, 565-571, 1997.
143. Ma P, Li X, Ku DN. Convective mass transfer at the carotid bifurcation. J
Biomech. 30, 565-571, 1997.
144. Malek AM, Alper SL, Izumo S. Hemodynamic Shear Stress and Its Role in
Atherosclerosis. JAMA J Am Med Assoc. 282, 2035-2042, 1999.
145. Malek AM, Izumo S. Mechanism of endothelial cell shape change and
cytoskeletal remodeling in response to fluid shear stress. J Cell Sci. 109 (Pt 4),
713-726, 1996.
146. Mallinger F, Drikakis D. Laminar-to-turbulent transition in pulsatile flow through
a stenosis. Biorheology. 39, 437-441, 2002.
147. Mani G, Feldman MD, Patel D, Agrawal CM. Coronary stents: A materials
perspective. Biomaterials. 28, 1689-1710, 2007.
261

Bibliography

148. Marinelli R, Furst B, van der Zee H, McGinn A, Marinelli W. The heart is not a
pump: A refutation of the pressure propulsion premise of heart function. Front
Perspect. 5, 15–24, 1995.
149. Marinelli R, Penney DG, Marinelli W, Baciewicz Jr. FA. Rotary motion in the
heart and blood vessels: A review. J Appl Cardiol. 6, 421-431, 1991.
150. Martin DM. Sequential Structural and Fluid Dynamics Analysis of BalloonExpandable Coronary Stents: A Multivariable Statistical Analysis. 2015.
151. Martin DM, Boyle FJ. Drug-Eluting Stents for Coronary Artery Disease : a
Review. Med Eng Phys. 33, 148-163, 2011.
152. Martin DM, Boyle FJ. Finite element analysis of balloon-expandable coronary
stent deployment: Influence of angioplasty balloon configuration. Int j numer
method biomed eng. 29, 1161-1175, 2013.
153. Martin DM, Murphy EA, Boyle FJ. Computational fluid dynamics analysis of
balloon-expandable coronary stents: influence of stent and vessel deformation.
Med Eng Phys. 36, 1047-1056, 2014.
154. Martini F, Nath JL, Bartholomew EF. Fundamentals of Anatomy & Physiology.
San Francisco: Benjamin Cummings; 2012, .
155. Massai D, Soloperto G, Gallo D, Xu XY, Morbiducci U. Shear-induced platelet
activation and its relationship with blood flow topology in a numerical model of
stenosed carotid bifurcation. Eur J Mech B/Fluids. 35, 92-101, 2012.
156. Mayr M, Sidibe A, Zampetaki A. The Paradox of Hypoxic and Oxidative Stress
in Atherosclerosis**Editorials published in the Journal of the American College
262

Bibliography

of Cardiology reflect the views of the authors and do not necessarily represent the
views of JACC or the American College of Cardio. J Am Coll Cardiol. 51, 12661267, 2008.
157. Mayr M, Sidibe A, Zampetaki A. The paradox of hypoxic and oxidative stress in
atherosclerosis. J Am Coll Cardiol. 51, 1266-1267, 2008.
158. Mclaren M. Endothelium II : inflammatory response. Vasc Dis. , 1-6, 2005.
159. Mehran R, Dangas G, Abizaid AS, et al. Angiographic Patterns of In-Stent
Restenosis :

Classification

and

Implications

for

Long-Term

Outcome.

Circulation. 100, 1872-1878, 1999.
160. Moazzam F, DeLano F a, Zweifach BW, Schmid-Schönbein GW. The leukocyte
response to fluid stress. Proc Natl Acad Sci U S A. 94, 5338-5343, 1997.
161. Mohamied Y, Rowland EM, Bailey EL, Sherwin SJ, Schwartz MA, Weinberg
PD. Change of Direction in the Biomechanics of Atherosclerosis. Ann Biomed
Eng. 43, 16-25, 2014.
162. Moore JA, Ethier CR. Oxygen mass transfer calculations in large arteries. J
Biomech Eng. 119, 469-475, 1997.
163. Moore JJE, Soares J, Rajagopal K. Biodegradable Stents: Biomechanical
Modeling Challenges and Opportunities. Cardiovasc Eng Technol. 1, 52-65,
2010.
164. Morbiducci U, Ponzini R, Grigioni M, Redaelli A. Helical flow as fluid dynamic
signature for atherogenesis risk in aortocoronary bypass. A numeric study. J
Biomech. 40, 519-534, 2007.
263

Bibliography

165. Morbiducci U, Ponzini R, Nobili M, et al. Blood damage safety of prosthetic
heart valves. Shear-induced platelet activation and local flow dynamics: a fluidstructure interaction approach. J Biomech. 42, 1952-1960, 2009.
166. Morbiducci U, Ponzini R, Rizzo G, et al. Mechanistic insight into the
physiological relevance of helical blood flow in the human aorta: an in vivo
study. Biomech Model Mechanobiol. 10, 339-355, 2011.
167. Mortier P, Holzapfel GA, De Beule M, et al. A novel simulation strategy for stent
insertion and deployment in curved coronary bifurcations: Comparison of three
drug-eluting stents. Ann Biomed Eng. 38, 88-99, 2010.
168. Motomiya M, Karino T. Flow patterns in the human carotid artery bifurcation.
Stroke. 15, 50-56, 1984.
169. Motterlini R, Kerger H, Green CJ, Winslow RM, Intaglietta M. Depression of
endothelial and smooth muscle cell oxygen consumption by endotoxin. Am J
Physiol. 275, H776-H782, 1998.
170. Murphy BP, Savage P, McHugh PE, Quinn DF. The stress-strain behavior of
coronary stent struts is size dependent. Ann Biomed Eng. 31, 686-691, 2003.
171. Murphy EA, Boyle FJ. Reducing in-stent restenosis through novel stent flow
field augmentation. Cardiovasc Eng Technol. 3, 353-373, 2012.
172. Murphy JB, Boyle FJ. A full-range, multi-variable, CFD-based methodology to
identify abnormal near-wall hemodynamics in a stented coronary artery.
Biorheology. 47, 117-132, 2010.
173. Murphy JB, Boyle FJ. A Numerical Methodology to Fully Elucidate the Altered
264

Bibliography

Wall Shear Stress in a Stented Coronary Artery. Cardiovasc Eng Technol. 1, 256268, 2010.
174. Naeraa N, Petersen ES, Boye E, et al. pH and molecular CO2 components of the
Bohr effect in human blood. Scand J Clin Lab Invest. 18, 96-102, 1966.
175. Naghavi M, Libby P, Falk E, et al. From Vulnerable Plaque to Vulnerable
Patient: A Call for New Definitions and Risk Assessment Strategies: Part I . Circ
. 108, 1664-1672, 2003.
176. Nakamura M, Yock PG, Bonneau HN, et al. Impact of Peri-Stent Remodeling on
Restenosis : A Volumetric Intravascular Ultrasound Study. Circulation. 103,
2130-2132, 2001.
177. Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in
human coronary implants: Bare-metal and drug-eluting stents. J Am Coll Cardiol.
57, 1314-1322, 2011.
178. National Institute for Health and Care Excellence. Early management of unstable
angina and NSTEMI. NICE Pathways. 2015.
179. National Institute for Health and Care Excellence. Managing Stable Angina.;
2015, .
180. National Institute for Health and Care Excellence. Guidance on the Use of
Coronary Artery Stents.; 2003, .
181. National Institute for Health and Care Excellence. Drug-Eluting Stents for the
Treatment of Coronary Artery Disease.; 2008, .

265

Bibliography

182. Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with
drug-eluting coronary stents: A review of available cases from the Research on
Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol. 47,
175-181, 2006.
183. Nelson R. Spiral Flow. 2011.
184. Newman VS, Berry JL, Routh WD, Ferrario CM, Dean RH. Effects of vascular
stent surface area and hemodynamics on intimal thickening. J Vasc Interv Radiol.
7, 387-393, 1996.
185. Niccoli G, Sgueglia GA, Crea F. The emerging role of allergic inflammation in
adverse reactions after coronary stent implantation. Atherosclerosis. 217, 70-71,
2011.
186. Padfield GJ, Newby DE, Mills NL. Understanding the role of endothelial
progenitor cells in percutaneous coronary intervention. J Am Coll Cardiol. 55,
1553-1565, 2010.
187. Papadaki M, McIntire L V, Eskin SG. Effects of shear stress on the growth
kinetics of human aortic smooth muscle cells in vitro. Biotechnol Bioeng. 50,
555-561, 1996.
188. Papafaklis MI, Bourantas C V, Theodorakis PE, Katsouras CS, Fotiadis DI,
Michalis LK. Relationship of shear stress with in-stent restenosis: bare metal
stenting and the effect of brachytherapy. Int J Cardiol. 134, 25-32, 2009.
189. Papaharilaou Y, Doorly DJ, Sherwin SJ. The influence of out-of-plane geometry
on pulsatile flow within a distal end-to-side anastomosis. J Biomech. 35, 1225-

266

Bibliography

1239, 2002.
190. Park SJ, Kang SJ, Virmani R, Nakano M, Ueda Y. In-stent neoatherosclerosis: A
final common pathway of late stent failure. J Am Coll Cardiol. 59, 2051-2057,
2012.
191. Paul MC, Larman A. Investigation of spiral blood flow in a model of arterial
stenosis. Med Eng Phys. 31, 1195-1203, 2009.
192. Paul RJ. Smooth muscle energetics and theories of cross-bridge regulation. Am J
Physiol - Cell Physiol. 258, C369-C375, 1990.
193. Perktold K, Leuprecht A, Prosi M, et al. Fluid Dynamics, Wall Mechanics, and
Oxygen Transfer in Peripheral Bypass Anastomoses. Ann Biomed Eng. 30, 447460, 2002.
194. Perktold K, Rappitsch G. Computer simulation of local blood flow and vessel
mechanics in a compliant carotid artery bifurcation model. J Biomech. 28, 845856, 1995.
195. Phelps JE, DePaola N. Spatial variations in endothelial barrier function in
disturbed flows in vitro. Am J Physiol - Hear Circ Physiol. 278, H469-H476,
2000.
196. Phillips RJ, Armstrong RC, Brown RA, Graham AL, Abbott JR. A constitutive
equation for concentrated suspensions that accounts for shear-induced particle
migration. Phys Fluids A. 41992.
197. Pittman RN. Oxygen Transport in the Microcirculation and Its Regulation. Vol
20. 2013, .
267

Bibliography

198. Pittman RN. Regulation of tissue oxygenation. Colloq Ser Integr Syst Physiol
From Mol to Funct. 3, 1-100, 2011.
199. Ponde CK, Aroney CN, McEniery PT, Bett JHN. Plaque prolapse between the
struts of the intracoronary Palmaz-Schatz stent: Report of two cases with a novel
treatment of this unusual problem. Cathet Cardiovasc Diagn. 40, 353-357, 1997.
200. Popel AS. Theory of oxygen transport to tissue. Crit Rev Biomed Eng. 17, 257321, 1989.
201. Pritchard WF, Davies PF, Derafshi Z, et al. Effects of wall shear stress and fluid
recirculation on the localization of circulating monocytes in a three-dimensional
flow model. J Biomech. 28, 1459-1469, 1995.
202. Qiu Y, Tarbell JM. Numerical simulation of pulsatile flow in a compliant curved
tube model of a coronary artery. J Biomech Eng. 122, 77-85, 2000.
203. Qiu Y, Tarbell JM. Numerical Simulation of Oxygen Mass Transfer in a
Compliant Curved Tube Model of a Coronary Artery. Ann Biomed Eng. 28, 2638, 2000.
204. Rappitsch G, Perktold K, Pernkopf E. Numerical Modelling of Shear-Dependent
Mass Transfer in Large Arteries. 857, 847-857, 1997.
205. Resnick N, Yahav H, Shay-Salit A, et al. Fluid shear stress and the vascular
endothelium: for better and for worse. Prog Biophys Mol Biol. 81, 177-199,
2003.
206. Richardson RB. Age-dependent changes in oxygen tension, radiation dose and
sensitivity within normal and diseased coronary arteries-Part B: modeling oxygen
268

Bibliography

diffusion into vessel walls. Int J Radiat Biol. 84, 849-857, 2008.
207. Rogers C, Edelman ER. Endovascular Stent Design Dictates Experimental
Restenosis and Thrombosis. Circ . 91, 2995-3001, 1995.
208. Rogers C, Parikh S, Seifert P, Edelman ER. Endogenous Cell Seeding: Remnant
Endothelium After Stenting Enhances Vascular Repair. Circulation. 94, 29092914, 1996.
209. Rogers C, Tseng DY, Squire JC, Edelman ER. Balloon-Artery Interactions
During Stent Placement : A Finite Element Analysis Approach to Pressure,
Compliance, and Stent Design as Contributors to Vascular Injury. Circ Res. 84,
378-383, 1999.
210. Ross R, Glomset JA. The Pathogenesis of Atherosclerosis. N Engl J Med. 295,
369-377, 1976.
211. Rouleau L, Copland IB, Tardif J-C, Mongrain R, Leask RL. Neutrophil adhesion
on endothelial cells in a novel asymmetric stenosis model: effect of wall shear
stress gradients. Ann Biomed Eng. 38, 2791-2804, 2010.
212. Rouleau L, Farcas M, Tardif J-C, Mongrain R, Leask RL. Endothelial cell
morphologic response to asymmetric stenosis hemodynamics: effects of spatial
wall shear stress gradients. J Biomech Eng. 132, 81013, 2010.
213. Rouleau L, Rossi J, Leask RL. The response of human aortic endothelial cells in
a stenotic hemodynamic environment: effect of duration, magnitude, and spatial
gradients in wall shear stress. J Biomech Eng. 132, 71015, 2010.
214. Rubanyi G. The role of endothelium in cardiovascular homeostasis and diseases.
269

Bibliography

J Cardiovasc Pharmacol. 1993.
215. Rydberg EK, Salomonsson L, Hultén LM, et al. Hypoxia increases 25hydroxycholesterol-induced

interleukin-8

protein

secretion

in

human

macrophages. Atherosclerosis. 170, 245-252, 2003.
216. Sanada J-I, Matsui O, Yoshikawa J, Matsuoka T. An experimental study of
endovascular stenting with special reference to the effects on the aortic vasa
vasorum. Cardiovasc Intervent Radiol. 21, 45-49, 1998.
217. Santilli SM, Stevens RB, Anderson JG, Payne WD, Caldwell MD. Transarterial
wall oxygen gradients at the dog carotid bifurcation. Am J Physiol - Hear Circ
Physiol. 268, H155-H161, 1995.
218. Santilli SM, Tretinyak a S, Lee ES. Transarterial wall oxygen gradients at the
deployment site of an intra-arterial stent in the rabbit. Am J Physiol Heart Circ
Physiol. 279, H1518-25, 2000.
219. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent
fractures after femoropopliteal stenting. J Am Coll Cardiol. 45, 312-315, 2005.
220. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation
of nitinol stents in the superficial femoral artery. N Engl J Med. 354, 1879-1888,
2006.
221. Schoephoerster RT, Oynes F, Nunez G, Kapadvanjwala M, Dewanjee MK.
Effects of local geometry and fluid dynamics on regional platelet deposition on
artificial surfaces. Arterioscler Thromb Vasc Biol. 13, 1806–1813, 1993.
222. Segadal L, Matre K. Blood velocity distribution in the human ascending aorta.
270

Bibliography

Circulation. 76, 90-100, 1987.
223. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloonexpandable-stent implantation with balloon angioplasty in patients with coronary
artery disease. N Engl J Med. 331, 489–495, 1994.
224. Shi H-J, Cao A-H, Teng G-J. Seeding Endothelial Progenitor Cells on a Selfexpanding Metal Stent: An in Vitro Study. J Vasc Interv Radiol. 21, 1061-1065,
2010.
225. Shi Z-D, Abraham G, Tarbell JM. Shear stress modulation of smooth muscle cell
marker genes in 2-D and 3-D depends on mechanotransduction by heparan
sulfate proteoglycans and ERK1/2. PLoS One. 5, e12196, 2010.
226. Shibata M, Ichioka S, Kamiya A. Estimating oxygen consumption rates of
arteriolar walls under physiological conditions in rat skeletal muscle. Am J
Physiol Heart Circ Physiol. 289, H295-H300, 2005.
227. Shigematsu K, Yasuhara H, Shigematsu H, Muto T. Direct and indirect effects of
pulsatile shear stress on the smooth muscle cell. Int Angiol a J Int Union Angiol.
19, 39-46, 2000.
228. Shinke T, Robinson K, Burke MG, et al. Abstract 6059: Novel Helical Stent
Design Elicits Swirling Blood Flow Pattern And Inhibits Neointima Formation In
Porcine Carotid Arteries. Circulation. 118, S_1054-, 2008.
229. Shoeb M, Fang MC. Assessing Bleeding Risk in Patients Taking Anticoagulants.
J Thromb Thrombolysis. 35, 312-319, 2013.
230. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular Stents
271

Bibliography

to Prevent Occlusion and Re-Stenosis after Transluminal Angioplasty. N Engl J
Med. 316, 701-706, 1987.
231. Simanonok JP. Non-ischemic hypoxia of the arterial wall is a primary cause of
atherosclerosis. Med Hypotheses. 46, 155-161, 1996.
232. Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM. Smooth Muscle
Progenitor Cells in Human Blood. Circulation. 106, 1199-1204, 2002.
233. Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C. Coronary Artery Bypass
Grafting vs Percutaneous Coronary Intervention and Long-term Mortality and
Morbidity in Multivessel Disease: Meta-analysis of Randomized Clinical Trials
of the Arterial Grafting and Stenting Era. JAMA Intern Med. 174, 223-230, 2013.
234. Sprague EA, Luo J, Palmaz JC. Human Aortic Endothelial Cell Migration onto
Stent Surfaces under Static and Flow Conditions. J Vasc Interv Radiol. 8, 83-92,
1997.
235. Sprague EA, Palmaz JC. A Model System to Assess Key Vascular Responses to
Biomaterials. J Endovasc Ther. 12, 594-604, 2005.
236. Spranger K, Capelli C, Bosi GM, Schievano S, Ventikos Y. Comparison and
Calibration of a Real- time Virtual Stenting Algorithm Using Finite Element
Analysis and Genetic Algorithms. Comput Methods Appl Mech Eng. 293, 462480, 2015.
237. Stangeby DK, Ethier CR. Computational analysis of coupled blood-wall arterial
LDL transport. J Biomech Eng. 124, 1-8, 2002.
238. Stary HC, Chandler AB, Dinsmore RE, et al. A Definition of Advanced Types of
272

Bibliography

Atherosclerotic Lesions and a Histological Classification of Atherosclerosis: A
Report From the Committee on Vascular Lesions of the Council on
Arteriosclerosis, American Heart Association . Circ . 92, 1355-1374, 1995.
239. Sterpetti A V, Cucina A, Fragale A, Lepidi S, Cavallaro A, Santoro-D’Angelo L.
Shear stress influences the release of platelet derived growth factor and basic
fibroblast growth factor by arterial smooth muscle cells. Eur J Vasc Surg. 8, 138142, 1994.
240. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and
paclitaxel-eluting coronary stents. N Engl J Med. 356, 998-1008, 2007.
241. Stonebridge PA, Brophy C. Spiral laminar flow in arteries? Lancet. 338, 1360–
1361, 1991.
242. Stonebridge PA, Buckley C, Thompson A, et al. Non spiral and spiral (helical)
flow patterns in stenoses. In vitro observations using spin and gradient echo
magnetic resonance imaging (MRI) and computational fluid dynamics modeling.
Int Angiol. 23, 276-283, 2004.
243. Stonebridge PA, Buckley C, Thompson A, et al. Non spiral and spiral (helical)
flow patterns in stenoses. In vitro observations using spin and gradient echo
magnetic resonance imaging (MRI) and computable fluid dynamics modeling. Int
Angiol. 23, 276-283, 2004.
244. Stonebridge PA, Ch M. Three-Dimensional Blood Flow Dynamics : Spiral /
Helical Laminar Flow. Methodist Debakey Cardiovasc J. 7, 21-26, 2011.
245. Stonebridge PA, Hoskins PR, Allan P, Belch J, others. Spiral laminar flow in

273

Bibliography

vivo. Clin Sci. 91, 17–22, 1996.
246. Sumagin R, Lamkin-Kennard KA, Sarelius IH. A separate role for ICAM-1 and
fluid shear in regulating leukocyte interactions with straight regions of venular
wall and venular convergences. Microcirculation. 16, 508–520, 2009.
247. Suo J. Investigation of Blood Flow Patterns and Hemodynamics in the Human
Ascending Aorta and Major Trucks of the Right and Left Coronary Arteries
using Magnetic resonance Imaging and Computational Fluid Dynamics. Biomed
Eng (NY). Ph.D.2005.
248. Tada S. Numerical study of oxygen transport in a carotid bifurcation. Phys Med
Biol. 55, 3993-4010, 2010.
249. Tada S, Tarbell JM. A computational study of flow in a compliant carotid
bifurcation–stress phase angle correlation with shear stress. Ann Biomed Eng. 33,
1202-1212, 2005.
250. Tada S, Tarbell JM. Oxygen mass transport in a compliant carotid bifurcation
model. Ann Biomed Eng. 34, 1389-1399, 2006.
251. Tammareddi S, Sun G, Li Q. Multiobjective robust optimization of coronary
stents. Jmade. 90, 682-692, 2016.
252. Tarbell JM. Mass transport in arteries and the localization of atherosclerosis.
Annu Rev Biomed Eng. 5, 79-118, 2003.
253. Tarbell JM, Qiu Y. Arterial wall mass transport: the possible role of blood phase
resistance in the localization of arterial disease. Vol (Bronzino EJD, ed.). Boca
Raton: CRC Press LLC; 2000, .
274

Bibliography

254. Tarbell JM, Shi Z-D, Dunn J, Jo H. Fluid Mechanics, Arterial Disease, and Gene
Expression. Annu Rev Fluid Mech. 46, 591-614, 2014.
255. Tardy Y, Resnick N, Nagel T, Gimbrone Jr MA, Dewey Jr CF. Shear Stress
Gradients Remodel Endothelial Monolayers in Vitro via a Cell ProliferationMigration-Loss Cycle. Arter Thromb Vasc Biol. 17, 3102-3106, 1997.
256. Texon M. Hemodynamic Basis of Atherosclerosis with Critique of the
Cholesterol-Heart Disease Hypothesis. Cardiovasc Eng An Int J. 1, 57-58, 2001.
257. Torrent-Guasp F, Ballester M, Buckberg GD, et al. Spatial orientation of the
ventricular muscle band: physiologic contribution and surgical implications. J
Thorac Cardiovasc Surg. 122, 389-392, 2001.
258. Tsai AG, Cabrales P, Intaglietta M. The physics of oxygen delivery: facts and
controversies. Antioxidants Redox Signal. 12, 683-691, 2010.
259. Tsai AG, Johnson PC, Intaglietta M. Oxygen gradients in the microcirculation.
Physiol Rev. 83, 933-963, 2003.
260. Ueba H, Kawakami M, Yaginuma T. Shear Stress as an Inhibitor of Vascular
Smooth Muscle Cell Proliferation : Role of Transforming Growth Factor-Beta1
and Tissue-Type Plasminogen Activator. Arterioscler Thromb Vasc Biol. 17,
1512-1516, 1997.
261. Vadapalli A, Pittman RN, Popel AS. Estimating oxygen transport resistance of
the microvascular wall. Am J Physiol Heart Circ Physiol. 279, H657-71, 2000.
262. Vavuranakis M, Sigala F, Vrachatis D a, et al. Quantitative analysis of carotid
plaque vasa vasorum by CEUS and correlation with histology after
275

Bibliography

endarterectomy. Vasa. 42, 184-195, 2013.
263. Vermassen F, Stonebridge PA. Spiral laminar flow arterial grafts: improved early
clinical results and theoretical basis. 36th Annu Symp Vasc Endovasc Issues.
2008.
264. Veryan. Veryan Medical Ltd - Anatomy of the BioMimics 3D vascular
biomimetic stent. 2014.
265. Virmani R, Guagliumi G, Farb A, et al. Localized Hypersensitivity and Late
Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be
Cautious? Circulation. 109, 701-705, 2004.
266. Wang H, Yan S, Chai H, et al. Shear stress induces endothelial
transdifferentiation from mouse smooth muscle cells. Biochem Biophys Res
Commun. 346, 860-865, 2006.
267. Whitcher FD. Simulation of in vivo loading conditions of nitinol vascular stent
structures. Comput Struct. 64, 1005-1011, 1997.
268. White FM. Fluid Mechanics S1.2.; 2010, .
269. Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Weatherall M, Beasley R.
Routine use of oxygen in the treatment of myocardial infarction: systematic
review. Heart. 95, 198-202, 2009.
270. Windecker S, Mayer I, De Pasquale G, et al. Stent Coating With TitaniumNitride-Oxide for Reduction of Neointimal Hyperplasia. Circulation. 104, 928933, 2001.

276

Bibliography

271. Zabielski L, Mestel a J. Helical flow around arterial bends for varying body
mass. J Biomech Eng. 122, 135-142, 2000.
272. Zeller T, Gaines PA, Ansel GM, Caro CG. Helical Centerline Stent Improves
Patency: Two-Year Results From the Randomized Mimics Trial . Circ
Cardiovasc Interv . 92016.
273. Zhan F, Fan Y, Deng X. Swirling flow created in a glass tube suppressed platelet
adhesion to the surface of the tube: Its implication in the design of small-caliber
arterial grafts. Thromb Res. 125, 413-418, 2010.
274. Zheng T, Fan Y, Xiong Y, Jiang W, Deng X. Hemodynamic performance study
on small diameter helical grafts. ASAIO J. 55, 192-199, 2008.
275. Zierenberg JR, Fujioka H, Hirschl RB, Bartlett RH, Grotberg JB. Pulsatile blood
flow and oxygen transport past a circular cylinder. J Biomech Eng. 129, 202-215,
2007.

277

APPENDIX A

APPENDIX

A

A. Validation of ANSYS Software
A.1 Introduction
To validate the accuracy of the WSS values predicted by the ANSYS CFX 15.0
software used in this study Validation Test Case 1 was devised. Validation Test Case 1
compares the normalised velocity profile and WSS values predicted using the ANSYS
CFX 15.0 to those calculated from the Blasius solution for laminar flow over a flat
plate. In addition to this, Validation Test Case 2 was designed to validate the transport
equation used in ANSYS CFX 15.0 to model the oxygen transport in the blood. This
validation test case compares the Sh predicted using ANSYS CFX 15.0 to the Lévêque
analytical solution of the Graetz-Nusselt problem. First, the boundary layer theory is
discussed below followed by the derivation of the boundary layer equations.

A.1.1 Boundary Layer Theory
Consider the 2D incompressible viscous flow over a flat plate, as shown in Figure A.1,
where the inlet velocity of the fluid is U∞. This inlet velocity is constant, with no
vertical gradient, in the entry region before the fluid meets the leading edge of the flat
plate. When the fluid meets the front edge and flows along the flat plate, the fluid
particles directly adjacent to its surface are slowed to a stop, because of frictional forces,
which numerically is modelled as a “no-slip” boundary condition. The fluid particles
neighbouring these particles are then in turn slowed by the viscous force between them
and the stationary fluid particles. Each layer of neighbouring fluid particles, with
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increasing distance normal to the surface, travels at a slightly higher velocity in
comparison with the preceding layer. This results in the characteristic velocity profile,
as shown in Figure A.1, with the velocity increasing until it reaches the free-stream
velocity, U∞. The thickness of the boundary layer, δ, is defined as the vertical distance
extending from the flat plate surface, where the fluid is stationary, to the point where u
is 99% of U∞. As the flow moves along a flat plate the boundary layer grows with more
fluid particles retarded by their neighbouring slower particles. Eventually the boundary
layer transitions from laminar to turbulent. To help predict where this transition may
occur the Reynolds Number, Re, is used which is defined as the ratio of inertial forces
to viscous forces. For a flat plate the local Re at any position, x, along the plate is
calculated as follows:

Rex 

Ux


(A.1)

where ρ is the density of the fluid, x is the distance from the leading edge of the plate
and μ is the dynamic viscosity of the fluid. The flow within the boundary layer exhibits
different characteristics at different Re with approximate ranges and characteristics
given in Table A.1.
As listed by White (2010), there are three techniques for analysing flows over a flat
plate: CFD, experimentation and boundary layer theory. The third technique, boundary
layer theory, was first formulated by Ludwig Prandtl in 1904 and the resulting boundary
layer equations were solved, only for laminar flow, by his student Heinrich Blasius in
1908. The derivation of the boundary layer equations is presented below.
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Re Range

Description of Flow Characteristics

0 < Re < 1

Highly viscous laminar “creeping motion

1 < Re < 100

Laminar, strong Re dependence

100 < Re < 103

Laminar, boundary-layer theory useful

103 < Re < 104

Transition to turbulence

104 < Re < 106

Turbulent, moderate Re dependence

106 < Re < ∞

Turbulent, slight Re dependence

Table A.1: Re ranges and the flow characteristics exhibited within the boundary
layer. Adapted from White (2010).268

y

U∞

U∞

U

Inviscid Flow

δ
Viscous Flow
Flat Plate

u
x

Figure A.1: Typical boundary layer development along a flat plate within a 2D
flow example.

Within the boundary layer viscous forces exert an influence over the velocity profile
while outside of the boundary layer the flow is considered inviscid where viscous forces
are small relative to inertial forces.
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A.1.2 Derivation of the Boundary Layer Equations
To analyse the 2D incompressible viscous flow over a flat plate, as described above, the
continuity equation and the momentum equations are needed:

u v
 0
x y

(A.2)

  2u  2u 
 u
u 
P
 u
v 
  2  2 
y 
x
y 
 x
 x

(A.3)

 2v 2v 
 v
v 
P
 u
v 
  2  2 
y 
x
y 
 x
 x

(A.4)

These should be solved for u, v and P with the imposed typical boundary conditions:
no-slip at the plate surface, an inlet velocity, and an outlet zero pressure boundary. To
solve these equations is actually too difficult in their present form, so some
approximations need to be made. First, Prandtl deduced that if the characteristic
Reynolds Number, ReL, is very large then the shear layer must be very thin resulting in
the following approximations:

v

u

(A.5)

u
x

u
y

(A.6)

v
x

v
y

(A.7)

When applied to the y-momentum equation, Equation (A.4), this results in the
simplification:

P
0
y
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which essentially means the pressure only varies with respect to x, and the y-momentum
equation can be neglected entirely. In the x-momentum equation, Equation (3.57), the
pressure gradient term can be calculated using Bernoulli’s equation as applied to the
outer inviscid flow, i.e.

P dP
dU
  U
x dx
dx

(A.9)

Additionally, one of the second derivatives within Equation (3.57) can be neglected due
to the previous approximations, i.e.

2u
x 2

2u
y 2

(A.10)

All of these assumptions and simplifications results in the three equations of motion
being reduced down to Prandtl’s two boundary layer equations:

u

u v
 0
x y

(A.11)

u
u
dU 1 
v U

x
y
dx  y

(A.12)

where τ is the shear stress and is given by:

u
for laminar flow
y

(A.13)

u
 u ' v ' for turbulent flow
y

(A.14)





where these are solved for u and v, which are both functions of x and y within the
boundary layer, with the following boundary conditions imposed:

u  v  0 (no-slip condition)

At y=0 (flat plate surface)
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u  U(x)

At y=δ (outer edge of boundary layer)

(A.16)

The boundary layer equations for laminar flow are mathematically parabolic and are
solved numerically by beginning at the leading edge and marched downstream.268
Blasius conceived the analytical solution to the equations in 1908 by showing that the
dimensionless velocity profile, u/U, is a function of a single composite dimensionless
variable, η:
u
 f '()
U

(A.17)

1/2

U
  y 
 x 

(A.18)

where the prime denotes differentiation with respect to η, and



is the kinematic

viscosity. Once Equations (A.17) and (A.18) are substituted into the boundary layer
equations the problem can be reduced to a single third-order non-linear ordinary
differential equation for f :

f''' 

1
ff''  0
2

(A.19)

where the boundary conditions become:
At y = 0:

f (0)  f' (0)  0

(A.20)

As y   :

f' ()  1.0

(A.21)

Equation (A.19) is known as the Blasius equation and can be solved for the velocity
profile within the boundary layer.
Based on this solution of the velocity profile within the boundary layer the WSS along
the flat plate can also be subsequently predicted. WSS,
as:
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w  

u
y y 0

(A.22)

To put this in terms of η, from Equation (A.17):

u  U f' ()

(A.23)

u
 U f'' ()


(A.24)

From Equation (A.18):
  U  


y  x 

1

2

(A.25)

Therefore, using the chain rule:
1

 u  
U  2 

w         U f'' () 
 

x  

  y  y0

 0

(A.26)

From Table A.2: f'' () =0.332 at η=0, and thus, the WSS, w (x) , can be calculated
using:

0.3321/21/2 U1.5
w (x) 
x1/2
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η

f ()

f' ()

f'' ()

0.00000

0.00000

0.00000

0.33203

0.20000

0.00664

0.06640

0.33196

0.40000

0.02656

0.13275

0.33144

0.60000

0.05973

0.19892

0.33005

0.80000

0.10610

0.26469

0.32736

1.00000

0.16556

0.32975

0.32298

1.50000

0.37011

0.48675

0.30256

2.00000

0.64997

0.62972

0.26674

2.50000

0.99624

0.75121

0.21740

3.00000

1.39671

0.84599

0.16136

3.50000

1.83757

0.91298

0.10777

4.00000

2.30559

0.95546

0.06424

4.50000

2.78995

0.97946

0.03398

5.00000

3.28306

0.99149

0.01591

∞

∞

1

0

Table A.2: Blasius solution in terms of η.

A.2 Validation Test Case 1
In order to validate the ANSYS CFX 15.0 software a validation test case was
constructed. The velocity profiles and WSS values along a flat plate predicted by
ANSYS CFX 15.0 were compared with the Blasius solution. First, a 3D geometry of a
fluid domain with a flat plate along one face was constructed, with dimensions as shown
in Figure A.2. The flat plate was 1.0m long with a no-slip boundary condition imposed
on the surface. The domain was given a height of 1.6m with an opening boundary
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condition placed on the upper surface to allow for unrestricted development of the
boundary layer. An entry region was added upstream of the flat plate 0.1m long which
ensures the inlet boundary condition does not interfere with the solution along the flat
plate. A velocity of 0.5m/s (U∞) was placed at the inlet and water was used as the
domain fluid with a density of 998kg/m3 and a kinematic viscosity of 8.899×10-4 Pa.s.
The geometry was discretised using a hexahedral mesh with 85626 nodes as shown in
Figure A.3. Inflation mesh refinement was designated at the front edge of, and along,
the flat plate to ensure accurate capture of the boundary layer. The convergence
criterion for the solution was a maximum residual of 1×10-6 with a high resolution
advection scheme used.
To compare the results predicted by ANSYS CFX 15.0 and the Blasius solution three
variables were analysed: u*, v*, and WSS, where the relevant calculations are shown in
Table A.3:

ANSYS CFX 15.0

u* 

v* 

WSS=

Blasius Solution

u
U
v
1

  2

 U
 U x 

ni  ij

f' ()

(11.1)

1
 f'    f  
2

(11.2)

0.3321/21/2 U1.5
x1/2

(11.3)

Table A.3: The relevant calculations for u*, v*, and WSS within ANSYS CFX 15.0
and according to the Blasius solution.

The results were imported into TecPlot 360 2012 for post-processing. Both u* and v*
were sampled at three locations at distances 0.25m, 0.50m and 0.75m from the leading
edge of the flat plate, and these were compared with the values calculated using the
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Blasius solution. Additionally, the WSS predicted by ANSYS CFX 15.0 along the flat
plate was compared with the WSS calculated using the Blasius solution. The boundary
layer velocity profiles, Figure A.4 and Figure A.5, and the WSS, Figure A.6, predicted
by ANSYS CFX 15.0 show good agreement with the Blasius solution. This validates
the WSS predicted by ANSYS CFX 15.0 and shows that the program is behaving as
expected in this regard.

Opening

Inlet

Outlet

U=0.5m/s
1.6m

Flat Plate
0.1m
Entry Region

1.0m

Figure A.2: Details of the computational domain geometry created for Validation
Test Case 1.
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Figure A.3: Mesh created for Validation Test Case 1.
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Figure A.4: Boundary layer velocity profiles, u* vs η, predicted by ANSYS CFX
15.0 at three locations with distances from the leading edge of the flat plate of
0.25m, 0.50m and 0.75m. The Blasius solution is shown for comparison.
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Figure A.5: Boundary layer vertical velocity profiles, v* vs η, predicted by ANSYS
CFX 15.0 at three locations with distances from the leading edge of the flat plate of
0.25m, 0.50m and 0.75m. The Blasius solution is shown for comparison.
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Figure A.6: WSS values predicted along the flat plate by ANSYS CFX 15.0 plotted
against the distance from the leading edge of the flat plate, x. The WSS predicted
by the Blasius solution is shown for comparison.
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A.3 Validation Test Case 2
As a validation of the transport equations used in ANSYS CFX 15.0, results from a
simulation of the developing PO2 boundary layer in a straight tube using Model 5 were
compared with the Lévêque analytical solution of the Graetz-Nusselt problem for the
development of a thermal boundary layer in a straight tube. This problem is analogous
to the developing mass transport boundary layer in fully developed laminar flow in a
straight tube. This is a standard validation test case, as used in previous studies, where
the local Sh predicted along the tube wall, with a constant PO2 boundary condition, is
compared with the Sh as calculated using the Lévêque analytical solution.117,248 For the
simulation a five degree circumferential wedge of the tube was modelled, as shown in
Figure A.7(a). The mesh was generated in ANSYS Meshing with refinement at the start
of the tube wall and prism layers inflated off the tube wall to accurately capture the
MTBL. The following boundary conditions were applied: a fully-developed HagenPoiseuille velocity profile, with mean velocity Vmean=0.116m/s, applied at the inlet with
PO2,in=100mmHg, a zero pressure entrainment at the outlet, and a no-slip boundary
condition set on the tube wall with PO2,w=0. The diameter of the tube, Dia=2.7mm, is
equivalent to the average diameter of the unstented LAD geometries modelled for Test
Cases 2 and 3.
The Lévêque solution was calculated based on a Reynolds number Re=75, typical of the
left coronary artery, and Sc=3538 as calculated using:

Sc=

μ
ρDb

(A.31)

where the dynamic viscosity μ=0.0044Pa.s (volume-averaged for the domain). The Sh
for the Lévêque analytical solution was calculated for a constant wall boundary
condition using:
292

Validation of ANSYS Software

x

x*= Dia
ReSc
Sh Lévêque =1.08  x*

(A.32)
-1

3

(A.33)

where x* is a dimensionless axial distance which accounts for differing rates of
concentration boundary layer growth due to convection and diffusion253 and x is the
axial distance from the inlet.

Figure A.7: (a) The mesh employed for Validation Test Case 2, (b) the PO 2
boundary layer in a tube using Model 5 in an axial cross-section.

A comparison of the predicted and calculated Sh is shown in Figure A.8. The Lévêque
analytical solution and the predicted results using Model 5 compare very well, which
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confirms that Model 5 is producing the expected results and that the mesh density is
sufficient for capturing the flow and oxygen transport accurately.

Figure A.8: Comparison of the predicted Sh using Model 5 with the Lévêque
analytical solution of the Graetz-Nusselt problem. The axial distance is normalised
with respect to the diameter of the tube with zero corresponding to the start of the
tube wall.

A.4 Summary
Both validation cases presented in this appendix serve to demonstrate that the
commercial software, ANSYS CFX 15.0, is accurately predicting the fluid dynamics
and the mass transport. Both validation cases show good agreement with analytical
solutions, Blasius and Lévêque.
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B. Mesh Convergence
B.1 Introduction
In this appendix the mesh convergence studies undertaken for all four test cases,
Chapters 6-8, are described. Mesh convergence studies comprise of refining a mesh
until the results are considered mesh independent, i.e. when the results do not change by
a user-specified tolerance with further refinement of the mesh. Accurate capture of the
MTBL for this work was one crucial aspect of the mesh convergence. Model 1 was used
for all the mesh convergence studies as it includes all non-linearities, and also because
the MTBL observed, as demonstrated in Chapters 6 and 7, has an extremely steep
gradient, which make the results susceptible to adverse effects from poor meshing.
Following the mesh convergence studies the details of the meshes employed for each
test case are listed along with figures to visually demonstrate the mesh densities used.
B.2 Mesh Convergence 1 – Prism Layers to Capture MTBL
Critical to accurate modelling of the oxygen transport is the refinement of the mesh
within the MTBL, which is thinner than the velocity boundary layer. The geometry used
was a 5° wedge with three domains: lumen, intima, and media, as shown in Figure
B.1(a). The meshes used for the Validation Test Case 2 (Lévêque solution) and Test
Case 1 (carotid bifurcation) are both hexa-dominant meshes and also, for this mesh
convergence study. Three meshes were created and the only parameter that was varied
was the height of the first layer inflated off the luminal wall surface: Mesh 1 – 6.7µm,
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Mesh 2 – 3.8µm, and Mesh 3 – 1.2µm. An inflation rate of 1.2 was used in all three
meshes. Mesh 3 is shown in Figure B.1(b) to demonstrate the structure of the mesh used
with refinement at the wall and the beginning of the arterial wall segment.
The boundary conditions used were a parabolic velocity profile with a maximum
velocity of 0.2313m/s and PO2,in=100mmHg set at the inlet, entrainment with a 0Pa
relative pressure and PO2,out=0mmHg set at the outlet, symmetry conditions set on the
wedge sides, free slip and zero PO2 flux set at entry wall, PO2=45mmHg set at media
outer wall, and free PO2 flux set across all domain interfaces.

B.2.1 Results
Figure B.1(c) shows a contour plot of the PO2 across a longitudinal slice within all three
domains. A line plot of the PO2 along the arterial wall luminal surface for each mesh
from the start of the wall surface to the end of the domain is shown in Figure B.2. As
can be seen from this figure the difference between Mesh 2 and Mesh 3 is minimal and
within a tolerance of 5%, with a maximum difference of 0.7%. From this mesh
convergence study the height of the first inflation layer for all meshes was set at 3µm.
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Figure B.1: (a) Diagram of set-up for Mesh Convergence Study 1, (b) Mesh 3
outline, and (c) contour plot of PO2 along slice within all three domains showing
how the MTBL develops.
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Figure B.2: Line plot of PO2 along the arterial wall luminal surface from the start
of the arterial wall to the end of the domain.

B.3 Mesh Convergence 2 – Carotid Artery
This mesh convergence study was undertaken with the same carotid artery geometry,
created using Rhinoceros 3D, with the measurements as discussed in Chapter 6. For
Test Case 1 the transarterial wall PO2 profiles at three locations, as shown in Figure B.3,
were the results of interest. Thus, these results were monitored for two different mesh
densities which are referred to as Carotid Mesh 1 and Carotid Mesh 2. The mesh
statistics for both meshes are displayed in Table B.1, and Figure B.4 and Figure B.5 are
presented to give an indication of the mesh densities adopted for both meshes.
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Figure B.3: Carotid bifurcation model with locations of transarterial wall PO2
profiles of interest highlighted.

Number of Nodes

Carotid Mesh 1

Carotid Mesh 2

Lumen

501546

2604504

Intima

295075

429200

Media

176500

635284

Total

973121

3668988

Table B.1: Node counts for the three domains (lumen, intima, and media) within
the two carotid meshes adopted for the mesh convergence.
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Figure B.4: (a) The luminal surface mesh and (b-d) cross-sectional views of the
volume mesh at the three locations for Carotid Mesh 1.
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Figure B.5: (a) The luminal surface mesh and (b-d) cross-sectional views of the
volume mesh at the three locations for Carotid Mesh 2.

B.3.1 Results
The transarterial wall PO2 profiles at each location for both meshes are presented in
Figure B.6, and it is clear from this figure that there is no significant difference between
the results at these three locations with the maximum deviation seen at Location 3 with
a percentage difference between the luminal surface PO2 value of 2.1% (1.4mmHg
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difference). Thus, Carotid Mesh 1 was adopted for all simulations undertaken for Test
Case 1.

Figure B.6: Transarterial wall PO2 profiles at all three locations for Carotid Mesh
1 and Carotid Mesh 2.
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B.4 Mesh Convergence 3 – Stented Coronary Artery
This mesh convergence study was undertaken to elucidate the mesh parameters to be
adopted for Test Cases 2, 3 and 4 in which stented coronary artery geometries were
used.

B.4.1 Geometry
A smaller stent geometry was used for the mesh convergence study, as shown in Figure
B.7, which is shorter than the stents used in all the test cases and differs in several ways
to the stent geometries used in Test Cases 2 and 3 in Chapter 7. First, the geometry was
not generated using FEA and therefore, there is no deformation of the stent or arterial
wall surface. Additionally, there is no over-expansion of the stent which would cause
the stented region to have a larger diameter than the unstented artery. This was done so
that the effect of the overexpansion would not impact the results; therefore, keeping the
geometry as simple as possible with the focus on the refinement of the MTBL on the
stented arterial wall luminal surface, and accurate capture of the diffusion within the
arterial wall. The stent design used resembles the Multilink Vision coronary stent
(Abbott Laboratories, North Chicago, IL, USA) with a 3.0mm internal diameter.

B.4.2 Geometry Discretisation
The meshing methodology adopted is the same as mentioned in Chapter 7; a volume
mesh was created using the Delaunay Method, which ensures smooth transition from
small to larger cells, from a surface mesh which was created using the Octree Method.
Prism layers (eight) were created along luminal and stent surfaces to accurately capture
the MTBL. Prism layers were also used within the arterial wall to ensure accurate
capture of the transarterial wall PO2 profiles.
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Figure B.7: Idealised stent geometry used for mesh convergence study (a segment
of the stent geometry used for Test Case 4). Note: additional entry and exit regions
(each 32mm long) are not shown.

B.4.3 Test 1 - Luminal Surface
With the size of the initial prism layer adjacent to the luminal surface fixed from the
first mesh convergence study described in Section B.2, the next sizing parameter to
refine for the stented coronary artery geometries was the luminal surface and stent strut
element size within the stented region. Thus, to ensure mesh convergence of the oxygen
transport results three separate meshes were generated where only the luminal surface
and stent strut element size within the stented region was varied, with the smallest cell
size implemented in Mesh 3. This resulted in three separate meshes, numbered one to
three, with node counts of 34232, 75518, and 91637 on the luminal surface within the
stented region. The three meshes are shown in Figure B.8.
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Figure B.8: Meshes 1, 2, and 3 with stented region luminal surface node counts of
34232, 75518, and 91637 respectively.
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B.4.3.1 Test 1 – Results
First, to confirm that the WSS values on the luminal surface of the stented region are
converged Table B.2 presents the area-averaged (AA), maximum and minimum WSS,
and WSSG values predicted on the luminal surface for each mesh, along with Figure
B.9 and Figure B.10 which show the WSS and WSSG distribution on the luminal
surface. Given that an accepted user-specified tolerance for the percentage change in
values between meshes is 5.0%, it is clear from both the table and figures that the WSS
and WSSG are converged on the luminal surface for all the meshes. This is expected
because the mesh refinement required for the haemodynamic variables would not be as
high as for the oxygen transport. The WSSG shows a slight variability in the maximum
value, but this has no significant effect on the AA WSSG value.
Table B.3 details the AA, maximum and minimum PO2 and Sh values predicted on the
luminal surface for each mesh, while Figure B.11 and Figure B.12 show the PO2 and Sh
distributions on the luminal surface. The PO2 values can be considered converged in
Mesh 2 as further refinement results in no significant difference in the AA, maximum or
minimum PO2 values predicted on the luminal surface. This is supported by the PO2
distribution plots presented in Figure B.11.
For the Sh there is a large variation in the maximum and minimum values. This is
because the Sh is calculated using the normal gradient in PO2 off the luminal surface, as
shown in Equation (3.54) in Chapter 3. Any slight variation in the PO2 gradient normal
to the wall produces a noticeable effect on the Sh value. What is clear from the 1%
difference in the AA Sh on the luminal surface between Meshes 2 and 3 is that the
minimum and maximum values are extreme outliers which do not affect the overall
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distribution significantly. This is also demonstrated clearly by analysing the predicted
Sh distribution in Figure B.12, which shows little difference in the predicted contour
levels on the luminal surface for Meshes 2 and 3.
To demonstrate that the prism layers implemented in the mesh generation accurately
capture the MTBL Figure B.13 shows the PO2 distribution around a stent strut and
across the intima for Mesh 2. The mesh is also displayed. As shown, eight layers were
inflated off the luminal and stent surfaces with at least three or four prism layers falling
within the MTBL. Three layers is the minimum required to accurately capture the high
PO2 gradient, as seen in Test Cases 1 and 2.
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WSS [Pa]

1

Diff. (1-2)

2

Diff. (2-3)

3

Max

1.22

1%

1.21

0%

1.21

AA

0.67

0%

0.67

1%

0.66

Min

0.00

0%

0.00

0%

0.00

WSSG [Pa/mm]

1

Diff. (1-2)

2

Diff. (2-3)

3

Max

12.00

47%

6.33

-84%

11.66

AA

1.38

1%

1.37

-3%

1.41

Min

0.00

0%

0.00

0%

0.00

Table B.2: The predicted maximum, area-averaged, and minimum WSS and
WSSG values calculated on the luminal surface of the stented region for Meshes 1,
2, and 3.

Sh [-]

1

Diff. (1-2)

2

Diff. (2-3)

3

Max

465.37

-47%

248.38

50%

372.07

AA

129.34

-14%

111.77

-1%

110.84

Min

18.14

-11%

16.11

-66%

5.45

PO2 [mmHg]

1

Diff. (1-2)

2

Diff. (2-3)

3

Max

71.34

-15%

60.54

0%

60.55

AA

32.30

-19%

26.02

0%

26.02

Min

12.30

-35%

7.95

0%

7.95

Table B.3: The predicted maximum, area-averaged, and minimum Sh and PO2
values calculated on the luminal surface of the stented region for Meshes 1, 2, and
3.
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Figure B.9: Predicted WSS distribution for Meshes 1, 2, and 3.
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Figure B.10: Predicted WSSG distribution for Meshes 1, 2, and 3.
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Figure B.11: Predicted PO2 distribution for Meshes 1, 2, and 3.
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Figure B.12: Predicted Sh distribution for Meshes 1, 2, and 3.
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Figure B.13: Typical prism layers mesh used on the luminal surface to capture the
MTBL, which is seen as the region lower than 90mmHg at the luminal surface.
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B.4.4 Test 2 – Arterial Wall
The percentages of the arterial wall exposed to low PO2 (<30mmHg) and hypoxic PO2
(<10mmHg) are needed for Test Cases 2, 3, and 4, therefore, in addition to the previous
test, two additional tests were undertaken to ensure that the mesh refinement was
appropriate.
First, the effect of refinement of the luminal surface mesh outside of the stented region
on the results within the stented region was assessed. Figure B.14 shows the two meshes
used to assess if increasing the mesh density on the luminal surface upstream and
downstream of the stented region, i.e. the region of interest, produced any significant
effect on the predicted oxygen transport. This refinement had the effect of increasing the
node count within the lumen for Mesh 2 and Mesh 2a were 2308558 and 2761248,
respectively.
Second, the effect of further refinement of the intima layer was assessed. Crosssectional views of the meshes employed in the second test are shown in Figure B.15
with Mesh 2b having the increased intima mesh density provided by prism layers on the
inner and outer surface of the intima. The node count within the intima for Mesh 2 and
Mesh 2b were 634154 and 1510538, respectively.
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Figure B.14: Mesh density on the luminal surface for Meshes 2 and 2a.
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Figure B.15: Cross-sections of Mesh 2 and Mesh 2b showing the mesh density
within the arterial wall and around a stent strut within the lumen.

B.4.4.1 Test 2 – Results
The results of the additional tests conducted to ensure mesh convergence are presented
in Table B.4 which shows the predicted percentage volume of the intima exposed to
PO2 values over a range of 0-30mmHg for Meshes 2, 2a, and 2b. The media was not
included in this as the PO2 levels within the intima are more strongly influenced by the
luminal surface PO2 values (as discussed in Chapters 7 – 9). The additional refinement
of the intima or the refinement of the luminal surface mesh outside of the stented region
does not produce any significant change in the predicted PO2 levels within the intima.
316

Mesh Convergence

Mesh 2

Diff.

Mesh 2a

Diff.

Mesh 2b

[%]

(2-2a)

[%]

(2-2b)

[%]

0-5

6.8

0.1

6.7

1.3

5.5

5-10

46.1

-0.2

46.4

0.6

45.6

10-15

22.3

-0.4

22.7

-0.4

22.7

15-20

11.7

0.1

11.6

-0.4

12.1

20-25

6.6

0.1

6.5

-0.3

6.9

25-30

3.3

0.1

3.2

-0.3

3.6

Total <30

96.77

-0.2

96.96

0.4

96.38

Total <10

52.91

-0.2

53.07

1.8

51.08

PO2 [mmHg]

Table B.4: Percentage volumes of intima exposed to PO2 range 0-30mmHg and the
totals <30mmHg and <10mmHg for Meshes 2, 2a, and 2b, along with the difference
between them.

317

Mesh Convergence

B.5 Meshes Employed in Test Cases 2 and 3
The node counts for the three stent geometries used in Test Cases 2 and 3 are shown in
Table B.5. Additionally, Figure B.16 to Figure B.21 show the mesh density on the
luminal surface and within the three volume domains for each stented coronary artery
geometry analysed in Test Cases 2 and 3.

Mesh

Stent A

Stent B

Stent C

Lumen

5148910

5030463

5084752

Intima

1703823

1699687

1696288

Media

1687966

1661928

1645520

Total

8540699

8392078

8426560

Table B.5: Node counts for the three stent geometries used for Test Cases 2 and 3.
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Figure B.16: (a) Geometry of Stent A with the two areas highlighted to shown
where (b) and (c) are located. (b) Mesh density around stent struts, (c) Mesh
density transitioning from stented region to unstented region.
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Figure B.17: (a) Longitudinal cross-section and (b) transverse cross-section
showing the mesh density at the luminal surface and across the arterial wall for
Stent A.
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Figure B.18: (a) Geometry of Stent B with the two areas highlighted to shown
where (b) and (c) are located. (b) Mesh density around stent struts, (c) Mesh
density transitioning from stented region to unstented region.
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Figure B.19: (a) Longitudinal cross-section and (b) transverse cross-section
showing the mesh density at the luminal surface and across the arterial wall for
Stent B.
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Figure B.20: (a) Geometry of Stent C with the two areas highlighted to shown
where (b) and (c) are located. (b) Mesh density around stent struts, (c) Mesh
density transitioning from stented region to unstented region.
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Figure B.21: (a) Longitudinal cross-section and (b) transverse cross-section
showing the mesh density at the luminal surface and across the arterial wall for
Stent C.
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B.6 Meshes Employed in Test Case 4
The node counts for the six stents used in Test Case 4 are shown in Table B.6
Additionally, Figure B.22 and Figure B.23 show the mesh density on the luminal
surface and within the three volume domains for just one of the helical stent geometries
analysed in Test Case 4.

Mesh

HS 01

HS 02

HS 03

HS 04

HS 05

HS 06

Lumen

8132554

8292765

8442955

8545144

8686147

8766917

Intima

2512188

2573811

2627794

2672542

2731482

2768639

Media

2264040

3083466

2443055

2504670

2543354

2566802

Total

12908782

13950042

13513804

13722356

13960983

14102358

Table B.6: Node counts for the six helical stent meshes used in Test Case 4.
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Figure B.22: (a) Geometry of Helical Stent 6 with the two areas highlighted to
shown where (b) and (c) are located. (b) Mesh density around stent struts, (c) Mesh
density transitioning from stented region to unstented region.
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Figure B.23: (a) Longitudinal cross-section and (b) transverse cross-section
showing the mesh density at the luminal surface and across the arterial wall for
Helical Stent 6.
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B.7 Conclusions
Following the mesh convergence studies presented in this appendix the mesh
parameters were set for each simulation analysed in the four test cases. Accurate capture
of the MTBL was ensured with at least three prism layers within MTBL, as described in
Section B.2. In comparison with previous studies of haemodynamic variables a more
refined luminal surface mesh was required to accurately capture the oxygen transport.
As a side note, this, along with the low diffusivity used, makes the analysis of oxygen
transport much more computationally expensive.
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